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“[…] Every night and every morn 
Some to misery are born, 
Every morn and every night 
Some are born to sweet delight. 
 
Some are born to sweet delight, 
Some are born to endless night.” 
 
William Blake, Auguries of Innocence 
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1.1 Molecular Recognition of Oxoanions Based on Guanidinium Receptors 
 
1.1.1 Introduction 
 
 Nature frequently uses the guanidinium group to coordinate anions. Present in 
the side chain of the amino acid arginine, the guanidinium group forms strong ion-
pairs with oxoanions such as carboxylates or phosphates of enzymes and antibodies, 
and also contributes to the stabilization of protein tertiary structures via internal salt 
bridges, mainly carboxylates.1 Not surprisingly, guanidinium-based compounds are 
found in many drugs and have been extensively used in molecular recognition studies, 
leading to the design and synthesis of various receptors for anions.2
 The capacity of the guanidinium group to bind oxoanions is due to its 
geometrical Y-shaped, planar orientation, which directs the hydrogen bonding, and to 
its high pKa value (around 12-13),3 which ensures protonation over a wide pH range. 
The positive charge is delocalized over the three nitrogen atoms, and four out of the 
five hydrogen bond donors present in the guanidinium group of arginine can 
complement bidentate oxoanion acceptors, along the two edges available (Fig 1). This 
accounts for the geometrical versatility of the binding modes. From the energy point 
of view, binding to oxoanions results from both ion-pairing and hydrogen bonding, 
and this turns out to be a difficult challenge in highly polar solvents or in water. In 
fact, the binding energy arises from the difference of the energy released by the host-
guest interactions and the energy penalty necessary to remove the solvation shell 
around the host, which is quite high in water. 
 
 
 
1 Schug, K. A.; Lindner. W. Chem. Rev. 2005, 105, 67-113. 
2 Best, M. D.; Tobey, S. L.; Anslyn, E. V. Coord. Chem. Rev. 2003, 240, 3-15. 
3 The pKa value of the guanidinium moiety may vary depending on adjacent group effects; in 
general it is lowered by acyl ≥ phenyl ≥ alkyl direct substitution (see ref. 1). 
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Fig 1. The guanidinium group of arginine and its two possible binding modes 
 with carboxylates. 
 
 In proteins, the guanidinium-oxoanion interaction usually occurs inside 
hydrophobic pockets or in areas of low dielectric constant. On the contrary, in 
artificial synthetic systems designed to work in water or polar solvents, complexation 
has to take place in an environment more exposed to solvation effects which compete 
with the donor and acceptor sites, causing a substantial decrease in binding. This is 
usually overcome by increasing the number of charges or hydrogen bond donors or by 
designing more sophisticated receptors where the access to the solvent is restricted. In 
this introductory review, several examples on how this has been achieved in artificial 
guanidinium receptors will be provided. 
 
1.1.2. Guanidinium-based Artificial Receptors for Oxoanions 
 
 Lehn and co-workers first reported in the late 1970’s guanidinium-containing 
macrocycles for the recognition of phosphate PO43- in water.4 The weak association 
constants (Ka = 50 (I), 158 (II) and 251 (III) M-1, (Fig 2), pH-metric titrations) as 
compared with the corresponding analogues could be explained in terms of the more 
delocalized charge of guanidinium over ammonium and accounts for the electrostatic 
prevailing interaction. 
                                                 
4 Dietrich, B.; Fyles, T. M.; Lehn, J.-M.; Pease, L. G.; Fyles, D. L. J. Chem. Soc. Chem. 
Commun. 1978, 934-936. 
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Fig 2. Guanidinium macrocycles for phosphate recognition. 
 
 The guanidinium can be incorporated into a bicyclic framework (Fig 3a) in 
order to improve its solubility in apolar solvents, where the hydrogen bonds are 
stronger, and to avoid the anti conformation, not suitable for hydrogen-bonding to 
oxoanions (Fig 3b). As a result, the hydration of the cation is reduced and the 
conformational freedom restricted. Inserted into a decaline framework, the 
guanidinium cation becomes therefore an almost ideal complement for oxoanions, 
since both NH protons are docking sites for the two syn lone pairs of the oxoanion. 
The resulting ionic DD-AA (donor-donor-acceptor-acceptor) hydrogen-bonded 
complex is particularly stable and geometrically well defined. Due to the large pKa 
difference between guanidinium and carboxylic acids (ca. 9 pKa units in water) a 
trans-protonation from the NH to the carboxylate oxygen that would destroy the salt 
bridge and give a less robust AD-DA hydrogen bond interaction (Fig 3c) 5 is unlikely, 
although it could occur in non-polar solvents, where the differences in pKa are 
substantially reduced. Finally, chirality (C2 symmetric or pseudo-symmetric 
structures) can be introduced into the molecule by means of two stereogenic centers 
located at the vicinal atoms, allowing chiral recognition of the oxoanion guest. Such a 
chiral bicyclic guanidinium binding subunit has been efficiently prepared in our group 
in multigram quantities in nine steps from chiral amino acids (asparagine and 
                                                 
5 The secondary interactions between the H-donor and the neighbouring acceptor atoms are 
attractive in a DD-AA scaffold, but repulsive in a DA-AD one: W. L. Jorgensen, W. L.; 
Pranata, J. J. Am. Chem. Soc. 1990, 112, 2008-2010. 
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methionine), in an optimized sequence following the synthesis reported by 
Schmidtchen.6
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Fig 3. a) Chiral bicyclic guanidinium receptor. b) Anti and syn conformations of 
guanidinium group. 
 
 The association constant between bicyclic guanidinium derivatives and 
carboxylates are quite high in chloroform or apolar solvents. Thus, UV titrations 
between IV (tetraphenylborate salt) and tetrabutylammonium (TBA) p-nitrobenzoate 
gave Ka = 7 × 106 M-1.7 The crystal structure of an acetate salt confirmed the formation 
of two strong symmetric hydrogen bonds between the host and the guest (N…O 2.850 
Å). This first binding study confirmed the linear arrangement of the guanidinium-
carboxylate hydrogen-bonded ion pair, like in most arginine-aspartate or arginine-
glutamate contacts in proteins. 
 We developed receptor V (with chloride as the counterion) for aromatic 
carboxylates, but the stability constant with TBA p-nitrobenzoate was much lower 
than in the previous example with tetraphenylborate as counterion (Ka = 1.6 × 103 M-1, 
1H NMR titrations in CDCl3).8 This example illustrates the competition with the initial 
counterion and the importance of the counterion in binding strength: the 
tetraphenylborate counterion results in a significantly stronger binding than chloride. 
Thus, poorly coordinating counterions such as hexafluorophosphate or 
tetraphenylborate are necessary if strong binding constants are desired. 
                                                 
6 a) Echavarren, A. M.; Galán, A.; de Mendoza, J.; Salmerón A.; Lehn, J.-M. Helv. Chim. Acta 
1988, 71, 685-692. b) Kurzmeier, H.; Schmidtchen, F. P.; J. Org. Chem. 1990, 55, 3749-3755. 
7 Müller, G.; Riede, J.; Schmidtchen, F. P. Angew. Chem. Int. Ed. Engl. 1988, 27, 1516-1518. 
8 Echavarren, A.; Galán, A.; Lehn, J.-M.; de Mendoza, J. J. Am. Chem. Soc. 1989, 111, 4994-
4995. 
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Fig 4. Bicyclic guanidinium receptors for carboxylate recognition (IV, V and VII) and 
phosphodiester recognition (VI). 
 
 The strong deshielding of the NH signals in the 1H NMR spectrum of V•p-
nitrobenzoate indicates the presence of hydrogen bonds. Moreover, stacking 
interactions between the naphthoyl side arms and the p-nitrophenyl moiety are 
evidenced by the shifting of the aromatic signals. Despite their ionic character, hosts 
IV and V are insoluble in water but easily dissolved in chlorinated solvents. 
Consequently, single liquid-liquid extractions of water solutions of carboxylate salts 
give quantitatively the ion pair in the organic solvent, free from any competing ion, 
which remains in the water phase. 
 Hamilton and co-workers reported that the bis-acylguanidinium salt VI was a 
receptor for phosphodiesters. The binding constant with TBA diphenylphosphate (Ka = 
4.6 × 104 M-1, measured by UV in CH3CN), was one order of magnitude higher than 
with a simpler benzoylguanidinium tetraphenylborate.9 The adjacent carbonyl groups 
contribute to the binding in two ways: they increase the acidity of the guanidinium 
NHs (but not to such an extent that trans-protonation can occur) and they pre-organize 
the host by intramolecular hydrogen bonds (chelation effect). The combination of 
these two factors allows strong complexation in more polar solvents, such as 
acetonitrile. 
                                                 
9 Dixon, R. P.; Geib, S. J.; Hamilton, A. D. J. Am. Chem. Soc. 1992, 114, 365-366. 
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 Schmidtchen studied guanidinium-carboxylate interactions by isothermal 
titration calorimetry (ITC).10 The isotherm binding curve from the titration between 
VII (bromide) and tetraethylammonium acetate in acetonitrile (Ka = 2.0 × 105 M-1) 
revealed that the process was both entropically and enthalpically favorable for a 1:1 
complex. Although thermodynamic parameters could be determined in both CH3CN 
and DMSO, the reaction in MeOH produced too little heat to allow quantification of 
the association constant. This result shows that the stabilization of the guanidinium-
carboxylate is not only due to the strong electrostatic interactions (∆Hº) but also to a 
favorable release of solvent molecules (∆Sº), which strongly emphasizes the 
importance of solvation in host-guest interactions, a factor often neglected in receptor 
design. 
∆ ∆ ∆
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Fig 5. Urea- (VIII), thiourea- (IX) and guanidinium-based (X-XI) receptors and 
association data for dicarboxylates XII and XIII by isothermal titration calorimetry. 
 
10 Berger, M.; Schmidtchen, F. P. J. Am. Chem. Soc. 1999, 121, 9986-9993. 
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 The thermodynamic aspects of dicarboxylate recognition by artificial receptors 
with increasingly acidic hydrogen bond donor groups such as two ureas (VIII), 
thioureas (IX), or guanidiniums (X and XI) in polar solvents (from DMSO to water) 
were studied by Hamilton (Fig 5).11
 As expected, association constants with carboxylates (XII and XIII) increase 
with hydrogen acidity but are decreased in more polar solvents. While guanidinium-
carboxylate association in DMSO is enthalpically driven, in more polar solvents such 
as methanol or water the association becomes an entropically driven process due to the 
liberation of solvent molecules upon binding. 
 Anslyn and co-workers developed receptor XIV, with three guanidinium 
moieties attached to a 1,3,5-triethyl-2,4,6-trimethylbenzene pre-organized tripodal 
platform,12 showing selective binding towards citrate XV in pure water (Ka = 6.9 × 103 
M-1, 1H NMR titrations). The host was able to complex citrate even from a crude 
extract of orange juice, which highlights its selectivity towards other carboxylates. 
This receptor shows how the solvent competition can be overcome by accumulation of 
hydrogen bond donors (three guanidinium subunits) in a suitable fashion. 
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Fig 6. Guanidinium receptor (XIV) for selective citrate (XI) selection. 
 
 The same principles inspired Schmuck’s 2-(guanidiniocarbonyl)-1H-pyrroles 
(Fig 7), designed to complex carboxylate groups in highly competitive media, even in 
water.13 Whereas the simple guanidinium cation XVI (pKa = 13) does not show any 
sign of complexation with carboxylates in aqueous DMSO, the increased acidity of the 
                                                 
11 Linton, B. R.; Goodman, M. S.; Fan, E.; van Arman, S. A.; Hamilton, A. D. J. Org. Chem. 
2001, 66, 7313-7319. 
12 Metzger, A.; Lynch, V. M.; Anslyn, E. V. Angew. Chem. Int. Ed. Engl. 1997, 36, 862-864. 
13 Schmuck, C. Chem. Eur. J. 2000, 6, 709-718..
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acylguanidinium XVII (pKa = 7-8), rises the binding affinity (Ka = 50 M-1). An 
additional hydrogen bond from the pyrrole NH (as in XVIII) increases the association 
significantly (Ka = 130 M-1) and the additional amide group (XIX) adds a further 
hydrogen donor, reasonably well oriented to reach the anti oxygen lone pair (Ka = 770 
M-1). The predicted geometries have been confirmed by X-ray crystal structures. Even 
dipeptides are bound efficiently in water by a receptor such as XX (Ka = 54300 M-1 for 
Val-Val).14 A similar scaffold has been used in a combinatorial approach showing the 
importance of additional interactions caused by the side arm to improve selectivity. 
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Fig 7. Guanidinium cations XVI-XX and their carboxylate complexes. 
 
1.1.3. Chiral Guanidines for the Enantioselective Recognition of Carboxylates 
 
 Chiral discrimination of anions based on abiotic receptors is still an 
underdeveloped area of supramolecular chemistry. Enantiomerically pure compounds 
are usually obtained by asymmetric synthesis, crystallization of diastereomeric salts, 
kinetic resolution of racemic mixtures or chiral chromatography. An interesting 
alternative to these methods is the separation of enantiomers based on the 
complementarity of a receptor. Those processes based on the translocation of a guest 
between immiscible phases (chromatography, extraction, membrane transport) are 
particularly attractive. If the receptor is chiral, one of the enantiomers can be 
                                                 
14 Schmuck; C.; Geiger, L. J. Am. Chem. Soc. 2004, 126, 8898-8899. 
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complexed preferentially and a kinetic resolution could be achieved. Moreover, the 
process needs only a catalytic amount of receptor since it can transfer several substrate 
molecules across the phases, without being removed from its own (stationary or 
liquid) phase. 
 In this context, a useful concept, developed for chiral chromatography, is the 
three-point binding rule, which states that a minimum of three simultaneous 
interactions between the chiral stationary phase and for instance one of the 
enantiomers are necessary to achieve enantioselection, with at least one of these 
interactions being stereochemically dependent.15 For anions, receptors containing 
ammonium groups, amides, ureas, thioureas and guanidinium subunits, as well as 
porphyrins, saphyrins, or metal-containing ligands have been employed. Only chiral 
guanidines aimed at the discrimination of the enantiomers of amino acids will be 
reviewed here. 
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H H OX
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O
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XXI X = O-2-naphthoyl
XXII X = OSitBuPh2
XXIII X = OSiiPr3
XXIV X = OH
 
 
Fig 8. Guanidinium receptors for enantiorecognition of Trp and Phe. 
 
 The first example of chiral recognition of a carboxylate by a guanidinium-based 
receptor was reported by de Mendoza in 1989. Indeed, compound V was shown to 
extract enantiomeric salts of N-protected amino acids, such as tryptophan, with modest 
selectivities (up to 17% excess of N-Ac-L-Trp or N-Boc-L-Trp were extracted by 
(S,S)-V from water into chloroform). 1H NMR titrations of the triethylammonium salts 
of N-acetyltryptophan in CDCl3 gave Ka = 1000 and 500 M-1 for the L- and D-
enantiomers, respectively. For the non protected, strongly solvated zwitterionic amino 
                                                 
15 Pirkle; W. H.; Pochapsky, T. C. Chem. Rev. 1989, 89, 347-362. 
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acids, receptor (S,S)-XXI was designed (Fig 8).16 The compound features non self-
complementary binding sites for carboxylate (the guanidinium function) and 
ammonium (namely a crown ether), preventing the receptor from internal collapse. An 
aromatic planar surface (a naphthalene ring) was attached as a third point for 
additional stacking interactions (Fig. 5a). Up to 40% of racemic tryptophan or 
phenylalanine were extracted by (S,S)-XXI from saturated aqueous neutral solutions 
into dichloromethane, with a ca. 80% content of the L-enantiomer. Reciprocally, 
chiral host (R, R)-XXI extracted mainly D-Trp. 
 
a) b) c)
 
Fig 9. a) Three-point binding mode for receptor (S,S)-XXI and L-Trp.16b b) Two-point 
binding mode for L-Trp.  c) Two-point binding mode for D-Trp.  
 
 Further guanidinium receptors were synthesized later by the same research 
group in order to optimize the binding and extraction properties, and were tested as 
membrane carriers (U-tube tests with dichloromethane between two water phases).17 
Interestingly, both single liquid-liquid extractions and U-tube transport experiments 
revealed that XXII and XXIII transported Trp with comparable degrees of selectivity 
as XXI. This suggests that the aromatic naphthoyl group does not play a significant 
role in the discrimination process. Even compound XXIV, lacking the potential π-π 
                                                 
16 a) Galán, A.; Andreu, D.; Echavarren, A. M.; Prados, P.; de Mendoza, J. J. Am. Chem. Soc. 
1992, 114, 1511-1512. b) de Mendoza, J.; Gago, F. Computational Approaches in 
Supramolecular Chemistry, NATO ASI Ser., Series C, 1994, 426, 79-99. 
17 Breccia, P.; Van Gool, M.; Pérez-Fernández, R.; Martín-Santamaría, S.; Gago, F.; Prados, P.; 
de Mendoza, J. J. Am. Chem. Soc. 2003, 125, 8270-8284. 
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interaction, was enantioselective, although to a lesser extent. Another binding mode 
was then proposed, without participation of the naphthoyl arm, as the outcome of 
molecular dynamics calculations with explicit solvent molecules. In this model, 
binding of D-Trp exposes a highly polar area of the receptor (around the crown ether 
nitrogen) to the apolar solvent, causing the overall energy to increase (Fig 9b,c).17 
 A series of receptors for N-protected amino acids, bearing guanidinium and 
carbamate moieties anchored to the curved and lipophilic surface of cholic acid 
(compounds XXV-XXVII, Fig 10) have been reported by Davies and co-workers.18 
The chirality is provided by the steroidal framework, the guanidinium as well as the 
carbamate groups establishing the ion pair and hydrogen bonds with the substrate. All 
these hosts efficiently extract (52-87%) N-acyl α-amino acids from an aqueous 
phosphate buffer solution (pH 7.4) into chloroform. Compound XXV showed high 
enantioselectivity (up to 7:1, 1H NMR measurements) for several N-acyl α-amino 
acids although this selectivity decreased dramatically for the more hindered N-Boc 
derivatives. On the contrary, chiral discrimination increased (9:1) with derivatives 
XXVI and XXVII, carrying the more acidic carbamoyl groups. 
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Fig 10. Guanidinium receptors for N-acyl α-amino acids recognition. 
 
                                                 
18 Lawless, L. J.; Blackburn, A. G.; Ayling, A. J.; Pérez-Payán, M. N.; Davis, A. P. J. Chem. 
Soc., Perkin Trans. 1 2001, 11, 1329-1341. 
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 The highly lipophilic receptor XXVIII was then synthesized in gram amounts 
for transport studies with N-acetylphenylalanine either in U-tube bulk liquid 
membranes (dichloromethane) or with hollow-fiber membrane contactors (2.5% 
octanol in hexane).19 High enantioselectivity and transport rates were observed in the 
U-tubes (27% of N-Ac-Phe transported in 24 h with 56% e.e.), as well as with the 
large scale hollow fiber system (ca. 70 equivalents of substrate transported after 48 
hours) although in this case the initial selectivity (ca. 30%) decreased over time. 
 Guanidiniocarbonyl pyrrole systems have also been tested for enantioselection. 
Schmuck reported host XXIX which was able to bind strongly carboxylates in water 
(Fig 11).  Despite its flexible structure and the fact that it bears only one chiral centre, 
this receptor showed enantioselectivity towards N-acetylalanine (Ka = 1610 and 910 
M-1 for N-Ac-L-Ala and N-Ac-D-Ala, respectively), a remarkable result considering 
the small size of alanine’s side chain. Curiously, other amino acids with bulkier side 
chains (such as N-acetylphenylalanine or N-acetyltryptophan) showed only slight 
differences in binding for both enantiomers. 
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H
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Fig 11. Guanidiniocarbonyl pyrrole receptors for enantioselection. 
 
More recently, tris-cationic receptors based on the guanidiniocarbonyl pyrrole 
                                                
 
scaffold were developed by combinatorial chemistry. One compound (XXX, R1 = R2 = 
Lys; R3 = Phe) showed efficient binding to the sequence D-Glu-L-Lys-D-Ala-D-Ala-
OH (XXXI) with Ka > 104 M-1 in buffered water.20 This peptide sequence is related to 
 
19 Baragana, B.; Blackburn, A. G.; Breccia, P.; Davis, A. P.; de Mendoza, J.; Padrón-Carrillo, 
J. M.; Prados, P.; Riedner, J.; de Vries, J. G. Chem. Eur. J. 2002, 8, 2931-2936. 
20 a) Schmuck; C.; Wich, P. Angew. Chem. Int. Ed. 2006, 45, 4277-4281. b) Schmuck, C.; Heil, 
M. Chem. Eur. J. 2006, 12, 1339-1348. 
 12 
1.1 Molecular Recognition of Oxoanions Based on Guanidinium Receptors 
_____________________________________________________________________ 
 13
 
1.1.4. Phosphate and Sulfate Recognition
In addition to carboxylates or phosphodiesters, other oxoanions such as 
.1.4.1. Phosphates 
Anslyn and co-workers showed that metallo-receptor XXXII displayed a 
the bacterial peptidoglycan that is recognized by the vancomycin family of antibiotics, 
preventing formation of the cell wall. 
 
 
 
phosphate, sulfate and nitrate are biologically relevant21 and chemically challenging to 
recognize, due to their weak basicity. At neutral pH, phosphate (as HPO42-) and sulfate 
present a tetrahedral binding mode with two negative charges, although nitrate has a 
trigonal planar binding motif with just one negative charge. Thus, for a neutral 
complex, two guanidines are required for phosphate and sulfate whereas only one is 
needed for nitrate, in addition to other hydrogen bond donor atoms. The design of 
suitable linkers between the hydrogen donors with optimal orientation and maximum 
participation of host’s lone pairs represents a major issue in the field. 
 
1
 
 
selective binding for monoprotonated phosphate (HPO42-) and arsenate (HAsO42-) over 
other anions (such as AcO-, NO3-, HCO3- or Cl-) at biological pH (Ka = 104 M-1 in 98:2 
water/methanol, UV/vis and ITC titrations).22 Hosts bearing only the Cu(II) centre 
were less effective (Ka = 102 M-1), highlighting the role of the cavity and the presence 
of the guanidinium groups. Thermodynamic data showed that association of HPO42- 
with guanidinium derivative XXXII was both enthalpically and entropically driven, 
whereas complexation with an ammonium analogue was mainly governed by entropy. 
The different mode of binding was rationalized in terms of the different solvation 
energies of both binding groups. 
 
                                                 
21 a) Jacobson, B. L.; Quiocho, F. A. J. Mol. Biol. 1988, 204, 783-787. b) Luecke, H.; Quiocho, 
F. A. Nature 1990, 347, 402-406. 
22 Tobey; S. L.; Anslyn, E. V. J. Am. Chem. Soc. 2003, 125, 14807-14815. 
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Fig 12. Guanidinium receptors for phosphate recognition. 
 Ferrocenyl-based receptor XXXIII ves moderately strong complexes with 
te (XXXVI, Fig 13) was 
                                                
 
 gi
pyrophosphate P2O74- (Ka = 4600 M-2, 50% methanol-water) showing a 2:1 host-guest 
stoichiometry.23 The presence of a redox active subunit (the ferrocene) allows its use 
as an electrochemical sensor for this biologically relevant anion. Another receptor 
binding pyrophosphate in a 2:1 fashion (Ka = 1.2 × 108 M-2 and 1.0 × 104 M-1 for 2:1 
and 1:1 complexes, respectively) is guanidinium XXXIV, containing a fluorescent 
pyrene antenna, which appeared to be highly selective for P2O74- over a variety of 
anions.24 Moreover, 1H NMR suggests that the two hosts in the 2:1 complex are self-
assembled through pyrene-pyrene stacking interactions. 
 Polyanionic messenger inositol-1,4,5-triphospha
recognized by receptor XXXV bearing up to six guanidinium subunits on top of a pre-
organized 2,4,6-triethylbenzene platform.25 Steric gearing causes the guanidinium 
groups to converge toward the cavity. As a result, a cleft-like cavity is formed. Since 
XXXV has no chromophore, the binding constant (Ka = 2.2 × 104 M-1 in a buffered 
solution, 1.0 × 108 M-1 in MeOH) was measured by competition with a fluorescent 
guest (5-carboxyfluorescein), which is released in the presence of the selected guest 
XXXVI. 
 
 
23 Beer, P. D.; Drew, M. G. B.; Smith, D. K. J. Organomet. Chem. 1997, 543, 259-261. 
24 Nishizawa, S.; Kato, Y.; Teramae, N. J. Am. Chem. Soc. 1999, 121, 9463-9464. 
25 Niikura, K.; Metzger, A.; Anslyn, E. V. J. Am. Chem. Soc. 1998, 120, 8533-8534. 
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Fig 13. Guanidinium receptors for triphosphate recognition. 
 
 Schmidtchen designed a urethane-linked bis-guanidinium receptor XXXVII for 
the binding of ditopic tetrahedral anions.26 A binding constant of 106 M-1 in water for 
p-nitrophenyl phosphate and cytidine-5’-phosphate was determined by 1H NMR. Such 
a high value in a polar solvent was explained by the simultaneous complexation of 
both guanidinium groups to the tetrahedral guest. 
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Fig 14. Bicyclic guanidinium receptor for phosphate recognition. 
 
 Recently, binding studies between XXXVIII and IV and phosphates of different 
sizes were measured by both 1H NMR and ITC in acetonitrile.27 For XXXVIII, 1H 
NMR gave a curve fitting for a 1:1 stoichiometry whereas ITC predicted a 1:2 host-
guest binding model and revealed that the binding was not caused by a large enthalpic 
contribution but to a strong entropic factor instead. In this regard, calorimetry prevents 
                                                 
26 Schmidtchen, F. P. Tetrahedron Lett. 1989, 30, 4493-4496. 
27 Jadhav, V. D.; Schmidtchen, F. P. Org. Lett. 2005, 7, 3311-3314. 
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misleading conclusions from NMR in cases where rapidly interconverting species are 
in equilibrium. Thus, introduction of several hydrogen bond donors in the receptor 
scaffold counteracts rather than enhances the enthalpic stabilization of the host-guest 
complex. 
 Macrocycle XXXIX, based on the chiral bicyclic guanidinium subunit, has been 
designed by de Mendoza and co-workers to afford six strong hydrogen bonds oriented 
inwards its cavity to facilitate wrapping around tetrahedral oxoanions.28 Although 
diphenylphosphate was readily extracted from water, the binding constant could not be 
measured from the tetraphenylborate salt (Ka > 105 M-1) by NMR in CDCl3. However, 
from the chloride salt the constant was 103 M-1, which indicates that the receptor is 
selective for diphenylphosphate over chloride. Contrary to the expectation that the 
guest would be threaded across the cavity, splitting of most signals at low temperature 
indicated the rapid counterion scrambling between both sides of the macrocycle. 
Consequently, attempts to make a rotaxane by using the bulkier 3,5-di-tert-
butyldiphenylphosphate as a template during the cyclization (clipping) were 
unsuccessful. 
 
1.1.4.2. Sulfates 
 
 Sulfate recognition by guanidinium receptors has been much less explored than 
carboxylate or phosphate binding. Therefore, no detailed comparative binding studies 
for sulfates and other anions are available. However, despite phosphate and sulfate are 
tetrahedral, the latter is less basic, thus the affinity for guanidinium receptors is shifted 
towards phosphate. 
 In 1996 de Mendoza and co-workers reported on chiral bicyclic bis-guanidinium 
(XXXX and XXXXI) and tetrakis-guanidinium (XXXXII) salts whose sulfate 
counterions, unlike the corresponding chloride salts, required hydrogen donors from 
two different molecules to balance the charges and to fully wrap around the anion, 
since the selected spacer CH2SCH2 was designed in such a way that it was simply too 
short to use guanidines from the same chain (Fig 15).29 Therefore, two subunits are 
 
28 Alcázar, V.; Segura, M.; Prados, P.; de Mendoza, J. Tetrahedron Lett. 1998, 39, 1033-1036. 
29 Sánchez-Quesada, J.; Seel, C.; Prados, P.; de Mendoza, J. J. Am. Chem. Soc. 1996, 118, 277-
278. 
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forced to self-assemble orthogonally around the tetrahedral anion in a double-helical 
structure (sulfate helicates). 1H NMR spectra showed large downfield shifts of 
guanidinium NH’s as dimers or tetramers complexed sulfate anion. Moreover, 
ROESY spectra confirmed intermolecular contacts due to the folded conformation. 
 
a) 
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Fig 15. a) Chiral bicyclic bis-guanidinium salts XXXX and XXXXI and tetrakis-
guanidinium salt XXXXII. b) Optimized model of a sulfate helicate from 
a strand of (S,S)-guanidines. 
 
 A recent computational study concludes that for simple sulphate-guanidinium 
interactions several minima of similar energies could be found.30 For more complex 
guanidines, such as the closely related ligands XXXXIII and XXXXIV, the crystal 
structure shows 1:1 sulfate complexes, with a good docking of the anion into the 
cavity of XXXXIV, but this was not the case for XXXXIII (Fig 16).31 Interestingly, 
the pyridine nitrogen of XXXXIII induces pre-organization by intramolecular 
hydrogen bonding but causes repulsion of the anion due to the increased charge 
density in the pocket around the heteroatoms. 
 17
                                                 
30 Rozas, I.; Kruger, P. K. J. Chem. Theory Comput. 2005, 1, 1055-1062. 
31 Grossel, M. C.; Merckel, D. A. S.; Hutchings, M. G. Cryst. Eng. Comm. 2003, 5, 77-81. 
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Fig 16. Crystal structure of XXXXIII?H2SO4 (a) and of XXXXIV?H2SO4 (b). 
 
 The energetics of the guanidinium-sulfate system have been analyzed by 
Schmidtchen using two bicyclic guanidinium subunits linked through a suitable 
spacer, such as XXXXV (Fig 17).32 ITC measurements revealed that guest 
complexation was strongly endothermic with entropy as the driving force. The 
interactions are strong enough in methanol (Ka = 6.8 × 106 M-1) to overcome the 
positive enthalpy change. Assuming that free host and free guest are more highly 
solvated than the complex, the positive enthalpy reflects the reorganization of the 
solvent shell upon complexation. A comparison between receptors which combine two 
guanidinium groups (such as XXXXV) and monotopic bicyclic guanidinium ones, 
which showed little or no interaction with sulfate in methanol, accounts for the 
importance of the bridging spacer between both cationic subunits. 
 
 18 
                                                 
32 Berger, M.; Schmidtchen, F. P. Angew. Chem. Int. Ed. 1998, 37, 2694-2696. 
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Fig 17. Bicyclic guanidinium receptor for sulfate recognion. 
 
2.2 Objectives 
 
2.2.1 Nitrate recognition 
 
 The second chapter of this Thesis reports on the synthesis of new chiral bicyclic 
guanidinium receptors to study host-guest interactions with small anions.33 Besides the 
good hydrogen bond donor ability of the guanidinium function, two urea groups have 
been incorporated in the scaffold of the receptors to enhance the affinity towards weak 
coordinative nitrate.34 Therefore, several receptors (either open or macrocyclic) with 
six hydrogen bond donors have been synthesized as well as some macrocycles of 
different cavity sizes (Fig 18). 
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Fig 18. Bicyclic guanidinium receptors for nitrate recognition.  
                                                 
33 a) Schmidtchen, F. P.; Berger, M. Chem. Rev. 1997, 97, 1609-1646. b) Beer P. D., Gale, P. 
A. Angew. Chem. Int. Ed. 2001, 40, 486-516. 
34 Hay, B. P.; Gutowski, M; Dixon, D. A.; Garza, J.; Vargas, R.; Moyer, B. A. J. Am. Chem. 
Soc. 2004, 126, 7925-7934. 
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 In summary, 1H-NMR and isothermal calorimetric (ITC) techniques were used 
to quantify the association between hosts and guests and to determine thermodynamic 
parameters. Small anions such as nitrate, acetate, chloride and bromide were 
investigated as well as larger one such as benzoate. Selectivity was established for the 
different anions under study. Solid state X-ray crystal structures have been resolved for 
several complexes, showing the inclusion of nitrate, acetate or chloride anions inside 
the cavity of the macrocyclic guanidinium receptors, and shedding light on the 
structural parameters governing the binding. 
 
2.2.2 Naproxen Enantiorecognition 
 
 The third chapter deals with the challenging problem of the chiral recognition of 
the NSAID (Non-Steroidal Anti-inflammatory Drug) Naproxen.35 To do so, two 
different strategies have been employed: on the first hand, the rational design for a step 
to step host-guest interactions assay, on the second hand, the combinatorial approach 
with the synthesis of amino acid libraries to be screened with a fluorescent Naproxen 
derivative. 
 Since multiple hydrogen bond donor hosts synthesized in the second chapter 
revealed as being good receptors for carboxylate, we first checked open-chain, 
symmetric guanidinium receptors for our target Naproxen. Therefore, chiral receptors 
with six hydrogen bond donors and bearing bulky group as adamantyl, 2-tert-butyl-6-
methylphenyl or diphenylmethyl were synthesized in order to discriminate one 
enantiomer from the other (Fig 19). 
 
 
 
 
35 Giordano, C.; Villa, M.; Panossian, S. Naproxen: Chirality in Industry, Wiley (New York), 
1992. 
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Fig 19. Symmetric chiral guanidinium receptors bearing bulky. 
 
 Moreover, several symmetric hosts bearing butyl or phenyl as well as benzyl or 
phenylethyl groups have been prepared as a preliminary step in the synthesis of pincer-
like receptors. Additional π-π stacking interactions were then investigated with 
Naproxen (bearing an electronically enriched ring). We also introduced additional 
chirality in both arms of the host in a view of leading the enantioselective recognition 
of (S)-Naproxen. Besides, this study was run for both chiral (R, R) and achiral meso (R, 
S) guanidinium scaffolds in an attempt to select the best pre-organized pocket. 
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Fig 20. Symmetric receptors for pincer-like binding assays. 
 
 A more rigid and pre-organized macrocycle 14, incorporating a lysine derivative 
with both additional hydrogen bond and an electronically poor aromatic ring, as a 
chiral linker between the two urea groups, was also designed and synthesized. 
 
 21
General Introduction  
_____________________________________________________________________ 
N
N
H
N
H SS
PF6-
HNNH
OHNO NH
O
HN
NO2
14
 
 
Fig 21. Lysine-containing macrocycle 14. 
 
 In an effort to introduce a new and strong chiral barrier into the receptor 
scaffold, we designed two guanidinium-based macrocycles employing NOBIN, a 
catalysis ligand as spacer.36 A short (4 carbon atoms, 15) or a rigid (xylylene, 16) 
linker was then introduced between the two urea moieties in order to restrict host 
conformational degree (Fig 22). 
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Fig 22. Nobin macrocycles 15 and 16. 
 
 Apart from rational design, combinatorial chemistry37 comes as a second 
approach for the chiral recognition of (S)-Naproxen. A fluorescent probe (Naproxen 
derivative 17, Fig 23) was then used to screen libraries of receptors susceptible of 
                                                 
36 a) Smrčina, M.; Lorenc, M.; Hanuš, V.; Sedmera, P.; Kočovskỳ, P. J. Org. Chem. 1992, 57, 
1917-1920. 
37 Lowe, G. Chem. Soc. Rev. 1995, 24, 309-317. 
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showing enantioselection. The fluorescent dansyl group was then attached to both 
Naproxen enantiomers. 
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Fig 23. Fluorescent Naproxen derivative (S) and (R)-17. 
 
 A peptide library was then synthesized and subsequently attached by alkylation 
to two guanidinium scaffolds: 18, with a protected guanidinium arm, and 19, with a 
better binding pocket with two additional hydrogen bond donor groups for the 
carboxylate function of the guest. 
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Fig 24. Guanidinium receptor libraries 18 and 19. 
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2 Nitrate Recognition 
 
2.1 Introduction 
 
2.1.1 Abiotic Receptors for Small Anions 
 
Molecular recognition of anions is a current important area of supramolecular 
chemistry with an increasing interest every year.1 Considering anion characteristics, 
synthesizing a host able to selectively distinguish it from its size, shape and basicity is 
still challenging.2 To do so, hydrogen bonds, electrostatic interactions, hydrophobic 
effect as well as metal or Lewis acid coordination have been employed in order to 
reach the ultimate goal of developing sensors.3 Taking into account supramolecular 
interactions, a rational design may thus lead to new receptors for a specific anion. 
 
 
 
Fig 1. Contour map of the electrostatic potential surface 
 for a positive point charge in the plane of nitrate.4
 
Nitrate is a weak basic anion with a highly symmetric trigonal planar binding 
mode (Fig 1), so selective binding to suitable hosts through multiple hydrogen bonds 
                                                 
1 a) Gale, P. A. Coord. Chem. Rev. 2006, 250, 2917. b) Gale, P. A.; Quesada, R. Coord. Chem. 
Rev. 2006, 250, 3219-3244. 
2 Schmidtchen, F. P.; Berger, M. Chem. Rev. 1997, 97, 1609-1646. 
3 Beer, P. D.; Gale, P. A. Angew. Chem. Int. Ed. 2001, 40, 486-516. 
4 Hay, B. P.; Gutowski, M.; Dixon, D. A.; Garza, J.; Vargas, R.; Moyer, B. A. J. Am. Chem. 
Soc. 2004, 126, 7925-7934. 
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is demanding. Even though nitrate is a biologically relevant substrate and plays a very 
important role in environmental pollution,5 comparatively little attention has been 
given to this target by supramolecular chemists relative to other anions, such as 
halides or acetate. Nitrate in groundwater originates primarily from fertilizers and 
excessive levels in drinking water may cause serious illness due to conversion into 
nitrite by reduction into the body. Anion exchange, reverse osmosis, electrodialysis 
and distillation have been approved for removing nitrates/nitrites.6 The health standard 
for nitrate is 50 mg/L in the European Community countries.7 We propose herein a 
supramolecular approach for removing nitrate from water by liquid-liquid extraction. 
However, its little tendency to establish robust hydrogen-bonded frameworks in 
solution makes it indeed difficult to compete with other anions such as chloride or 
carboxylates for the hydrogen donor sites of the receptors (Table 1). 
 
Anions Ionic size 
pKa of corresponding 
acid 
Binding mode 
 
NO3-
 
179 
 
-1.3 
 
Trigonal planar 
F- 133 +3 Spherical 
Cl- 181 -7 Spherical 
Br- 196 -9 Spherical 
I- 220 -10 Spherical 
HCOO- 156 +3.75 Bidentate planar 
 
Table 1. Ionic size (pm), pKa of HA and binding mode of selected anions A-. 
 
Anslyn et al. designed a bicyclic cyclophane I (Fig 2) to recognize anions 
through NH-π hydrogen bonds (hydrogen bond donation through the π-system of the 
oxoanion rather than the oxygen lone pairs) resulting in an enhancement of nitrate 
                                                 
5 Mason, C. F. Biology of Freshwater Pollution, 2nd ed., Longman:Harlow, U. K., 2nd ed. 
1991. 
6 http://www.nesc.wvu.edu/ndwc/pdf/OT/TB/TB4_IonExchange.pdf. 
7 European Communities Off. J. Eur. Commun. 1998, L330, 32. 
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complexation over other anions tested (Ka = 300 M-1 in CD2Cl2/CD3CN 1:3).8 This 
amide-based receptor is one of the few that has a higher affinity for nitrate than 
chloride (Ka = 40 M-1) although acetate binds better (Ka = 770 M-1). Besides, this 
receptor was employed in an optical sensing assay with colorimetric dyes confirming 
its selectivity over Br- and ClO4-.9 Moreover, this receptor was tested as a new optical 
absorption-based disposable sensor for the analysis of nitrate in water.10
Herges et al. synthesized macrocycles of different rigidity bearing three urea or 
thiourea subunits and did calculate binding constants with tetrabutylammonium nitrate 
in polar media by 1H-NMR titrations, revealing however no selectivity towards this 
guest (for II, Ka = 17.1 M-1 in DMSO-d6).11
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Fig 2. Anion receptors by Anslyn (I) and Herges (II). 
 
 Hamilton et al. described a rigid amide-based macrocycle III able to selectively 
bind sulfate and phosphate oxoanions and reported one of the largest Ka observed for 
nitrate (Ka = 4.6 x 105 M-1 in 2% DMSO-d6/CDCl3, Fig 3).12
                                                 
8 Bisson, A. P.; Lynch, V. M.; Monahan, M. K.; Anslyn, E. V. Angew. Chem. Int. Ed. Engl. 
1997, 36, 2340-2343. 
9 Niikura, K.; Bisson, A. P.; Anslyn, E. V. J. Chem. Soc., Perkin Trans. 2 1999, 1111-1114. 
10 Capitán-Vallvey, L. F.; Arroyo-Guerrero, E.; Fernández-Ramos, M. D.; Santoyo-Gonzalez, 
F. Anal. Chem. 2005, 77, 4459-4466. 
11 Herges, R.; Dikmans, A.; Jana, U.; Köhler, F.; Jones, P. G.; Dix, I.; Fricke, T.; König, B. 
Eur. J. Org. Chem. 2002, 17, 3004-3014. 
12 Choi, K.; Hamilton, A. D. J. Am. Chem. Soc. 2003, 125, 10241-10249. 
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Jeong et al. have recently developed an indole-based macrocycle IV that acts as 
a chemosensor and is able to strongly bind anions through hydrogen bonds (Ka = 3.9 x 
105 M-1 in CH3CN).13
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Fig 3. Anion receptors from Hamilton (III) and Jeong (IV). 
 
Various anions receptors have been designed and shown nitrate complexation 
through hosts containing metal entities,14 metal complexation,15 ion-pair formation,16 
and mainly hydrogen bonding as pyrrole,17 ammonium,18 amide,19 and urea20 as 
                                                 
13 Chang, K. -J.; Moon, D.; Soo Lah, M.; Jeong, K.-S. Angew. Chem. Int. Ed. 2005, 48, 7926-
7929. 
14 Schnebeck, R.-D.; Freisinger, E.; Lippert, B. Angew. Chem. Int. Ed. 1999, 38, 168-171. 
15 Drew, M. G. B.; Guillaneux, D.; Hudson, M. J.; Iveson, P. B.; Madic, C. Inorg. Chem. 
Commun. 2001, 4, 462-466. 
16 Mahoney, J. M.; Stucker, K. A.; Jiang, H.; Carmichael, I.; Brinkmann, N. R.; Beatty, A. M.; 
Noll, B. C.; Smith, B. D. J. Am. Chem. Soc. 2005, 127, 2922-2928.
17 Sessler, J. L.; An, D.; Cho, W.-S.; Lynch, V.; Marquez, M. Chem. Eur. J. 2005, 11, 2001-
2011. 
18 Motekaitis, R. J.; Martell, A. E.; Lehn, J.-M.; Watanabe, E.-I. Inorg. Chem. 1982, 21, 4253-
4251. 
19 Bondy, C. R.; Gale, P. G.; Loeb, S. J. Chem. Commun. 2001, 729-730. 
20 a) Jagessar, R. C.; Burns, D. H. Chem. Commun. 1997, 1685-1686. b) Albrecht, M.; Zauner, 
J.; Burgert, R.; Rottele, H.; Frohlich, R. Materials Science and Engineering 2001, 185-190. c) 
Turner, D. R.; Paterson, M. J.; Steed, J. W. J. Org. Chem. 2006, 71, 1598-1608. d) Russell, J. 
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hydrogen bond donors. These synthetic anion receptors revealed an increase of its 
association even in polar media, although selectivity for nitrate remained difficult to 
achieve. For instance, similar sized Cl- often gives a better association with the host 
because of its spherical shape mode and higher basicity. Most remarkably, Beer and 
co-workers succeeded in inverting the chloride vs nitrate selectivity by using a 
solvation effect. In a 9:1 (CH2Cl2/MeOH) mixture, the ruthenium(II) tris(5,5´-
diamide-2,2´-bipyridine) receptor is indeed selective towards chloride whereas in 1:1 
(CH2Cl2/MeOH) mixture, this order is inversed.21
 
2.1.2 Design of Guanidinium-based Receptors for Nitrate Recognition 
 
  Although guanidinium-based systems have been widely used to recognize 
oxoanions such as carboxylates and phosphates,22 its use for nitrate binding has not 
been reported so far.23 From a recent theoretical study, the combination of both 
guanidinium and urea moieties should provide an almost ideal complement to the 
guest (Fig 4a).4,24 An important feature of the receptor design is therefore the 
orientation of the nitrate inside the cavity. Each oxygen atom should share its lone 
pairs either with a single NH donor from different functions (Fig 4b), or alternatively 
from the same function, by means of bifurcated hydrogen bonds (Fig 4c). So far, 
evidence from reported X-ray structural data indicates that nitrate binds to one or two 
urea functions in a linear fashion giving rise to linear hydrogen bonds with the 
host.20c,d,  25 Those results are in good agreement with energy data from theoretical 
 
M.; Parker, A. D. M.; Radosavljevic-Evans, I.; Howard, J. A. K.; Steed, J. W. Chem. Commun. 
2006, 269-271. 
21 Uppadine, L. H.; Drew. M. G. B.; Beer, P. D. Chem. Commun. 2001, 291-292. 
22 a) Houk, R. J. T.; Tobey, S.L.; Anslyn, E.V. Top. Curr. Chem. 2005, 255, 199-230. b) 
Blondeau, P.; Segura, M.; Pérez-Fernández, R.; de Mendoza, J. Chem. Soc. Rev. 2007, 36, 198-
210. 
23 For a X-ray structure of a nitrate-guanidinium salt, see: Gleich, A.; Schmidtchen, F. P.; 
Mikulcik, P.; Müller, G. J. Chem. Soc., Chem Commun. 1990, 1, 55-57. 
24 Hay, B. P.; Firman, T. K.; Moyer, B. A. J. Am. Chem. Soc. 2005, 127, 1810-1820. 
25 a) Custelcean, R.; Moyer, B. A.; Bryantsev, V. S.; Hay, B. P. Cryst. Growth Des. 2006, 6, 
555-563. b) Aakeroy, C. B.; Beffert, K.; Desper, J.; Elisabeth, E. Cryst. Growth Des. 2003, 3, 
837-846.
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calculations, which revealed that forcing urea to bind a single oxygen atom in a 
bifurcated fashion yields complexes that are less stable (more than a 10% difference) 
than those involving hydrogen bonds with two oxygen atoms.24 Considering the 
hydrogen bond donor strength26 and the electrostatic interactions, the hydrogen donor 
atoms should be along the edge of the polyhedron defined by the oxygen atoms (Fig 
4b). Higher stability of linear hydrogen bonds should indeed prevent formation of a 
second complex based on significant geometrically unfavorable bonds (Fig 4c). 
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Fig 4. Top and side views of optimized geometries (B3LYP) for representative 
examples of (a) 3:1 urea: NO3- complexes24 and (b) & (c) binding mode for nitrate 
inclusion. 
 
 The nitrate anion offers six optimal sites for proton location according to the 
number and orientation of the lone pair orbitals, but so far no structural evidence on an 
example fulfilling this feature has been reported. This represents in fact a key point in 
host design because spacing between hydrogen bond donors is different for linear and 
non-linear host-guest bonds. We present herein a nitrate recognition example for the 
first binding mode. 
We have prepared a number of hosts endowed with multiple hydrogen bond 
donors. Common to these designs is a bicyclic guanidinium scaffold and two ureas 
attached through an ortho-aminothiophenylene aromatic spacer in such a way that the 
distance between the nitrogen atoms of ureas and guanidines is ideal (five atoms apart) 
                                                 
26 Linton, B. R.; Goodman, M. S.; Fan, E.; van Arman, S. A.; Hamilton, A. D. J. Org. Chem. 
2001, 66, 7313-7319. 
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for the hydrogen donors to complement both the syn and anti lone pairs of each 
oxygen.27 Moreover, the aromatic ring increases the acidity of the urea and brings pre-
organization to the overall structure (Fig 5). Also, the sulfur atoms should contribute 
to shape the host by chelation while not introducing a too electronegative atom that 
would cause electronic repulsion with the guest.28 The second urea NH’s, located 
seven atoms away from guanidinium NH, would interact with each lone pair of the 
third oxygen atom guest. Besides, among the receptors reported so far, use of 
macrocycles take the advantage of affording a pre-organized scaffold with convergent 
binding groups to include the guest by size and shape complementarities.29 
Macrocycles of different cavity sizes (four, five and six carbon atoms spacers) and 
rigidities (xylylene based host) have been synthesized for nitrate inclusion. Regarding 
the linker between the ureas in the macrocycles, a five carbon chain should be again 
the best choice for nitrate encapsulation. 
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Fig 5. Design of guanidinium receptors for nitrate recognition. 
                                                 
27 González, S.; Peláez, R.; Sanz, F.; Jiménez, M. B.; Morán, J. R.; Caballero, M. C. Org. Lett. 
2006, 21, 4679-4683. 
28 Kavallieratos, K.; Bertao, C. M.; Crabtree, R. H. J. Org. Chem. 1999, 64, 1675-1683. 
29 Choi, K.; Hamilton, A. D. Coord. Chem. Rev. 2003, 240, 101-110. 
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2.2 Guanidinium Receptors Synthesis 
 
 The synthesis of all receptors was performed starting from the chiral bicyclic 
guanidinium salt 1, obtained on a multi-gram scale following the methodology 
described by Schmidtchen and improved in our group. 1 was obtained bearing two 
different protecting groups in 9 steps with a 46% overall yield. Chirality comes from 
the two starting amino acids: thus, D-Asn and D-Met produce the (R,R) enantiomer. In 
chapter 2 and 3, meso (R,S) guanidinium salt was also used (produced from D-Asn and 
L-Met).30
 
N
NH
NH
OTBDPS
OTBDMS
Cl-
1
NH2
O
NH2HOOC
SCH3
COOHH2N
D-Asn D-Met  
 
Scheme 1. Chiral bicyclic guanidinium precursors. 
 
  The synthesis of the guanidinium-based receptors is described in Scheme 2. First, 
deprotection of both silyl groups (OTBDPS and OTBDMS) was easily achieved with 
HCl to give 2 in 97% yield. Then, guanidinium dichloride 3 was obtained by reaction 
with thionyl chloride in a 95% yield. Compound 3 was then transformed into diamine 4 
(hexafluorophosphate salt) with 2-aminothiophenol in a 60% yield. 
Hexafluorophosphate, as a less competitive anion than chloride, was selected as the 
counterion for all receptors. Linear amide receptor 5 was obtained with good yield 
(70%) using PyBOP as the coupling reagent. For compounds 6, 7, 9 and 10, the 
appropriate isocyanate or diisocyanate reagents were employed. Thus, butylisocyanate 
reacted with 4 in a sealed vessel in CH2Cl2 to form 6 in 85% yield, whereas hosts 7, 9 
and 10 resulted in 40% and 15% respectively, under more dilute conditions, using 1,4-
diisocyanatobutane, 1,6-diisocyanatohexane and m-xylylene diisocyanate respectively. 
For the synthesis of macrocycle 8 a different procedure was followed, since 1,5-
diisocyanatopentane is not commercially available. We used a bis-imidazolide 
                                                 
30 Synthesis of (R,S)-1 was performed by Delphine Guichard. 
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intermediate (11, 95% yield), prepared from 1,5-diaminopentane and 1,1’-
carbonyldiimidazole (CDI) which was reacted afterwards with 4 in dry MeOH to obtain 
8 though in a modest 8% yield. 
 Aromatic receptor 10 was obtained also in a rather modest yield (15%) as 
compared to alkyl analogues 7 and 9 using the same procedure. We then studied the 
cyclization of receptor 10 from 4 with PF6-, Cl- or AcO- as counterions. In situ 
macrocyclization was followed with analytical HPLC during 24 hours but did not 
show any templating effect. Since HPLC monitoring did not show substantial amounts 
of impurities, the rather low yield was attributed to the purification process (column 
chromatography). 
 Receptors 5-10 were soluble in solvents like CH2Cl2, CH3CN or MeOH. For 
NMR and ITC determinations, aprotic CH3CN of medium polarity seemed thus 
appropriate to avoid solvent interferences. 
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Reagents and conditions: a) 3N HCl-CH3CN (1:2), 2 days (97%). b) SOCl2, reflux, 4 h (95%). 
c) 2-aminothiophenol, NaI, KOtBu, acetone, room temperature, 4 h, then 0.1M NH4PF6 (60%). 
d) Acetic acid, NMM, PyBOP, HOBt, CH2Cl2, 1 day (75%). e) butylisocyanate, dry CH2Cl2, 
45ºC, overnight, then 0.1M NH4PF6 (85%). f) butyl diisocyanate (for 7 and 9), CH2Cl2, 45 ºC, 
overnight, then 0.1M NH4PF6 and Dowex ion-exchange resin (PF6-) (40%) or 1,5-
diaminopentane (for 8), CDI, 80 ºC, 2 days, then Dowex ion-exchange resin (PF6-) (8%). g) m-
xylylene diisocyanate, dry CH2Cl2, 45 ºC, overnight, then 0.1M NH4PF6 and Dowex ion-
exchange resin (PF6-) (15%). 
Scheme 2. Synthesis of receptors 5-10. 
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2.3 Binding Study 
 
2.3.1 1H-NMR and ITC Titrations with Nitrate 
 
TBA nitrate equivalents
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Fig 6. 1H-NMR titration curves of receptors 1 and 4-7 with TBA nitrate in CD3CN at 
25ºC; 1 (■), 4 (◊), 5 (▲), 6 (□) and 7 (●), (∆δ of guanidinium NH). 
 
 1H-NMR titrations with tetrabutylammonium (TBA) nitrate and hosts 1 and 4-
10 were performed in CD3CN. As the amount of guest added increased, guanidinium 
NH chemical shifts suffer a downfield shift for all receptors (∆δ = 1.80 ppm for 1, 
1.05 ppm for 4, 0.80 ppm for both 6 and 7, 0.25 ppm for 5, Fig 6). Saturation was 
observed for hosts 5, 6 and 7 after addition of 1,5 equivalents of nitrate, whereas a 
control with starting compound 1 and diamine 4 did not show saturation even after 
addition of 10 equivalents, accounting for the importance of additional hydrogen 
bonds (ureas) to stabilize the complex. Indeed, Ka values increased almost by two 
orders of magnitude from 373 M-1 for 1 to 9.94 × 103 M-1 for 7 (Table 2). Different 
binding modes or complementarities are thus involved depending on the number of H-
bonds provided by the receptor (amine, amide and urea). In all cases, the amine and 
guanidinium NH protons, the amide and guanidinium NH protons, or the urea and 
guanidinium NH protons involved in hydrogen bonding, showed strong downfield 
shifts upon addition of guest (see Fig 7 for a titration between 7 and TBA nitrate). 
Diamine receptor 4 gave an association constant higher than the starting material 1 
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due to the better pre-organization of the system as well as to the participation of two 
additional weak hydrogen bond (amine NH2). In amide host 5 the association was 
enhanced by the presence of two strong hydrogen bonds. However 6 showed a Ka 
twice higher, revealing that the urea receptor allows a full hydrogen bonding to all 
oxygen lone pairs of the guest. Even if the overall binding value was not that highly 
shifted from amide to urea receptor (revealing once again that amide hydrogen bonds 
are strong enough to reach saturation), urea receptors are more suitable due to their 
array of hydrogen bonds. Macrocyclic effect was evidenced by the twice bigger 
binding constant for 7 than for the linear analogue 6. Guest inclusion inside the cavity 
of 7 could not be detected by 1H-NMR, as no significant chemical shifts of the protons 
of the four carbon atom spacer were observed, revealing no significant rearrangement 
of the macrocycle scaffold to complex nitrate. 
  The titrations corresponds to a widely studied31 anion exchange process of the 
type: 
Host (PF6-) + TBA+ (NO3-) Host (NO3
-) + TBA+ (PF6-)  
 
NHa NHb NHc
ppm (f1)
6.006.507.007.508.00
0.0 eq
0.2 eq
0.4 eq
0.6 eq
0.7 eq
0.9 eq
1.1 eq
1.2 eq
1.4 eq
1.6 eq
5.0 eq
 
Fig 7. 1H-NMR titration between 7 and TBA nitrate in CD3CN. 
 
 Single liquid-liquid extraction experiments between 6 (in CH2Cl2) and NaNO3 
(in a saturated water solution) confirmed the strong host-guest interaction, since one 
                                                 
31 a) Berger, M.; Schmidtchen, F. P. J. Am. Chem. Soc., 1999, 121, 9986-9993. b) Haj-Zaroubi, 
M.; Mitzel, N. W.; Schmidtchen, F. P. Angew. Chem. Int. Ed., 2002, 41, 104-107. 
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full equivalent of nitrate was extracted and a 1:1 stoichiometry was observed in the 
organic layer.32 An important characteristic of lipophilic bicyclic guanidinium 
receptors is thus the property of extracting anions from aqueous media to organic 
phases through single liquid-liquid extraction or membrane transport such anions from 
a feeding to a receiving phase.33
  No accurate NMR binding data could be obtained for 8, 9 and 10 due to in situ 
crystallization at the concentrations required by the titrations. To overcome this 
problem, we used isothermal titration calorimetry (ITC) as an alternative tool for 
measuring binding constants and thermodynamic parameters at much lower 
concentrations.34 The binding isotherms are characteristic of exothermic 1:1 complexes 
and values for Ka are in good agreement with those previously obtained by 1H-NMR 
(Table 2). 
  Increase of cavity size results in a binding affinity enhancement between the 
macrcocycle and nitrate. Hence, macrocycle 9 showed an increase of two orders of 
magnitude respect to 4 and presents one of the highest Ka values reported so far for 
nitrate. Increase of cavity rigidity afforded however a weaker association between the 
host and the guest. Indeed, macrocycle 10 afforded the lowest Ka among all macrocycles 
synthezised and even lower than linear receptor 6. Likely, the aromatic xylylene proton 
pointing inward the cavity prevents the guest to get inside and difficults the correct 
orientation of the urea NHs towards the nitrate oxygen atoms. 
 
 
 
 
 
32 Single liquid-liquid extractions were performed by shaking for 5 min a 1 mg ml-1 host 
solution in CH2Cl2 and a saturated NaNO3 solution in water. The organic phase was isolated 
after centrifugation, the solvent removed (without addition of any drying agent) and the 1H-
NMR spectrum was recorded. As for other related guanidinium receptors and carriers,33 spectra 
of both aqueous and organic phases confirmed the complete partition of the host into the 
organic phase in a 1:1 host-guest stoichiometry. 
33 Breccia, P.; Van Gool, M.; Pérez-Fernández, R.; Martín-Santamaría, S.; Gago, F.; Prados, P.; 
de Mendoza, J. J. Am. Chem. Soc. 2003, 125, 8270-8284. 
34 a) Ladbury, J. E.; Chowdhry, B. Z. Chem. Biol. 1996, 3, 791-801. b) Wadsö, I. Chem. Soc. 
Rev. 1997, 79-86. 
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 1 4 5 6 7 8 9 10 
 
Ka(103)a
 
0.37 
 
0.99 
 
2.26 
 
5.50 
 
9.94 
 
c 
 
c 
 
c 
Ka(103)b 0.19 0.35 1.14 5.83 7.26 15.2 73.7 3.90 
∆H -1.90 -2.00 -8.25 -3.74 -1.07 -3.02 -3.48 -0.97 
∆S 4.14 5.06 -12.8 4.72 14.2 9.16 10.8 13.2 
∆G -3.15 -3.53 -4.37 -5.17 -5.37 -5.79 -6.76 -4.97 
a Determined by 1H-NMR titrations in CD3CN at 298 K. b Determined by ITC titrations in 
CH3CN at 303 K. c Not determined because of in situ crystallization. ∆H and ∆G in kcal mol-1, 
∆S in cal mol-1 K-1. 
Table 2. Association constants (M-1) and thermodynamic parameters 
for the binding of 1 and 4-10 with TBA nitrate. 
 
The binding isotherms reveal that binding of nitrate with 7 and 10 is governed 
mainly by entropy (Fig 8, see also Table 2), whereas for the other receptors, especially 
the macrocycles, both enthalpic and entropic contributions play a significant role. As 
the cavity size of the macrocycle increases, the enthalpy is enhanced whereas entropy 
diminishes. The strong negative enthalpy values indicate that hydrogen bonding with 
the oxygen acceptors of the guest is almost optimal, the entropic contribution being 
likely due to solvent release from the cavity upon guest inclusion, and increases as the 
conformational freedom of the macrocycle is reduced. In macrocycles 7 and 10 the 
cavity is too small for optimal inclusion. Indeed, the hydrogen bonding is weaker, and 
the smaller enthalpy change is compensated by a stronger entropy contribution. 
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Fig 8. ITC titration curves of receptors 6-10 with TBA nitrate in CD3CN at 303K; 
6 (○), 7 (◊), 8 (■), 9 (●) and 10 (▲). 
 
2.3.2 ITC Binding Titrations and Selectivity 
 
In view of the good binding properties shown by the receptors towards nitrate, 
we then determined by ITC their selectivity with respect to spherical anions of 
different size and basicity such as bromide or chloride, as well as to carboxylates like 
the small acetate and aromatic benzoate. Starting compound 1 and the guanidinium 
diamine salt 4 are strongly selective towards carboxylates (NO3- < Br- < Cl- < AcO- ≃ 
BzO-, Table 3). For host 4 the increase is one order of magnitude relative to 1 for 
spherical guests Br- and Cl-. The presence of weak additional amine H-bonds causes 
the enthalpic contribution to multiply by a factor of two. Similarly, in the presence of 
additional urea H-bonds, receptor 6 shows an increase of one order of magnitude of 
binding in both cases and the association becomes both enthalpically and entropically 
driven. Interestingly, receptor 6 prefers Cl- to AcO- (NO3- < Br- < AcO- < Cl- ≃ BzO-, 
Table 3). From 1 to 6, additional stabilization by H-bonds causes enthalpy 
enhancement and entropy diminishment for all anions tested although overall 
carboxylate binding stays almost similar (Ka ≈ 105 M-1). The Ka obtained for 1 with 
benzoate salt is consistent with the previously reported result measured by 
Schmidtchen with a similar diprotected bicyclic guanidinium salt.31b Authors 
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emphasize on the risk of discussing binding exclusively in terms of free energy when 
similar values for different hosts with additional interaction sites are observed. For 
instance, an ITC titration between 6 and acetate shows a complexation mainly 
enthalpically driven whereas both thermodynamic factors play a significant role in 
association between 1 and the guest. 
For Br- and Cl-, the binding constants with macrocycles 7, 8 and 9 are similar 
and one order of magnitude higher than for the linear urea receptor 6. The macrocyclic 
effect is significant for the spherical anions resulting in a change in selectivity order 
(NO3- < Br- ≃ AcO- < BzO- ≃ Cl-). As pointed out for additional H-bonds, increasing 
the cavity size by changing the bridge between the ureas from 4 to 6 carbon atoms has 
a similar influence for Br- and Cl-. Enthalpy indeed increases (flexibility allows a 
better adjustment to optimize the host-guest interactions) whereas entropy decreases 
due to a larger cavity and higher conformational freedom. Among the compounds 
tested, receptor 9 is indeed the best macrocycle for anion complexation and the first 
guanidinium-based receptor reported so far that is selective toward Cl- over AcO-. 
Assuming a strong entropic contribution with benzoate, receptor 9 behaves as with 
chloride (Ka ≈ 106 M-1 with similar enthalpy and entropy contributions). 
ITC titrations between macrocycle 10 and anion salts gave an association one 
order of magnitude lower than macrocycles 7, 8 and 9 (as pointed out previously, the 
aromatic hydrogen atom pointing inwards the cavity may contribute to diminish guest 
association). Unlike 7-9, spherical anions present a strong entropically driven binding. 
As guest size increases from Cl- to Br-, entropy increases but enthalpy decreases 
accounting for the better accommodation of a smaller guest in the small cavity of the 
more rigid macrocycle. With acetate, receptor 10 shows the smallest association 
whereas for benzoate the binding is similar to receptors 1 and 4. A strong entropic 
contribution allows benzoate to keep macrocycles selective towards aromatic 
carboxylates over smaller acetate. 
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1 4 6 7 8 9 10 
Br-        
Ka (103)a 0.63 3.40  55.9  118  156  238  37.8  
∆H  -0.59 -1.05 -3.32 -1.72 -2.41 -3.85 -0.47 
∆S  10.8 12.7 10.8 17.2 15.8 11.9 19.4 
∆G  -3.86 -4.89 -6.59 -6.93 -7.20 -7.45 -6.35 
Cl-        
Ka (103)a 5.85 14.7  781 2240  1040  2090 305 
∆H  -0.84 -2.20 -4.92 -4.05 -4.96 -5.38 -2.09 
∆S  14.4 11.8 10.7 15.7 11.2 11.2 18.2 
∆G  -5.21 -5.77 -8.16 -8.81 -8.35 -8.77 -7.60 
AcO-        
Ka (103)a 128  268  306 147 222 322 30.5 
∆H  -3.97 -4.33 -6.97 -4.89 -3.49 -6.95 -5.47 
∆S  10.2 10.5 2.06 7.49 12.9 2.25 2.46 
∆G  -7.06 -7.51 -7.59 -7.16 -7.39 -7.63 -6.22 
BzO-        
Ka (103)a 202 176 895 1970 1340 1360 122 
∆H  -3.92 -4.78 -5.99 -5.40 -5.40 -5.65 -5.27 
∆S  11.3 8.21 7.43 10.9 10.2 9.39 6.00 
∆G  -7.35 -7.27 -8.24 -8.70 -8.49 -8.49 -7.04 
a Determined by ITC titrations in CH3CN. ∆H and ∆G in kcal mol-1, ∆S in cal mol-1 K-1. 
 
Table 3. Thermodynamic parameters evaluated by ITC of TBA bromide, chloride, 
acetate and benzoate complexes of 1, 4 and 6-10. 
 
Comparing receptors, the binding order is as follows: 1 < 4 < 10 < 6 < 7 ≃ 8 ≃ 
9. The thermodynamic factors variation between 7, 8 and 9 is not as important as for 
NO3- and does not allow prediction of guest inclusion. Spherically shaped chloride 
accommodates well in all the macrocycles series but seems to be penalized in the most 
rigid scaffolds where rearrangement of the macrocycle structure is more difficult. 
Bromide displays association with macrocycles with binding constants one order of 
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magnitude lower than chloride due to its larger size. Acetate association is constant for 
all receptors (Ka = 105 M-1) whereas benzoate is favored in the case of macrocycle (Ka 
= 106 M-1). For acetate, linear host 6 gives an enthalpically favored complexation as 
for host 9 (as the cavity size increases, the macrocycle structure recovers enough 
flexibility to behave like the linear receptor). 
Selectivity was calculated for receptors 1, 4, 6-10 by the ratios (∆GX-/∆GX’-) 
(Table 4). For all anions, (∆G X-/∆G NO3-) decreases from starting material 1 to the 
best receptor 9 accounting for the weak coordinative abilities of this anion (Fig 9). 
Additional H-bonds, pre-organized scaffolds as well as appropriate cavity sizes suit 
indeed better for NO3- than for the other anions. Receptor 9 gives the most favorable 
ratio for nitrate, and this ratio dramatically decreases from 1 to 9 for carboxylate 
anions [(i.e. ∆G AcO-/∆G NO3-) from 2.24 to 1.13 and (∆G BzO-/∆G NO3-) from 2.36 
to 1.26]. Selectivity between spherical anions Br- and Cl- stays almost similar for 
every receptor (from 1.35 down to 1.16) whereas for acetate ((∆G Cl-/∆G AcO-) is 
inverted from 0.73 up to 1.15). Protected bicyclic guanidinium salt 1 is selective for 
acetate whereas macrocycle 9 is chloride-selective. This selectivity is less significant 
with benzoate since this guest is favored by a strongest entropic contribution. 
Therefore, among small anions macrocycle 9 is chloride-selective and among 
carboxylate anions it is benzoate-selective. 
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Fig 9. Nitrate selectivity compared to Br-, Cl-, AcO- and BzO- 
for receptors 1, 4, 6-10. 
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1 4 6 7 8 9 10 
Cl-/NO3- 1.65 1.63 1.58 1.64 1.44 1.30 1.52 
Br-/ NO3- 1.22 1.39 1.28 1.29 1.24 1.10 1.27 
AcO-/ NO3- 2.24 2.12 1.47 1.33 1.27 1.13 1.25 
BzO-/ NO3- 2.33 2.06 1.59 1.62 1.46 1.26 1.41 
Cl-/ Br- 1.35 1.18 1.24 1.27 1.16 1.18 1.20 
Cl-/ AcO- 0.73 0.77 1.07 1.23 1.13 1.15 1.22 
Cl-/ BzO- 0.71 0.79 0.99 1.01 0.98 1.03 1.08 
Br-/ AcO- 0.55 0.65 0.87 0.97 0.97 0.98 1.02 
Br-/ BzO- 0.53 0.67 0.80 0.80 0.85 0.88 0.90 
AcO-/ BzO- 0.96 1.04 0.92 0.82 0.87 0.90 0.88 
 
Table 4. Selectivity ratios for receptors 1, 4 and 6-10 (∆G X-/∆G X’-). 
 
Receptor 1 is strongly carboxylate-selective due to the large pKa difference 
between the guanidinium function and carboxylic acids. Macrocycle 9 presents a 
totally different association in which spherical binding mode is favored over pKa 
difference (Fig 10). As some additional hydrogen bonds through urea groups and pre-
organization are incorporated in the host structure, the association is thus not governed 
by pKa differences anymore. Anions of suitable shape and size complementarities with 
the host overcome their weak binding affinity compared to carboxylate anion with 
guanidinium-based receptors. 
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Fig 10. Binding constants Ka of TBA salts with 1 (○) and 9 (●) versus pKa of the 
corresponding acid. 
 
2.3.3 ITC titrations with TBA Fluoride 
 
Macrocycle 9 is selective toward Cl- over Br- with association constants 
differing by one order of magnitude. This prompted us to measure the binding with 
smaller anion F-. Fluoride is a much smaller anion but much more basic (Table 1). So 
far, few data have been reported about guanidinium-fluoride interactions.35
ITC titration between 9 and TBAF was performed and the binding isotherm 
presents a different stoichiometry than for chloride (Fig 11). Indeed, the titration curve 
fits well for a 1:3 complex: 3 F- atoms are complexed by one receptor molecule 
through six hydrogen bonds. A first fast exothermic complexation is observed until 
one equivalent of guest is added, then a second one until two equivalents, followed by 
a last slow endothermic interaction.  
A control ITC titration was achieved between linear receptor 6 and TBAF in 
order to evaluate the influence of the macrocycle in the observed host-guest 
stoichiometry (Fig 11). A similar binding isotherm was however obtained as for 9 
accounting for a 1:3 stoichiometry. The urea functions of macrocycle 9 could easily 
fold to bind one F- atom each, in addition to a guanidinium-fluoride interaction, 
whereas the flexibility of the open chain receptor 6 should allow it to wrap around 
                                                 
35 Bonner, O. D. J. Phys. Chem. 1977, 81, 2247-2249. 
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only one anion. Guest sizes might be responsible for such different binding mode with 
the receptors and halides, as it has been previously reported for receptors bearing two 
urea moieties.36
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   a)     b) 
Fig 11. ITC titrations between TBAF and receptor a) 6 & b) 9 in CH3CN at 303 K. 
 
Thermodynamic parameters from ITC titrations between TBAF and 6 or 9 are 
comparable (Table 5). The first association is both enthalpically and entropically 
driven giving rise to the first guanidinium-fluoride complex because of the ion pair 
and the superior binding strength of the guanidinium moiety over urea (Fig 12). 
The entropic factor is higher for the macrocycle than for the open structure due 
to the release of solvent molecule. The second interaction is mainly entropically 
driven resulting from the formation of one urea-fluoride association. Among the 
several different possible equilibria two are depicted in Fig 12. Binding mode (a) is 
quite difficult to achieve without severe repulsions with both guest anions. As this 
complexation is mainly entropically driven, due to strong release of solvent molecules 
                                                 
36 Kim, K. S.; Kim, H.-S. Tetrahedron 2005, 61, 12366-12370. 
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and much less influenced by electrostatic interactions, model (b) would better fit to 
this complexation (strong rearrangement of the receptor scaffold in order to bind a 
new guest). Eventually, the last complexation is the result of folding the second arm of 
the receptor (again mainly entropically driven and even enthalpically disfavored). 
Because of the different stoichiometries data cannot be compared with Cl- and 
establish selectivity. 
 
 
 
1:1 1:2 1:3 
6    
Ka a 2.52 x 10
5
2.35 x 10
5 106 
∆H  -5.44 -0.60 80.47 
∆S  6.75 22.6 289 
∆G  -7.48 -7.45 -2.82 
9    
Ka a 4.93 x 10
5
1.76 x 10
7
1.93 x 10
4
∆H  -4.24 -0.84 2.20 
∆S  12.0 30.4 26.9 
∆G  -7.88 -10.05 -5.95 
               aKa in M-1, ∆H and ∆G in kcal mol-1, ∆S in cal mol-1 K-1. 
 
Table 5. Thermodynamic parameters between TBAF and 6 and 9 evaluated by ITC. 
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Fig 12. Binding steps for a 1:3 complex of 9 (F-)3. 
 
2.3.4 Influence of Stereochemistry of the Guanidinium Scaffold on Anion 
Association  
 
Measuring the influence of the guanidinium scaffold stereochemistry under the 
molecular recognition of anions appears to be relevant in a rational design approach to 
improve the receptor for nitrate. In achiral (R,S) guanidinium receptors both arms are 
oriented towards the same side of the bicyclic main plane, which might favor the 
binding of planar anions such as nitrate (Fig 4a, side view of optimized geometry 
representing a planar arrangement of the 3:1 urea:nitrate complex). The best receptor 
for nitrate 9 and macrocycle 10 with a rigid aromatic xylylene spacer were thus 
proposed as optimal candidates in this respect (Chart 1). (R,S)-9 and (R,S)-10 were 
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synthesized similarly as their (R,R) analogue with similar yields, and ITC titrations 
were performed (Ka and thermodynamic parameters are shown in Table 6). 
 
N
N
N
H H
+
S S
PF6-
NH HN
O ONH HN
N
N
N
H H
+
S S
PF6-
NH HN
O ONH HN
(R,S)-9 (R,S)-10  
 
Chart 1. Achiral receptor (R,S)-9 and (R,S)-10. 
 
Binding constants are similar for spherical anions Cl- and Br- and also for the 
sterically unhindered carboxylate AcO- whereas the association diminishes for 
aromatic benzoate. Nitrate behaves different with a Ka decreasing for (R,S)-9 and 
increasing for (R,S)-10. A common trend is an enthalpy increase and an entropy 
decrease when going from the (R,R) to the (R,S) series. There is a general 
compensation between both contributions governing the overall association. The 
enhancement of enthalpy may be due to a better orientation of the NH towards the 
guest leading therefore to a better match between complexing partners. Electrostatic 
interactions are thus favored for the meso form (R,S) with respect to the chiral (R,R) 
one. Consequently, the release of solvent molecules participates less as the pre-
organization of the receptor is more effective. The well balanced association between 
enthalpy and entropy observed for (R,R)-9 translates into a mainly enthalpy driven 
process for (R,S)-9. This remark is not that obvious for (R,S)-10 as the binding is 
strongly entropic for NO3-, Cl- and Br-. 
 (R,S)-9 is selective toward Cl- (one order of magnitude higher than Br-, AcO- 
and BzO- and two orders of magnitude higher than NO3-) whereas (R,S)-10 does not 
differentiate so strongly between these anions ( 12.1 < Ka < 232 x 103 M-1). 
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 NO3- Cl
- Br- AcO- BzO-
(R,S)-9      
Ka (103)a 17.4 2040 176  371 201 
∆H  - 3.43 - 7.89 -4.15 - 7.23 -7.75 
∆S  8.08 2.83 10.3 1.62 -1.39 
∆G  -5.88 - 8.75 -7.27 - 7.71 -7.33 
(R,S)-10      
Ka (103)a 12.1 232 98.7 69.7  42.7 
∆H  - 1.89 - 3.32 -1.69 - 5.47 -6.33 
∆S  12.4 13.6 17.3 4.07 0.31 
∆G  -5.65 - 7.44 -6.94 - 6.71 -6.42 
              a Ka in M-1, ∆H and ∆G in kcal mol-1, ∆S in cal mol-1 K-1. 
 
Table 6. Thermodynamic parameters evaluated by ITC titrations of TBA salts 
complexation by (R,S)-9 and (R,S)-10. 
 
(R,S)-10 affords one of the best binding constants so far measured for NO3- with 
the urea receptors (10 < 6 < 7 < (R, S)-10 ≈ 8 ≈ (R, S)-9 < 9). Nevertheless the 
association remains strongly entropically driven. Predictably, nitrate inclusion will 
take place when the association is both enthalpically and entropically driven, and even 
when the enthalpic factor is much higher, such as for (R,S)-10, it seems that the cavity 
is still too tight to allow the guest properly fitting inside. 
 
2.3.5 Liquid-Liquid Extractions: CH-π Interactions 
 
Among macrocycles, 10 presents the weakest binding although it possesses the 
advantage of an aromatic surface linking the two urea functions. Aromatic host-guest 
interactions would afford a new stabilization for carboxylates. Single liquid-liquid 
extraction between 10 (in CH2Cl2) and sodium benzoate (NaBzO, saturated water 
solution) allows formation of the 1:1 complex. However, control experiments with the 
6 (BzO-) and 10 (AcO-) did not show any significant shift of the aromatic protons of 
both host and guest. Indeed, a NOESY experiment confirmed the absence of contact 
between the aromatic protons of host and guest. Nevertheless, the guest methyl group 
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of 10 (AcO-) was shifted upfield up to 1.56 ppm. Control experiments between 8 (with 
a five carbon atoms spacer instead of a xylylene) or 6 (linear host) and NaAcO did not 
show any shift of the acetate methyl group (δ (CH3) = 2.05 ppm for 8 and 6, Fig 13). 
This significant 0.5 ppm upfield shift accounts for CH-π interactions between the 
acetate methyl group and the aromatic ring of the xylylene spacer 10 (Fig 14). A 
similar shift was obtained for (R,S)-10 in 1H-NMR. 
 
CH3
a)
b)
c)
 
 
Fig 13. 1H-NMR spectra of the organic phase after liquid-liquid extractions between 
aqueous NaAcO and an organic solution of a) 10, b) 8 and c) 6. 
 
Although CH-π interactions can be considered as weak hydrogen bonds, various 
examples in chemistry and biology have been reported, using experimental methods 
such as X-Ray, NMR and IR.37 However, the enthalpic contribution of one CH-π 
interaction is rather small compared to other H-bonds (about 1 kcal mol-1).38 From ITC 
titration, acetate gives the lowest binding with receptor 10. These interactions are 
indeed not detectable in a quantitative manner compared to the strong interaction 
between the carboxylate and the NHs of the host. 
                                                 
37 Castellano, R. K.; Diederich, F.; Meyer, E. A. Angew. Chem. Int. Ed. 2003, 42, 1210-1250. 
38 Nishio, M.; Umezawa, Y.; Hirota, M.; Takeushi, Y Tetrahedron 1995, 51, 8665-8701. 
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Fig 14. CH-π interactions between the acetate CH3 and the xylylene spacer. 
 
In order to further study these CH-π interactions, single extractions with 
NaC2H5COO and NaC3H7COO have been performed. Figure 15 shows again an 
upfield shift for CH2 and CH3 of the guest when complexed with 10 (0.43 ppm upfield 
shift of δ (CH2) and 0.25 ppm upfield shift of δ (CH3)). This interaction diminishes 
from acetate to propionate but still remains significant. Besides, the shift is higher for 
CH2 than for CH3 because of the closer environment and lower flexibility.  
 
CH3
a)
b)
CH2
 
 
Fig 15. 1H-NMR spectra of the organic phase after liquid-liquid extractions between 
aqueous NaC2H5COO (0.1M-1) and an organic solution of a) 10 and b) 6. 
 
Extractions with butyrate gave a similar pattern (0.28 ppm upfield shift of δ 
(CH2), 0.17 ppm upfield shift of δ (CH2) and 0.10 ppm upfield shift of δ (CH3), Fig 
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16). Therefore, as the carbon chain of the carboxylate increases, the magnitude of the 
shift decreases (accounting for the higher flexibility of the guest). 
 
CH3
a)
b)
CH2
CH2
 
 
Fig 16. 1H-NMR spectra of the organic phase after liquid-liquid extractions between 
aqueous NaC3H7COO (0.1M-1) and an organic solution of a) 10 and b) 6. 
 
 
2.4 X-Ray Solid State Structures  
 
7 (NO3-) was able to crystallize in CH3CN and its X-ray solid state structure was 
resolved (an ORTEP plot is shown in Fig 17). The asymmetric unit contains three 
independent molecules partially disordered (molecules A/B/C). The NO3- anion and 
the NHs of the hydrogen bond donor functions are not affected by this disorder (atoms 
C2, C3, C4 and C25, C26, C27 involved). The three refined independent molecules 
differ broadly in their conformations, but have a similar arrangement of the NO3- in 
the center of the molecule. In all cases, NO3- is bound to both NHguan and to one of the 
NHurea of only one of the urea functions (distances in Table 8). The second urea is 
pointing away from the macrocycle cavity forming intermolecular hydrogen bonds 
with another urea (NH···O=C hydrogen bonding network). As a result, the macrocycle 
is strongly folded with the guest pointing to the centre of the molecule with only two 
of the oxygen atoms located in this central area. The third oxygen is pointing to 
neighboring molecules achieving additional intermolecular contacts. Besides, for 
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molecule B, the distance between one oxygen atom of the urea group and a sulfur 
atom is shorter than the sum of their Van der Waals radii (S2B···O2B: 3.07 Å). 
 
 
 
Fig 17. ORTEP plot of the X-ray structure of 7 (NO3-). 
 
8 (NO3-) single crystals were obtained in CH2Cl2 and the crystal cell contains 
two independent molecules (A/B) (A is shown as an ORTEP plot in Fig 18). In both 
cases the guest forms hydrogen bonds with the two NHguan and the four NHurea (see 
distances in Table 8). Considering the plane formed by the nitrogen atoms of the 
bicyclic guanidinium scaffold, the guest is not exactly oriented in a planar 
arrangement to it. Indeed, nitrate forms a dihedral angle of 24.0º/9.7º (A/B) with 
respect to this latter. The pentane chain in between the urea moieties is folded out of 
the defined plane, and one of the guest oxygen atoms (O3S) is thus pointing outside 
the ring. On the other hand, there is a dihedral angle formed between planes (N1, N2, 
N7) and urea groups in opposite directions (21º/27º (A) and 12º/35º (B)). Again, 
distances between one of the oxygen atoms of the anion and one of the sulfur atoms, is 
shorter than the sum of their Van der Waals radii (S2···O2: 3.221/3.218 Å). Moreover, 
no relevant intermolecular interactions can be observed in this structure. 
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Fig 18. ORTEP plot of the X-ray structure of 8 (NO3-). 
 
9 (NO3-) crystallizes in DMF and only one independent molecule was observed 
for the hexylene chain between the urea functions (C13-C18), although disordered in 
two orientations (Fig 19). The nitrate is not located at the same plane as the 
guanidinium (defined by the N1, N2, and N7 atoms), so NHguan are not pointing to the 
centre of the macrocyclic ring. A dihedral angle of 49.2º is indeed formed between the 
(N1, N2, N7) plane and the guest. In contrast, the planes of the aromatic rings form a 
dihedral angle of only 17.4º. Despite the observed angle between (N1, N2, N7) and the 
nitrate, NHguan are forming hydrogen bonds with two oxygen atoms of the anion 
(distances in Table 8). Both NHurea bind also to the guest’s oxygen atoms with O3S 
located between N4 and N5. Due to the different orientation of the bicyclic 
guanidinium fragment compared to the two previous molecules, the measured dihedral 
angles between the urea groups and the (N1, N2, N7) plane are not comparable 
(64.3º/26.2º). Therefore, the dihedral angles formed between the urea plane and the 
nitrate were considered (24.9º/34.2º). Again, the distances between the sulfur atoms 
and respectively one of the oxygen atoms of the anion, are shorter than the sum of 
their Van der Waals radii (S2···O2: 3.220/3.305 Å). 
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Fig 19. ORTEP plot of the X-ray structure of 9 (NO3-). 
 
(R,S)-9 (NO3-) structure was also resolved by single crystal X-ray diffraction 
(Fig 20). The macrocycle shows a more pronounced folding arrangement than in the 
case of (R,R)-9 (NO3-). The guest presents a more distorted arrangement with two 
oxygen atoms (O2S, O3S) pointing towards one urea group (N6, N5) and the third 
oxygen atom (O1S) pointing away from the ring. The shortest hydrogen bonds are 
between (O2S) and (N7) and (N6) (Table 8). The dihedral angle between (N1, N2, 
N7) and the nitrate is 45.7º [similar to the (R,R)-9 (NO3-) one]. However, the angle is 
more pronounced due to an axial rotation of the anion with O1S out of the macrocycle. 
The dihedral angles (26.5º, 15.0º) between (N1, N2, N7) and the urea groups are lower 
than for (R,R)-9 (NO3-). Interestingly, the sulfur atoms do not show any relevant 
interactions with the nitrate oxygens. 
 The comparison of the long range contacts in (R,S)-9 gives shorter distances 
(NO3-) between the sulfur atoms and between N3 and N6. The distance between N4 
and N5 is slightly longer (Table 7). 
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Fig 20. ORTEP plot of the X-ray structure of (R,S)-9 (NO3-). 
 
Distances (Å) (R,R)-9 (NO3-). (R,S)-9 (NO3-). 
 
S1···S2 
 
7.37 
 
7.06 
N3···N6 7.73 7.59 
N4···N5 5.39 5.46 
 
Table 7. Long range contacts in (R,R)-9 (NO3-) and (R,S)-9 (NO3-). 
 
  Most remarkably, in the solid state, all four nitrate salts behave as predicted and 
anticipated from the studies in solution. Salt 7 displays a distorted structure, with one 
urea twisted away from the cavity (hydrogen-bonded to an urea from another 
macrocycle) and only three well identified hydrogen bonds with the nitrate. On the 
contrary, in 8, (R,R)-9 and (R,S)-9 the nitrate nicely fits inside the cavity surrounded by 
six NH donors. Moreover, the X-ray structure shows that the guest oxygen atoms form 
two hydrogen bonds with the host in such a way that each oxygen shares its lone pairs 
with single NH donors from different functions (ureas or guanidinium). This orientation 
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(Fig. 4b) is preferred in the solid state over the alternative one where the oxygen lone 
pairs bind to NH donors from the same function (Fig. 4c). These results are thus in good 
agreement with energy data from the computational study by Hay et al.24 Optimized 
geometry of a 3:1 urea:NO3- complex shows a planar arrangement (Fig 4a) whereas 
none of the 3:1 guanidinium/urea: NO3- complexes reported in the literature display a 
planar arrangement (Fig 21). 
 
 a)    b)    c) 
Fig 21. Binding motifs from the X-ray structures of a) 8 (NO3-) 
b) (R,R)-9 (NO3-) and c) (R,S)-9 (NO3-). 
 
It is tempting to compare association constants in solution to structures in the 
solid state, so hydrogen bonds distances were therefore evaluated (Table 8). The 
weakest Ka is given by macrocycle 7 which has only three well identified H-bonds 
with the nitrate. 8 and (R,S)-9 give a similar association constant with nitrate whereas 
for (R,R)-9 this value is multiplied by a factor of 5. 8 possesses two strong H-bonds 
between the guanidinium moiety and the oxygen guest (2.03 and 2.04 Å) but the four 
other ones from the two urea moieties (> 2.20 Å) are much weaker. In contrast, (R,R)-
9 provides five strong H-bonds (< 2.20 Å) and only one weak one (2.32 Å). 
Eventually, (R,S)-9 gives three strong and three weak H-bonds. In all cases, the H-
bonds between the NHguan and the oxygens guest are strong (< 2.10 Å), with the 
exception of one in (R,S)-9 (2.31 Å) due to the orientation of one oxygen guest away 
from the cavity (Fig 21). Even though the orientation is not optimal in all cases (no 
planar arrangements), the hydrogen bond distances in the solid state provide 
interesting details on the different binding properties of each receptor. 
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Distance in Åa 7 8 9 (R,S)-9 
 
O1S···N2 (O1S···H2) 
 
2.887 (2.04) 
 
2.864 (2.04) 
 
2.842 (2.02) 
 
3.135 (2.31) 
O2S···N7 (O2S···H7) 2.884 (2.03) 2.883 (2.03) 2.951 (2.10) 2.917 (2.07) 
O1S···N3 (O1S···H3) 2.904 (2.05) 3.205 (2.39) 3.114 (2.32) 3.089 (2.35) 
O3S···N4 (O3S···H4) 3.082 (2.30) 3.036 (2.28) 2.932 (2.18) 3.047 (2.17) 
O3S···N5 (O3S···H5)  3.067 (2.23) 2.903 (2.07) 3.095 (2.26) 
O2S···N6 (O2S···H6)  3.074 (2.23) 3.048 (2.19) 2.961 (2.10) 
a The observed distances to hydrogen atoms are uncorrected. 
Table 8. Intramolecular contacts of 7, 8, 9 and (R,S)-9 with NO3-. 
 
4 (Cl-) crystallizes in an ideal C2 symmetry with two independent half molecules 
(A/B) in the crystal packing (Fig 22). The independent molecules differ in the 
orientation of the aromatic rings and the conformation of the central bicyclic 
guanidinium. The guest is located on the C2-axis centered between the hydrogen atoms 
of N2 forming hydrogen bonds (Table 9). On the other hand, the guest is stabilized by 
one of the hydrogen atoms of each N3. Moreover, chloride has intermolecular contacts 
to different hydrogen atoms of neighboring molecules: the shortest one is with the N3-
atoms (Cl1A···N3B2: 3.705, Cl1A···H3BE 2.83 Å, uncorrected). Considering the plane 
(C1, N1, N2) and the plane formed by N3 and the hydrogen atoms linked to it a 
dihedral angle of 41.8º/49.1º (A/B) results. This dihedral angle indicates that one 
hydrogen atom of N3 is pointing to the central Cl- whereas the second one is pointing 
to the guest of a neighboring molecule. 
 
2.4 X-Ray Solid State Structures  
_____________________________________________________________________ 
 
 
Fig 22. ORTEP plot of the X-ray structure of 4 (Cl-). 
 
The X-ray solid structure of 9 (Cl-) also shows an ideal C2 axis of symmetry 
with a half molecule in the crystal packing (Fig 23). As for 4 (Cl-), the guest is located 
on the C2-axis, centered between the six NHs and forming hydrogen bonds with all of 
them (Table 9). It can be observed that the atoms N1, C1, N2, Cl2, C15 and their 
symmetry equivalents are located on a same plane with the C2-axis crossing at the 
center of the bond formed by C15/C15’ and on the atoms C1 and N1. In contrast, the 
urea group formed by the nitrogen atoms N3 and N4 is out of the described plane, 
pointing to the guest rotated to each side. Considering the described plane and the 
plane formed by one of the ureas, a dihedral angle of 41.14º can be measured. In 
agreement with the ideal C2 symmetry observed, the identical urea groups at the same 
molecule are rotated to opposite directions. Only weak intermolecular interactions can 
be observed. 
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Fig 23. ORTEP plot of the X-ray structure of 9 (Cl-). 
 
Distance in Å 4 9 
 
Cl1···N2 (Cl1···H2) 
 
3.220 (2.40) 
 
3.405 (2.54) 
Cl1···N3 (Cl1···H3) 3.495 (2.73) 3.344 (2.57) 
Cl1···N4 (Cl1···H4)  3.301 (2.51) 
  a The observed distances to hydrogen atoms are uncorrected. 
Table 9. Intramolecular contacts of 4 and 9 with Cl-. 
 
8 (AcO-) crystallizes in two independent molecules (A/B) (Fig 24). Both 
macrocycles crystallize with the two anion oxygen atoms pointing to the center of the 
molecules and the methyl group having a weak intermolecular interaction with the 
carbonyl function of neighboring urea groups (C···N: 3.137/3.231 Å). The NHguan 
protons point to the acetate oxygen atoms forming well oriented hydrogen bonds 
(Table 10). The H-bonds are slightly shorter than the one previously reported from a 
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bicyclic guanidinium-based receptor acetate complex (2.850 Å).39 Moreover, the 
NHurea point to one of the oxygen atoms of the anion. Considering the plane (N1, N2, 
N7) and the one formed by the urea groups, dihedral angles of 17.5º/23.4º (molecule 
A) and 3.2º/29.2º (molecule B) in opposite directions are observed. Particularly 
interesting is the orientation of the hydrogen bonds O2···N5 and O1···N4 (Fig 25). 
Whereas the NHguan and the NHurea (located five atoms away) are forming hydrogen 
bonds with the lone pairs of the oxygen guest, N4 and N5 contact to the π-system of 
the acetate guest. These NH-π H-bonds have been previously reported by Anslyn et 
al.8,40 These additional hydrogen bonds enhance stabilization of the complex (this is 
consistent with the enthalpic factor increase observed by ITC). 
 
 
 
Fig 24. ORTEP plot of the X-ray structure of 8 (AcO-). 
 
 
 
 
 
 
                                                 
39 Müller, G.; Riede, J.; Schmidtchen, F. P. Angew. Chem. Int. Ed. Engl. 1988, 27, 1516-1518. 
40 Snowden, T. S.; Bisson, A. P.; Anslyn, E. V. J. Am. Chem. Soc. 1999, 121, 6324-6325. 
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Distance in Åa 8 
 
O1S···N2 (O1S···H2) 
 
2.812 (1.93) 
O2S···N7 (O2S···H7) 2.806 (2.10) 
O1S···N3 (O1S···H3) 3.273 (2.65) 
O1S···N4 (O1S···H4) 2.928 (2.24) 
O2S···N5 (O2S···H5) 2.858 (2.06) 
O2S···N6 (O2S···H6) 2.947 (2.28) 
  a The observed distances to hydrogen atoms are uncorrected. 
Table 10. Intramolecular contacts of 8 with AcO-. 
 
 
Fig 25. Binding motif from the X-ray structure of 8 (AcO-) 
(only three H-bonds are shown for clarity). 
 
Comparison of these X-ray structures revealed that the guanidinium-based 
receptors are flexible enough to adapt themselves to the guest structures. Spherical 
anions of suitable size (such as Cl-) fit nicely inside the macrocycle cavity of 9 with 
six strong hydrogen bonds wrapping around the anion. The structural results in the 
solid state are in good agreement with those obtained in solution (ITC titrations) and 
by the theoretical model studies by Hay et al. (Fig 26). 
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  a)      b) 
 
Fig 26. a) Top and side views of B3LYP optimized geometries for representative 
examples of 3:1 urea: Cl- complexes24 and b)binding motif from the X-ray structure of 
(R,R)-9 (Cl-). 
 
 
2.5 Conclusions 
 
In this chapter, guanidinium-based macrocycles have been synthesized and their 
binding ability measured. 8, 9 and (R,S)-9 shown an enthalpy driven nitrate 
complexation with all six lone pairs of the guest complemented by well oriented 
hydrogen bond donors from the guanidinium and urea moieties. All complexes show a 
1:1 stoichiometry apart from small and strongly basic F- which comes up with a 1:3 
complex. Selective complexation towards a spherical guest of suitable size (Cl-) was 
shown in solution. Additionally, macrocycle 10 with an aromatic moiety displays CH-
π interactions towards different carboxylate anions. Solid state X-ray crystal structures 
have been resolved for several complexes showing the inclusion of nitrate, chloride 
and acetate inside the cavity of the macrocyclic guanidinium receptors, and shedding 
light on the structural parameters governing the binding. 
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2.6 Experimental section 
 
2.6.1 General Procedures 
 
Synthesis. All commercially available reagents (Aldrich, Fluka, Acros, 
NovaBiochem, Panreac) were used without any further purification. The solvents were 
dried and distilled as described in the literature.41 Unless specified, all reactions were 
performed under nitrogen.  
Chromatography. Thin layer chromatography (TLC) was performed on 
aluminum supported Alugram Sil G/UV254 (Macherey-Nagel). Column 
chromatography was done using silica gel by SDS (chromagel 60 ACC, 40-60 mm) 
following the procedure described by W. C. Still.42 HPLC chromatograms were 
recorded on an Agilent Technologies Serie 1100, with UV-diode array, fluorescence 
and light scattering detectors. The template synthesis experiments was followed by 
analytical HPLC (column: Synergi Max-RP 4 µm, 4.6 x 250 mm, UV-detector with λ 
= 254 nm). The mobile phase consisted of (ACN (0.1% TFA) / H2O (0.1% TFA), 
gradient: 35-100% ACN (0.1%TFA) in 15 minutes. The solvents were provided by 
Scharlau (HPLC gradient grade). 
Analysis. Melting points were measured with a Büchi B-540 apparatus. The 
optical rotations [α]25D were determined on a Perkin-Elmer 241 MC polarimeter using 
a cell (1 dm) at 20°C (NaD 589 nm). 1H-NMR and 13C-NMR spectra were recorded on 
a Bruker Avance 500 Ultrashield NMR spectrometer (1H: 500 MHz; 13C: 125 MHz) 
using the residual solvent peak as internal standard. Mass spectra were recorded on a 
Waters LCT Premier spectrometer using ESI technique or on a Bruker Autoflex 
MALDI-TOF instrument. Elemental analyses were performed on Perkin-Elmer 2400 
CHN and 2400 CHNS apparatus. 
ITC titrations. ITC titrations were performed using an isothermal titration 
Microcal VP-ITC microcalorimeter. All measurements were performed at 303K. The 
host solution was filled into the cell of the ITC instrument and guest solutions were 
added with the syringe. In each case control experiments with dilution of guest in the 
 
41 Perrin, D. D.; Perrin, D. R.; Amarego, W. L. F. Purification of Laboratory Chemicals, 2nd 
Edition, Pergamon Press Ltd, Oxford, 1980. 
42 Still, W. C.; Kahn, M.; Mitra, A. J. Org. Chem. 1978, 43, 2923-2925.  
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solvent were performed and were found to be negligible. Concentration of host (PF6-) 
(c = 1 mM in acetonitrile) and concentration of guest, tetrabutylammonium salts (c = 
14 mM in acetonitrile) were similar for all titrations. The volume of injection was 5 
µL and the stirring speed was 300 rpm. The solvent was previously degassed by 
sonication during 15 minutes. Titrations were made 3 times in order to be 
reproducible. Analysis and curve fitting was done using the software Origin 7. 
Samples were weighted with a microbalance Mettler Toledo MX5. 
Tetrabutylammonium salts of acetate, benzoate and chloride were weighted in a dry 
box.  
1H NMR titrations. Two standard solutions were prepared in acetonitrile, one for 
the receptor ([R]0 = 0.005 M) and the other one for the substrate and receptor together 
([S] = 0.05M and [R]0 = 0.005M). All titrations were performed using an initial 
amount of 0.5 mL of receptor solution. To this solution was added an increasing 
amount of standard solution of the substrate (0.4 mL, 0 up to 5 equivalents). After 
each addition, the 1H NMR spectra was registered and the variation in the chemical 
shifts of the protons affected were plotted against guest concentration. Association 
constants were obtained by using a non-linear square curve fitting program.43
 
2.6.2 Synthesis 
 
(2R,8R)-2,8-Bis-(hydroxymethyl)-3,4,6,7,8,9-hexahydro-2H-pyrimido-[1,2-a]-
pyrimidin-1-ium chloride (2). 
 
N
NH
NH
OTBDPS
OTBDMS
Cl- N
NH
NH
OH
OH
Cl-
3N HCl:CH3CN
(97%)
1 2  
Procedure 
A solution of 1 (3 g, 5.10 mmol) in 3 N HCl/CH3CN (1:2, 75 mL) was stirred at room 
temperature for 2 days. The solvent was removed and the resulting crude dissolved in 
H2O (50 mL) and washed with CH2Cl2 (4 × 50 mL). The aqueous phase was 
                                                 
43 http://www.shef.ac.uk/uni/projects/smc/software.html 
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evaporated under reduced pressure affording 2 (1.16 mg, 97%) as a white solid. Mp 
178-180°C. [α]25D -64 (c = 0.5, H2O). 1H-NMR (200 MHz, D2O) δ 3.46 (m, 2H, 
CH2O), 3.35 (m, 2H, CH2O), 3.32 (m, 2H, CHα), 3.26-3.13 (m, 4H, CH2γ), 1.86-1.66 
(m, 4H, CH2β). 13C-NMR (50 MHz, D2O) δ 151.2 (Cguan), 64.3 (CH2O), 48.8 (CHα), 
45.0 (CH2γ), 22.7 (CH2β). FAB/LSIMS m/z 200.13 [(M - Cl–)+, 100%]. 
 
(2R,8R)-2,8-Bis-(chloromethyl)-3,4,6,7,8,9-hexahydro-2H-pyrimido-[1,2-a]-
pyrimidin-1-ium chloride (3). 
 
N
NH
NH
OH
OH
Cl- N
NH
NH
Cl
Cl
Cl-
(95%)
2 3
SOCl2
 
 
Procedure 
A solution of compound 2 (350 mg, 1.48 mmol) in SOCl2 (12 mL) was stirred at 
reflux for 4 h. The solvent was removed and the crude was purified by silica gel 
column chromatography eluting with a solvent mixture (CH2Cl2/MeOH, 96:4) 
afforded 3 (379 mg, 95%) as a light yellow solid. Mp 76-79°C. [α]25D -16 (c = 0.5, 
CHCl3). 1H-NMR (500 MHz, CDCl3) δ 8.57 (s, 2H, NH), 3.57-3.53 (m, 2H, CH2Cl), 
3.50-3.40 (m, 4H, CH2Cl, CHα), 3.28-3.25 (m, 4H, CH2γ), 2.02-1.96 (m, 2H, CH2β), 
1.86-1.80 (m, 2H, CH2β). 13C-NMR (125 MHz, CDCl3) δ 151.3 (Cguan), 49.4 (CH2Cl), 
44.2 (CHα), 45.6 (CH2γ), 23.5 (CH2β). ESI-MS m/z 236.1 (M - Cl–)+. 
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(2R,8R)-2,8-Bis-((2-aminophenylthio)methyl)-3,4,6,7,8,9-hexahydro-2H-
pyrimido[1,2-a]pyrimidin-1-ium hexafluorophosphate (4). 
 
N
NH
NH
Cl
Cl
Cl- N
NH
NH
S
S
PF6-(60%)
3 4
NH2
NH2
2-aminothiophenol,
KOtBu, NaI, Acetone
 
 
Procedure 
To a solution of guanidinium salt 3 (200 mg, 0.73 mmol) in acetone (20 mL) were 
added NaI (440 mg, 2.93 mmol), potassium tert-butoxide (400 mg, 3.52 mmol) and 2-
aminothiophenol (0.39 mL, 3.66 mmol). The mixture was then stirred for 4 hours. 
After evaporation of the solvent, the resulting solid was dissolved in CH2Cl2, washed 
with a 0.1N NH4PF6 solution and dried under Na2SO4. The organic layer was filtered 
over cotton and concentrated in vacuo. Purification by silica gel column 
chromatography (CH2Cl2/MeOH, 97:3) afforded 4 (190 mg, 60%) as a yellow pale 
solid. Mp 162-164ºC. [α]D25 -105.76 (c = 0.5, CHCl3). 1H-NMR (500 MHz, CD3CN) 
δ 7.35 (dd, J = 1.5, 7.7 Hz, 2H, CHAr), 7.09 (td, J = 1.4, 7.5 Hz, 2H, CHAr), 6.81 (s, 
2H, NHguan), 6.67 (dd, J = 1.2, 7.9 Hz, 2H, CHAr), 6.61 (td, J = 1.1, 7.4 Hz, 2H, CHAr), 
3.40 (m, 2H, CHα), 3.24 (m, 10H, CH2γ, CH2S, NH2), 2.80 (dd, J = 1.1, 7.4 Hz, 2H, 
CH2S), 2.16-1.75 (m, 4H, CH2β). 13C-NMR (CD3CN, 125 MHz) δ 150.8 (Cguan), 148.8 
(CN), 136.1, 130.3, 118.3, 115.6, 115.2 (CHAr, CAr), 47.9 (CHα), 45.4 (CH2S), 39.5 
(CH2γ), 25.6 (CH2β). ESI-MS m/z 414.2 (M-PF6-)+. 
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(2R,8R)-2,8-bis((2-acetamidophenylthio)methyl)-3,4,6,7,8,9-hexahydro-2H-
pyrimido[1,2-a]pyrimidin-1-ium hexafluorophosphate (5). 
 
N
NH
NH
S
S
PF6-(75%)
4 5
HN
HN
N
NH
NH
S
S
PF6-
NH2
NH2
O
O
CH3COOH, PyBOP, HOBt,
NMM, CH2Cl2
 
 
Procedure 
To a solution of acetic acid (0.006 mL, 0.10 mmol) in CH2Cl2, were added N-
methylmorpholine (NMM) (0.012 mL, 0.10 mmol), PyBOP (0.054 g, 0.10 mmol) and 
HOBt (catalityc amount) After stirring for 15 minutes, guanidinium salt 4 (0.03 g, 
0.05 mmol) was added and the mixture was stirred overnight. After evaporation of the 
solvent, the resulting solid was dissolved in CH2Cl2, washed with a 0.1N NH4PF6 
solution and dried under Na2SO4. The organic layer was filtered over cotton and 
concentrated in vacuo. Purification by silica gel column chromatography 
(CH2Cl2/MeOH, 98:2) afforded 5 (23 mg, 70%) as a yellow pale solid. Mp 167-169ºC. 
[α]D25 -50.65 (c = 1, CHCl3). 1H-NMR (500 MHz, CD3CN) δ 8.42 (s, 2H, NHguan), 
7.74 (d, J = 7.3 Hz, 2H, CHAr), 7.51 (d, J = 7.8 Hz, 2H, CHAr), 7.28 (t, J = 7.1 Hz, 2H, 
CHAr), 7.19 (t, J = 7.0 Hz, 2H, CHAr), 7.02 (s, 2H, NHAmide), 3.24-2.84 (m, 8H, CH2γ , 
CHα, CH2S), 2.71 (dd, J = 1.2, 7.5 Hz, 2H, CH2S), 1.92-1.78 (m, 4H, CH2β), 1.77 (m, 
6H, CH3).13C-NMR (CD3CN, 125 MHz) δ 168.9 (CO), 149.8 (Cguan), 140.4, 130.2, 
129.5, 124.1, 123.9, 116.2 (CHAr, CAr), 46.5 (CHα), 45.3 (CH2S), 39.2 (CH2γ), 25.7 
(CH2β), 25.6 (CH3). ESI-MS m/z 498.2 (M-PF6-)+. 
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(2R,8R)-2,8-Bis-((2-(3-butylureido)phenylthio)methyl)-3,4,6,7,8,9-hexahydro-2H-
pyrimido[1,2-a]pyrimidin-1-ium hexafluorophosphate (6). 
 
N
NH
NH
S
S
PF6-(85%)
4 6
HN
HN
N
NH
NH
S
S
PF6-
NH2
NH2
O
HN
O
HN
butylisocyanate,
dry CH2Cl2
 
 
Procedure 
To a solution of guanidinium salt 4 (100 mg, 0.18 mmol) in dry CH2Cl2 (2 mL) in a 
sealed tube was added butylisocyanate (45 µL, 0.39 mmol) under nitrogen atmosphere 
and the mixture was stirred overnight at 45ºC. After evaporation of the solvent, the 
resulting solid was dissolved in CH2Cl2, washed with a 0.1N NH4PF6 solution and 
dried under Na2SO4. The organic layer was filtered over cotton and concentrated in 
vacuo. Purification by silica gel column chromatography (CH2Cl2/MeOH, 98:2) 
afforded 6 (110 mg, 80%) as a yellow pale solid. Mp 169-171ºC. [α]D25 -175.76 (c = 
0.5, CHCl3). 1H-NMR (500 MHz, CD3CN) δ 8.34 (d, J = 7.3 Hz, 2H, CHAr), 7.50 (d, J 
= 7.8 Hz, 2H, CHAr), 7.37 (s, 2H, NHguan), 7.26 (t, J = 7.1 Hz, 2H, CHAr), 7.12 (t, J = 
7.41 Hz, 2H, CHAr), 7.09 (s, 2H, NHurea), 5.91 (s, 2H, NHurea), 3.24-2.84 (m, 10H, 
CH2γ , CHα, CH2), 3.14 (dd, J = 1.1, 7.4 Hz, 2H, CH2S), 2.71 (dd, J = 1.0, 7.5 Hz, 2H, 
CH2S), 1.92-1.78 (m, 4H, CH2β), 1.58 (m, 4H, CH2), 1.39 (m, 4H, CH2), 0.89 (t, J = 
7.6 Hz, 6H, CH3). 13C-NMR (CD3CN, 125 MHz) δ 155.6 (CO), 150.0 (Cguan), 138.4, 
134.2, 129.5, 122.1, 119.9, 118.5 (CHAr, CAr), 47.9 (CHα), 45.4 (CH2S), 40.1 (CH2), 
39.5 (CH2γ), 32.2 (CH2), 25.6 (CH2β), 19.7 (CH2), 14.5 (CH3). ESI-MS m/z 612.4 (M-
PF6-)+. 
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(2R,8R) bicyclic guanidinium macrocycle (7). 
 
N
NH
NH
S
S
PF6-(40%)
4 7
HN
HN
N
NH
NH
S
S
PF6-
NH2
NH2
O
HN
O
HN
1,6-diisocyanatobutane,
dry CH2Cl2
 
 
Procedure 
To a solution of guanidinium salt 4 (30 mg, 0.06 mmol) in dry CH2Cl2 (2 mL), in a 
sealed tube was added 1,4-diisocyanatobutane (0.01 mL, 0.06 mmol) under nitrogen 
atmosphere and the mixture was stirred overnight at 45ºC. After evaporation of the 
solvent, the resulting solid was dissolved in CH2Cl2, washed with a 0.1N NH4PF6 
solution and dried under Na2SO4. The organic layer was filtered over cotton and 
concentrated in vacuo. Purification by silica gel column chromatography 
(MeOH/CH2Cl2 100:0 to 98:2) afforded 7 as a pure yellow pale solid. The solid was 
then dissolved in acetonitrile and eluted in a Dowex resin (PF6-) column to obtained 7 
(PF6-) (15 mg, 40 %). Mp 123-125ºC. [α]D25 -76.24 (c = 0.25, CHCl3). 1H-NMR (500 
MHz, CD3CN) δ 7.61 (d, J = 8.3 Hz, 2H, CHAr), 7.48 (d, J = 7.8 Hz, 2H, CHAr), 7.15 
(s, 2H, NHguan), 7.09 (t, J = 7.6 Hz, 2H, CHAr), 6.98 (t, J = 11.0 Hz, 2H, CHAr), 6.82 (s, 
2H, NHurea), 5.92 (s, 2H, NHurea), 3.24-3.06 ( m, 10H, CH2γ, CHα, CH2S), 2.89 (m, 4H, 
CH2), 2.01-1.71 (m, 4H, CH2β), 1.51 (m, 4H, CH2). 13C-NMR (CD3CN, 125 MHz) δ 
165.5 (Curea), 150.6 (Cguan), 140.9, 133.5, 128.5, 121.8, 120.1, 119.6 (CHAr, CAr), 46.9 
(CHα), 44.4 (CH2S), 41.9 (CH2γ), 28.7 (CH2β), 25.9 (CH2), 25.0 (CH2). ESI-MS m/z 
554.2493 (M-PF6-)+. 
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(2R,8R) bicyclic guanidinium macrocycle (8). 
 
N
NH
NH
S
S
PF6-(8%)
4 8
HN
HN
N
NH
NH
S
S
PF6-
NH2
NH2
O
HN
O
HN
11, dry MeOH
 
 
Procedure 
To a solution of guanidinium salt 4 (Cl-) (100 mg, 2.26 mmol) in dry MeOH (6 mL), 
in a sealed tube was added 11 (0.64 mg, 2.26 mmol) under a nitrogen atmosphere and 
the mixture was stirred for two days at 80ºC. After removing the solvent, the resulting 
solid was purified by column chromatography (MeOH/CH2Cl2 100:0 to 98:2) and then 
precipitated in acetonitrile to afford compound 8 (Cl-) as a white pure solid. The solid 
was then dissolved in MeOH and eluted in a Dowex resin (PF6-) column to obtained 8 
(PF6-) (20 mg, 8 %). Mp 136-138ºC. [α]D25 -26.24 (c = 0.25, CH3CN). 1H-NMR (500 
MHz, CD3CN) δ 7.62 (d, J = 7.9 Hz, 2H, CHAr), 7.48 (d, J = 7.8 Hz, 2H, CHAr), 7.23 
(s, 2H, NHguan), 7.05 (t, J = 7.5 Hz, 2H, CHAr), 6.97 (t, J = 7.1 Hz, 2H, CHAr), 6.85 (s, 
2H, NHurea), 5.89 (s, 2H, NHurea), 3.45-2.90 (m, 10H, CH2γ, CHα, CH2S), 2.89 (m, 4H, 
CH2), 2.21-1.81 (m, 4H, CH2β), 1.62 (m, 6H, CH2). 13C-NMR (CD3CN, 125 MHz) δ 
165.5 (Curea), 150.6 (Cguan), 140.9, 133.5, 128.5, 121.8, 120.1, 119.6 (CHAr, CAr), 46.9 
(CHα), 44.4 (CH2S), 41.9 (CH2γ), 28.7 (CH2β), 26.2 (CH2), 25.9 (CH2), 25.0 (CH2). 
ESI-MS m/z 568.3 (M-PF6-)+. 
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(2R,8R) bicyclic guanidinium macrocycle (9). 
 
N
NH
NH
S
S
PF6-(40%)
4 9
HN
HN
N
NH
NH
S
S
PF6-
NH2
NH2
O
HN
O
HN
1,6-diisocyanatohexane,
dry CH2Cl2
 
 
Procedure 
To a solution of guanidinium salt 4 (30 mg, 0.06 mmol) in dry CH2Cl2 (2 mL), in a 
sealed tube was added 1,6-diisocyanahexane (0.01 mL, 0.06 mmol) under nitrogen 
atmosphere and the mixture was stirred overnight at 45ºC. After evaporation of the 
solvent, the resulting solid was dissolved in CH2Cl2, washed with a 0.1N NH4PF6 
solution and dried under Na2SO4. The organic layer was filtered over cotton and 
concentrated in vacuo. Purification by silica gel column chromatography 
(MeOH/CH2Cl2 100:0 to 98:2) afforded 9 as a pure yellow pale solid. The solid was 
then dissolved in acetonitrile and eluted in a Dowex resin (PF6-) column to obtained 9 
(PF6-) (15 mg, 40 %). Mp 151-153ºC. [α]D25 -17.20 (c 0.25, CH3CN). 1H-NMR (500 
MHz, CD3CN) δ 7.70 (d, J = 8.1 Hz, 2H, CHAr), 7.48 (d, J = 7.7 Hz, 2H, CHAr), 7.35 
(s, 2H, NHguan), 7.05 (m, 4H, CHAr), 6.90 (s, 2H, NHurea), 5.82 (s, 2H, NHurea), 3.40(m, 
2H, CH2S), 3.24-2.84 ( m, 12H, CH2γ, CHα, CH2S, CH2), 2.01-1.74 (m, 4H, CH2β), 
1.39-1.25 (m, 4H, CH2). 13C-NMR (CD3CN, 125 MHz) δ 164.9 (Curea), 151.1 (Cguan), 
140.7, 132.8, 128.9, 122.3, 120.2, 119.9 (CHAr, CAr), 47.1 (CHα), 44.1 (CH2S), 41.9 
(CH2γ), 28.7 (CH2β), 25.8 (CH2), 25.1 (CH2), 24.8 (CH2). ESI-MS m/z 582.3 (M-PF6-
)+. 
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(2R,8R) bicyclic guanidinium macrocycle (10). 
 
N
NH
NH
S
S
PF6-(15%)
4 10
HN
HN
N
NH
NH
S
S
PF6-
NH2
NH2
O
HN
O
HN
m-xylylene diisocyanate,
dry CH2Cl2
 
 
Procedure 
To a solution of guanidinium salt 4 (60 mg, 0.10 mmol) in dry CH2Cl2 (4 mL), in a 
sealed tube was added m-xylylene diisocyanate (0.17 mL, 0.10 mmol) under a 
nitrogen atmosphere and the mixture was stirred overnight at 45ºC. After evaporation 
of the solvent, the resulting solid was dissolved in CH2Cl2, washed with a 0.1N 
NH4PF6 solution and dried under Na2SO4. The organic layer was filtered over cotton 
and concentrated in vacuo. Purification by silica gel column chromatography 
(MeOH/CH2Cl2 100:0 to 98:2) afforded 10 as a pure yellow pale solid. The solid was 
then dissolved in acetonitrile and eluted in a Dowex resin (PF6-) column to obtained 10 
(PF6-) (13 mg, 15 %). Mp 170-172ºC. [α]D25 -24.36 (c = 0.5, CH3CN). 1H-NMR (500 
MHz, CD3CN) δ 7.57 (d, J = 8.0 Hz, 2H, CHAr), 7.44 (d, J = 7.9 Hz, 2H, CHAr), 7.37 
(s, 2H, NHguan), 7.31 (m, 6H, CHAr), 7.15 (d, J = 7.9 Hz, 2H, CHAr), 7.04 (t, J = 6.2 Hz, 
2H, CHAr), 6.74 (m, 4H, NHurea, CHAr), 6.23 (s, 2H, NHurea), 4.79 (dd, J = 8.4, 16.7 Hz, 
2H, NCH2), 4.09 (d, J = 17.8 Hz, 2H, NCH2), 3.22-2.77 ( m, 10H, CH2γ, CHα, CH2S,), 
2.19-1.65 (m, 4H, CH2β). 13C-NMR (CD3CN, 100 MHz) δ 156.9 (Curea), 150.4 (Cguan), 
140.7, 139.2, 133.2, 128.5, 128.3, 125.8, 125.2, 124.9, 124.5 (CHAr, CAr), 47.6 (CHα), 
44.4 (CH2N), 43.1 (CH2S), 37.9 (CH2γ), 24.1 (CH2β). ESI-MS m/z 602.5 (M-PF6-)+. 
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N,N'-(pentane-1,5-diyl)bis(1H-imidazole-1-carboxamide) (11). 
 
NH2H2N
H
N
H
NO
N
O
N
N N
11
CDI, THF
(96%)
 
 
Procedure 
To a solution of CDI (0.476 g, 2.978 mmol) in THF, 1,5-diaminopentane (0.114 mL, 
0.978 mmol) was added dropwise. After 30 minutes, the solvent was removed and the 
pure product precipitated as a white solid (280 mg, 96%) in ethyl acetate. M.p. 89-
91°C. 1H-NMR (500 MHz, CD3OD) δ 8.24 (s, 2H, CH), 7.60 (s, 2H, CH), 7.01 (s, 2H, 
CH), 3.35 (t, J = 7.1 Hz, 4H, CH2), 1.79 (q, J = 7.7 Hz, 4H, CH2), 1.67 (m, 2H, CH2). 
13C-NMR (125 MHz, CD3OD) δ 150.8 (CO), 137.4, 130.1, 130.0 (CAr), 41.6 (CH2), 
29.9 (CH2), 25.0 (CH2). 
 
 
2.6.3 X-ray Data 
 
  For crystal growth, a solution of 8 (NO3-) or 8 (AcO-), (3 mg) in CH2Cl2 (1 mL) 
were prepared and then left to evaporate in a saturated atmosphere of hexane for 2 days. 
To a solution of 4 (Cl-) in CHCl3 (3 mg, 05 mL) was added dropwise diethyl ether (0.5 
mL) and the mixture was left to air-evaporate for one day. For 7 (NO3-) and 9 (Cl-), a 
solution in CH3CN (3 mg, 0.5 mL) was left to air-evaporate for three days. For 9 (NO3-), 
(R,S)-9 (NO3-), a solution in DMF (3 mg, 0.5 mL) was left to air-evaporate for 5 days at 
80 ºC in a fume hood. The selected crystals were prepared under inert conditions 
immersed in perfluoropolyether as protecting oil for manipulation. All ORTEP plots are 
shown with ellipsoids drawn at the 50% probability level. 
Data were collected on a Bruker-Nonius diffractometer equipped with a APPEX 
2 4K CCD area detector, a FR591 rotating anode with MoKα radiation, Montel mirrors 
as monochromator and a Kryoflex low temperature device (T = -173 oC). Full-sphere 
data collection was used with ω and ϕ scans. Programs used: Data collection Apex2 
V. 1.0-22 (Bruker-Nonius 2004), data reduction Saint + Version 6.22 (Bruker-Nonius 
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2001) and absorption correction SADABS V. 2.10 (2003). Structure Solution and 
Refinement: SHELXTL Version 6.10 (Sheldrick, 2000) were used.44
The structure of 7 (NO3-) can be solved and refined in the higher symmetric 
orthorhombic chiral space group P212121 or in the lower symmetric monoclinic chiral 
space group P21 as a monoclinic twin which emulates a higher symmetric 
orthorhombic crystal with a β angle close to 90º. In the higher symmetric space group 
the three independent refined structures are partly disordered and the obtained R-
values are higher [R1 = 0.0752 (Fo > 4σFo)]. In the lower symmetric space group 
which refines with better R-values applying a twin matrix (1 0 0 0 -1 0 0 0 -1, basf 
0.43), six different independent molecules without disorder can be refined [R1 = 
0.0654 (Fo > 4σFo)]. In this case the six independent molecules are showing 
correlation effects. In order to discuss the crystal packing and the arrangement of the 
NO3- anions the higher symmetrical and partly disordered structure solution was 
selected. 
The different data obtained for compound 8 (NO3-) corresponded always to the 
overlap of the reflections of more than one crystal. The best R1-value (Fo > 4σFo) 
reached was not lower than 11%. Using the program Gemini45 the overlapped data of 
two crystals could be first separated for integration and later refined as one data set 
taking in account the overlapping reflections. If only the reflections with not overlap 
were considered the R1-value (Fo > 4σFo) reached for 6182 independent reflections 
was 6.86%. If a factor was included for reflections overlapping more than 50% a R1-
value (Fo > 4σFo) 8.12% (20146 reflections) was reached. If different factors were 
applied in correlation with the different degrees of overlapping of the reflections a R1-
value (Fo > 4σFo) 9.31% (35238 reflections) could be reached. For the structure 
description the refinement model with one overlapping factor was used. Additionally 
to the described overlapping of crystals pseudosymmetry from P1 to P-1 was detected, 
being, for a chiral structure, the correct space group P1. 
 
 
 
44 G. M. Sheldrick (1998) SHELXTL Crystallographic System Ver. 5.10, Bruker AXS, Inc.: 
Madison, Wisconsin. 
45 Gemini, Autoindexing Program for Twinned Crystals, Vers. 10.02 Release 5/2000; Bruker 
AXS Inc., Madison, Wisconsin (USA). 
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Table 11. Crystal data for 4 (Cl-), 9 (Cl-), and 7 (NO3-). 
 
Compound 4 9 7 
Formula  C21H28Cl1N5S2 C29H40Cl1N7O2S2 C27H36N8O5S2  
Solvent detected --- --- ¼ H2O for 3 molecules of 7
Formula weight 450.05 618.25 618.09 
Crystal size (mm3) 0.40 x 0.40 x 0.40 0.20 x 0.10 x 0.05 0.10 x 0.02 x 0.01 
Crystal color colorless colorless colorless 
Temp (K) 100 100 100 
Crystal system Orthorhombic Tetragonal Orthorhombic 
Space group  P212121 P41212 P212121
A (Å) 9.7597(4) 10.31310(10) 9.1246(10) 
B (Å) 24.4855(9) 10.31310(10) 20.319(2) 
C (Å) 9.2271(4) 27.9314(7) 47.951(5) 
α (deg) 90 90 90 
β (deg) 90 90 90 
γ (deg) 90 90 90 
V (Å3) 2205.01(15) 2970.78(8) 8890.1(16) 
Z 4 4 12 
ρ (g/cm3) 1.356 1.382 1.385 
µ (mm-1) 0.381 0.310 0.232 
θmax (°) 38.56 39.69 25.39 
Reflec. measured 44207 61564 78274 
Unique reflections 11879 [Rint=0.0371] 8870 [Rint=0.0267] 15128 [Rint=0.0952] 
Obs. Reflec. Fo>4σ(Fo) 10548 8467 11345 
Absorption correction SADABS (Bruker) SADABS (Bruker) SADABS (Bruker) 
Trans. min/max 0.68259/1.00000 0.87131/1.00000 0.71015/1.00000 
Parameters 265 216 1193 
R1/wR2 [I>2σ(I)] 0.0534/0.1384 0.0265/0.0735 0.0748/0.1620 
R1/wR2 [all data] 0.0607/0.1440 0.0285/0.0747 0.1046/0.1761 
Goodness-of-fit (F2) 1.061 1.114 1.094 
Flack (Std Dev.) -0.14(5) 0.01(2) -0.05(9) 
Peak/hole (e/Å3) 1.174/-0.384 0.478/-0.247 1.285/-0.481 
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Table 12. Crystal data for compounds 8 (NO3-), 9 (NO3-) and 8 (AcO-). 
 
Compound 8 (NO3-) 9 (NO3-) 8 (AcO-) 
Formula  C28H38Cl1N8O5S2 C29H40N8O5S2 C30H41N7O4S2  
Solvent detected --- --- --- 
Formula weight 630.78 644.81 627.82 
Crystal size (mm3) 0.08 x 0.05 x 0.05 0.20 x 0.10 x 0.02 0.20 x 0.20 x 0.10 
Crystal color colorless colorless colorless 
Temp (K) 100 100 100 
Crystal system Triclinic Monoclinic Triclinic 
Space group  P1 P21 P1 
A (Å) 10.8570(15) 12.8416(10) 10.8173(10) 
B (Å) 12.4706(16) 8.7033(7) 12.7233(12) 
C (Å) 12.9263(16) 13.7476(11) 12.9472(12) 
α (deg) 98.088(3) 90 71.619(2) 
β (deg) 112.786(3) 96.649(2) 66.523(2) 
γ (deg) 107.966(3) 90 71.889(2) 
V (Å3) 1465.8(3) 1526.2(2) 1515.5(2) 
Z 2 2 2 
ρ (g/cm3) 1.429 1.403 1.376 
µ (mm-1) 0.236 0.228 0.225 
θmax (°) 39.44 39.51 38.84 
Reflec. measured 22507 Twin Gemini 30934 29169 
Unique reflections 17936 [Rint=0.0345] 14681 [Rint=0.0406] 18391 [Rint=0.0169] 
Obs. Reflec. Fo>4σ(Fo) 20146 Twin Gemini 14085 17135 
Absorption correction SADABS (Bruker) SADABS (Bruker) SADABS (Bruker) 
Trans. min/max 0.89235/1.00000 0.73350/1.00000 0.78172/1.00000 
Parameters 776 467 1081 
R1/wR2 [I>2σ(I)] 0.0812/0.2163 0.0329/0.0881 0.0379/0.1011 
R1/wR2 [all data] 0.0863/0.2213 0.0346/0.0897 0.0422/0.1053 
Goodness-of-fit (F2) 1.026 1.032 1.038 
Flack (Std Dev.) -0.07(4) 0.01(2) 0.04(3) 
Peak/hole (e/Å3) 0.437/-0.408 0.558/-0.499 0.926/-0.462 
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Table 13. Crystal data for compound (R,S)-9 (NO3-). 
 
Compound (R,S)-9 (NO3-). 
Formula  C29H40N8O5S2  
Solvent detected --- 
Formula weight 644.81 
Crystal size (mm3) 0.06 x 0.06 x 0.01 
Crystal color colorless 
Temp (K) 100 
Crystal system Triclinic 
Space group  Pī 
A (Å) 8.487(6) 
B (Å) 13.831(9) 
C (Å) 13.855(9) 
α (deg) 101.602(16) 
β (deg) 98.297(19) 
γ (deg) 93.981(18) 
V (Å3) 1568.2(18) 
Z 2 
ρ (g/cm3) 1.366 
µ (mm-1) 0.222 
θmax (°) 27.53 
Reflec. measured 17707 
Unique reflections 8980 [Rint=0.1113] 
Obs. Reflec. Fo>4σ(Fo) 4307 
Absorption correction SADABS (Bruker) 
Trans. min/max 0.77887/1.00000 
Parameters 397 
R1/wR2 [I>2σ(I)] 0.0788/0.1671 
R1/wR2 [all data] 0.1794/0.2139 
Goodness-of-fit (F2) 1.005 
Flack (Std Dev.) --- 
Peak/hole (e/Å3) 0.588/-0.603 
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3.1 Introduction 
 
3.1.1 Naproxen Overview 
 
 Naproxen is the international non-proprietary name for (+)-(S)-2-(6-
methoxynaphthalen-2-yl)propanoic acid, a Non-Steroidal Anti-inflammatory Drug 
(NSAID).1 Naproxen was first sold by Synthex2 as a prescription drug under the trade 
name Naprosyn in 1976 and Naproxen sodium as Anaprox in 1980. The U. S. Food 
and Drug Administration (FDA) approved its use as an over-the-counter drug in 1991. 
 In 2003 Roche was the biggest seller in the small sub sector of Naproxen 
painkillers. Although Naproxen sales are relatively small, combined Bayer-Roche 
sales amount to $1.3 billion (€970 million) making it the best-selling NSAIDs in the 
U.S.A.. 
 Naproxen is a member of the 2-arylpropionic acid (profen) family of NSAIDs, 
as Ibuprofen, Flurbiprofen and Ketoprofen (Fig 1). These drugs are used for the 
management of mild to moderate pain, fever, and inflammation. They work by 
reducing the levels of prostaglandins, chemicals that are responsible for those 
symptoms. Naproxen blocks the enzyme cyclooxygenase-2 (COX-2) that produces 
prostaglandins, resulting in lower concentrations of these compounds and, as a 
consequence, reducing inflammation, pain and fever. 
 
OH
O
OMe
OH
O
OH
O
OH
O
Naproxen Ibuprofen Flurbiprofen Ketoprofen
O
F
 
Fig 1. Examples of non-steroidal anti-inflammatory drugs. 
                                                 
1 Giordano, C.; Villa, M.; Panossian, S. Naproxen: Chirality in Industry, Wiley (New York), 
1992. 
2 Harrington, P. J.; Lodewijk, E. Organic Process Research & Development 1997, 1, 72-76. 
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 In the late 1970s, due to the large activity range of the steroidal anti-
inflammatory drugs, many laboratories tried to synthesize NSAIDs. Studies showed 
that arylacetic acid derivatives had the basic structure suitable for this biological 
activity, so a large amount (more than 100 compounds per year) of these derivatives 
was prepared. At the beginning, the indoleacetic acid structure (such as 
Indomethacin), seemed to be the best, but the strong side effects made it come down. 
Methylphenylacetic acid derivatives looked like a good alternative as their activity 
range was smaller. Further studies confirmed the importance of the α-methyl group. 
Two enantiomers indeed exist with the potential for different biological effects and 
metabolism for each one. Only the S-enantiomers of arylpropionic acid NSAIDS can 
potently inhibit COX-2, whereas the R-enantiomers exert almost no COX-2 activity. 
Regarding Naproxen, the S-configuration appears to be essential for its 
pharmacological action.3 In fact, the S-enantiomer is 28 times more effective than the 
R one. Although, Ibuprofen and Ketoprofen are now available in single, active 
enantiomer preparations (Dexibuprofen and Dexketoprofen), Naproxen has always 
been the only NSAID marketed as a pure single active enantiomer. 
 
3.1.2 Naproxen Synthesis 
 
 The Naproxen patent expired in December 1993 leading to a search for new 
asymmetric technology. In fact, (S)-Naproxen ranked fourth in sales of optically pure 
pharmaceuticals in 1991. 
 Several methods have been described for the synthesis of chiral 2-arylpropionic 
acids.4 After two large scale synthesis processes, Synthex developed a synthetic route 
diminishing the undesirable features and wastes (Scheme 1). Researchers focused on 
two steps, the naphthol alkylation and the racemate resolution. In fact production 
yields increased from 50% in 1984 to more than 90% in early 1995. The N-
 
3 Harrison, I. T.; Lewis, B.; Nelson, P.; Rooks, W.; Roszkowski, A.; Tomolonis, A.; Fried, J. 
H. J. Med. Chem. 1970, 13, 203-211. 
4 a) Rieu, J. M.; Boucherle, A.; Cousse, H.; Mouzin, G. Tetrahedron 1986, 42, 4095-4131. b) 
Sonawane, H. R.; Bellur, N. S.; Ahuja, J. R.; Kulkarni, D. G. Tetrahedron: Asymmetry 1992, 3, 
163-192. 
3.1 Introduction  
_____________________________________________________________________ 
alkylglucamine5 was preferred to cinchonidine keeping the resolution efficient (> 
95%) with lower cost and greater availability (from reductive amination of D-
glucose).6
 
HO MeO
Br
1) Br2
2) NaHSO3
3) CH3Cl, Base MeO
COOH1) Mg
2)
Br
OMgCl
O
N -Alkylglucamine
MeO
COOH
 
 
Scheme 1. Large-scale manufacturing process of Naproxen. 
 
 Two-thirds of the total production cost was attributed to the resolution-
racemization process whereas one third was in the production of the racemic acid. 
Therefore, research for the production of the desired enantiomer was undertaken. 
 Several asymmetric technologies were designed for Naproxen production 
(Scheme 2). The Zambon7 process affords the (S)-enantiomer (e.e. > 98%) using (R, 
R)-tartaric acid as chiral auxiliary, bromination of the activated methylene and ester 
hydrolysis but was somehow considered as too complicated by Synthex to be 
processed. A catalytic asymmetric hydrogenation of a naphthacrylic acid using a 
ruthenium (S)-BINAP catalyst gives (S)-Naproxen (e.e. > 98%).8 Again Synthex 
judged this method too expensive to be settled. A catalytic hydroformylation of 2-
methoxy-6-vinylnaphthalene using a rhodium catalyst with BINAPHOS ligand 
                                                 
5 Holton, P. G.; U.S. Pat. 4, 515, 811, May 7, 1985. 
6 a) Wilth, P.; Dannenberg, G. E. M.; Schmied-kowarzik, V.; Weinhold, P.; Gudel, D Ger. Pat. 
2 319 245, 1973. b) Felder, E.; Pitre, H.; Zutter, M.M. U.K. Pat. GB 2 025 968A, 1980. 
7 Giordano, C.; Castaldi, G.; Cavicchioli, S.; Villa, M. Tetrahedron 1989, 45, 4243-4252. 
8 a) Wan, K. T.; Davis, M. E. Nature 1994, 370, 449-450. b) Ohta, T.; Takaya, H.; Kitamura, 
M.; Nagai, K.; Noyori, R. J. Org. Chem. 1987, 52, 3174-3176. 
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produces an optically active aldehyde which on oxidation yields (S)-Naproxen.9 This 
approach was also refused due to cost and product availability issues. 
 
MeO
O
MeO
OO
MeOOC COOMe
Br
(S)-Naproxen
1) (R , R )-dimethyl
tartrate
2) Br2
1) 90ºC, H2O
2) H2
3) H3O+
Br
a)
b)
c)
MeO
COOH
H2, Ru catalyst
(S)-Naproxen
MeO
H2, CO, Rh catalyst
MeO
CH3
CH(OEt)2
H 1) Hydrolysis
2) [O]
(S)-Naproxen
 
 
Scheme 2. a) Naproxen synthesis by Zanbon ,b) asymmetric hydrogenation and  
c) asymmetric hydroformylation . 
 
 One example of Naproxen production by the chiral pool approach was 
developed at Synthex in 1982 (Scheme 3). (S)-Ethyl lactate is converted to a mesylate, 
then ester hydrolysis and conversion to the acid chloride provides a chiral acylating 
agent. Acrylation, ketalization with 2,2-dimethyl-1,3-propanediol followed by 
rearrangement and ester hydrolysis yields (S)-Naproxen. 
 
MeO
MgBr
MeO
O
(S)-Naproxen
OMs
Cl
O
OMs
HO OH1)
2) 115-120ºC,
IRC-50S resine
3) H3O+  
 
Scheme 3. Naproxen synthesis using the chiral pool approach. 
                                                 
9 a) Stille, J. K.; Su, H.; Brechot, P.; Parinello, G.; Hegedus, L. S. Organometallics 1991, 10, 
1183-1189. b) Babin, J. E.; Whiteker, G. T. WO 93 03,839, March 4, 1993. 
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 As Naproxen catches so much attention and interest in research area, many other 
synthetic pathways have been described10 but for cost reasons or environmental 
concerns, the racemic synthesis by Synthex is still processed nowadays. 
 
3.1.3 Racemates Resolution 
 
Worldwide sales of chiral drugs in single-enantiomer dosage forms continued 
growing at a more than 13% annual rate to $133 billion in 2000 (Table 1).11 At a 
future growth rate, the figure could hit $200 billion in 2008. Among chiral drugs 
approved by the FDA in 2003 more than 80% were single enantiomers.12 The efficient 
and economical production of enantiomerically pure compounds is thus one of the 
major challenges facing the modern chemical industry. Moreover, a need for 
developing new technologies to produce optically pure drugs is primary. Although 
considerable advances in synthesis, analysis and separation have been achieved, 
production of enantiopure chemicals from resolution of racemates is still significant.13 
Although resolution only gives 50% yield, in combination with racemization may 
become a 100% yield concept (dynamic kinetic resolution).14
 
 
 
 
10 a) Gu, Q.; Chen, C.; Sih, C. J. Tetrahedron Lett. 1986, 27, 1763-1766. b) García, M.; del 
Campo, C.; Llama, E. F.; Sánchez-Montero, J.; Sinisterra, J. V. Tetrahedron 1993, 49, 8433-
8440. c) Vedejs, E.; Kruger, A. W. J. Org. Chem. 1998, 63, 2792-2793. d) Vedejs, E.; Lee, N.; 
Sakata, S. T. J. Am. Chem. Soc. 1994, 116, 2175-2176. e) Rajanbabu, T. V.; Casalnuovo, A. L.; 
Ayers, T. A.; Warren, T. H. J. Am. Chem. Soc. 1994, 116, 9869-9882. f) Effenberger, F.; 
Graef, B. W.; Osswald, S. Tetrahedron: Asymmetry 1997, 8, 2749-2755. g) Brunner, H.; 
Schmidt, P. Eur. J. Org. Chem. 2000, 2119-2133. 
11 http://www.technology-catalysts.com/ 
12 http://pubs.acs.org/cen/coverstory/7940/7940chiral.html 
13 a) Chiral Separation Techniques, Subramanian, G., Ed., Wiley-VCH, 2001. b) Rouhi, A. M. 
Chem. Eng. News 2002, 80, 23, 51-57. 
14 a) Kroutil, W.; Faber, K. Tetrahedron: Asymmetry 1998, 9, 2901-2913. b) Shi, Y. J.; Wells, 
K. M.; Pye, P. J.; Choi, W. B.; Churchill, H. R. O.; Lynch, J. E.; Maliakal, A.; Sager, J. W.; 
Rossen, K.; Volante, R. P.; Reider, P. J. Tetrahedron 1999, 55, 909-918. 
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 ALL DRUGS SINGLE-ENANTIOMER DRUGS 
$ MILLIONS 1999 2000 1999 2000 2005 
Analgesics $21,500 $23,000 $1,173 $1,291 $1,395 
Antibiotic/antifungals 29,300 31,700 24,918 26,140 29,747 
Antiviral 17,700 19,100 6,717 8,820 12,201 
Cancer 13,700 15,600 8,891 10,690 13,605 
Cardiovascular 42,700 46,600 24,895 27,650 34,627 
Central nervous system 47,700 53,900 8,439 9,094 14,700 
Dermatology 17,900 18,400 16,202 1,272 1,540 
Gastrointestinal 43,900 47,200 1,970 4,033 6,590 
Hematology 16,500 15,400 7,405 8,879 11,295 
Hormone/endocrinology 20,000 22,000 14,510 15,384 19,790 
Ophthalmics 7,100 7,400 1,270 2,265 2,705 
Respiratory 36,500 40,500 5,696 6,615 9,620 
Vaccines 6,500 7,300 2,503 3,349 4,320 
Other 39,000 41,900 6,248 7,032 9,730 
TOTAL $360,000 $390,000 $117,763 $132,514 $171,865 
NOTE: Figures are for dosage formulations. SOURCE: Technology Catalysts International 
 
Table 1. Worldwide sales of single-enantiomer drugs. 
 
 The “classical method of resolution” using crystallization of diastereomeric salts 
is widely used on industry because of the easy scale up and rapid screening of 
resolving agents possible.15 Through often the best method available, this technology 
suffers from drawbacks like the use of a stoichiometric quantity of resolving agents. 
Resolution via hydrolytic enzymes gives a high enantioselectivity for fairly wide 
range of products as esters, amides, acids, alcohols and amines. Nevertheless, the 
availability of only one enantiomer presents a major limitation to this technique. 
 Physical separations represent still an attractive area for producing optical pure 
compounds. These methods require a chiral phase that induces the enantiomers 
separation (a need for chiral phases for multiple products application is primary). 
Solid-liquid based separations still have important disadvantages, chiral 
                                                 
15 Fogassy, E.; Nógrádi, M.; Kozma, D.; Egri, G.; Pálovics, E.; Kiss, V. Org. Biomol. Chem. 
2006, 4, 3011-3030. 
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chromatography suffer from low capacity and chiral simulated moving bed (SMB)16 
from high investment. In contrast, liquid-liquid separation is considered as a very 
effective way of producing enantiopure products, as it largely avoids solids handling 
and can be a very rapid process. This technology requires transfer from one liquid 
phase to another, the use of chiral transferring agent with preferentially transport one 
enantiomer with sufficient selectivity and a high concentration of racemates. Still, the 
technology is not mature enough due to lack of wide range of readily cheap selectors 
as well as solubility problems in one of the two liquid phases. 
Despite its limited application in industrial scale, supported liquid membrane 
(SLM)17 continues to attract large academic interest. Goto and co-workers have 
reported a highly enantioselective separation of the NSAID Ibuprofen using this 
technology (Fig 2).18 Combining the use of SLM with enzymes (enantioselective 
catalysts of hydrolysis or esterification of drugs and amino acids) affords indeed 
elevated resolution of both Ibuprofen and phenylalanine. The surfactant-lipase (from 
Candida rugosa) complex was encapsulating in the SLM and another lipase (from 
porcine pancreas) was dissolved in the receiving phase. An enantiomeric excess of 
91% and 99% was achieved after 48 hours for (S)-Ibuprofen and L-phenylalanine 
respectively. 
 
Fig 2. Concept of enantioselective separation of racemic mixtures through the SLM 
encapsulating the surfactant-enzyme complex. 
                                                 
16 Wei, F.; Shen, B.; Chen, M. Ind. Eng. Chem. Res. 2006, 45, 1420-1425. 
17 a) Jönsson, J. Å.; Mathiasson, L. Trends Anal. Chem. 1999, 18, 318-325. b) de Gyves, J.; de 
Miguel, E. R. Ind. Eng. Chem. Res. 1999, 38, 2182-2202. 
18 a) Miyako, E.; Maruyama, T.; Kamiya, N.; Goto, M. Chem. Commun. 2003, 2926-2927. b) 
Miyako, E.; Maruyama, T.; Kamiya, N.; Goto, M. J. Am. Chem. Soc., 2004, 126, 8622-8623. 
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3.1.4 Current Strategy 
 
The recent developments in supramolecular chemistry suggest an alternative 
approach to the traditional resolution of racemates. Certain synthetic receptors are able 
to bind their substrates with sufficient power to extract them from an aqueous medium 
into an organic solvent. Therefore the transport is facilitated between separated phases 
(such as an aqueous–organic–aqueous system). If the receptor is enantioselective,19 
one enantiomer of racemic substrate will be transported preferentially and resolution 
could be achieved.20 Moreover, since the process is catalytic in the amount of receptor; 
one receptor molecule can indeed transfer many molecules of substrate between the 
two phases.21 The selector would stay in the organic phase and could be reused 
without difficulty. 
The importance of the development of an efficient method for the resolution of 
the racemate of Naproxen is double. On the one hand the academic interest of being 
able to design a receptor so subtle that it could discriminate between a methyl group 
and a hydrogen atom, and on the other hand the industrial interest. Chiral recognition 
of Naproxen is therefore a challenging goal in supramolecular chemistry. 
 
3.1.5 Synthetic Receptors for Naproxen Recognition 
 
The enantiomers of Naproxen differ only in the orientation of one methyl group. 
It is therefore a quite demanding target substrate for recognition and there are indeed 
few receptors described in the literature regarding the resolution of this compound. 
Diederich and co-workers reported an optically active cyclophane I able to bind 
Naproxen derivatives.22 By complexation studies in 1H-NMR, (S)-Naproxen 
 
19 a) Webb, T.H.; Wilcox, C. S. Chem. Soc. Rev. 1993, 2, 383-395. b) Martín, M.; Raposo, C.; 
Almaraz, M.; Crego, M.; Caballero, C.; Grande, M.; Morán, J. M. Angew. Chem. Int. Ed. Engl. 
1996, 35, 2386-2389. c) Zhang, X. X.; Bradshaw, J. S.; Izatt, R. M. Chem. Rev. 1997, 97, 
3313-3361. d) Ragusa, A.; Rossi, S.; Hayes, J. M.; Stein, M.; Kilburn, J. D. Chem. Eur. J. 
2005, 11, 5674-5688. 
20 Afonso, C. A. M.; Crespo, J. G. Angew. Chem. Int. Ed. 2004, 43, 5293-5295. 
21 Pirkle, W. H.; Doherty, E. M. J. Am. Chem. Soc. 1989, 111, 4113-4114. 
22 a) Dharanipragada, R.; Diederich, F. Tetrahedron Lett. 1987, 28, 2443-2446. b) 
Dharanipragada, R.; Ferguson, S.; Diederich, F. J. Am. Chem. Soc. 1988, 110, 1679-1690. c) 
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derivatives form different 1:1 diastereomeric complexes with (R)- and (S)-I. 
Enantiomeric ratios were nevertheless quite modest (from ∆(∆Gº) = 0.15 up to 0.33 
kcal mol-1, for Naproxen ∆(∆Gº) = 0.16 kcal mol-1 in D2O/MeOH-d4 (60:40)). 
In our group, an optically abiotic receptor II containing the chiral bicyclic 
guanidinium binding subunit was evaluated in the late 80’s for chiral recognition of 
aromatic carboxylates.23 Although extraction experiments of sodium (S)-mandelate 
and (S)-Naproxenate with both (R,R)- and (S,S)-II afforded diastereomeric salts with 
different NMR spectra, no enantiodiscrimination was reported. 
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Fig 3. Receptors by Diederich (I) and de Mendoza [(S,S)-II]. 
 
Pirkle and co-workers employed a chromatographic approach to design, 
synthesize and evaluate new chiral selectors for Naproxen.24 They employed the 
principle of reciprocity in chiral recognition, which means that if a single molecule of 
a chiral selector has different affinities for the enantiomers of another substance, then 
a single enantiomer of the latter will have different affinities for the enantiomers of the 
initial selector. Two chiral stationary phases (CSPs) derived from (S)-Naproxen were 
therefore produced and HPLC techniques were used to screen Naproxen receptors. A 
third (R,R) CSP III (Fig 4) was then produced from the best candidate displaying a 
high level of enantiodiscrimination not only for Naproxen (α = 2.25) but also towards 
most of NSAIDs (for profen, α = 1.09 up to 1.71). 
                                                                                                                                 
Castro, P. P.; Georgiadis, T. M.; Diederich, F. J. Org. Chem. 1989, 54, 5835-5838. d) 
Georgiadis, T. M.; Georgiadis, M. M.; Diederich, F. J. Org. Chem. 1991, 32, 6277-6280. 
23 Echavarren, A.; Galán, A.; Lehn, J.-M.; de Mendoza, J. J. Am. Chem. Soc., 1989, 111, 4994-
4995. 
24 Pirkle, H. W.; Welch, J. C.; Lamm, B. J. Org. Chem. 1992, 57, 3854-3860. 
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Fig 4. Chiral stationary phase by Pirkle’s (R,R) CSP III. 
 
A neutral host IV (Fig 5) based on a rigid xanthene scaffold was developed by 
Rebek and co-workers.25 1H-NMR titrations in CD3OD show a slight enantioselection 
[for (S)-Naproxenate, Ka = 160 M-1 and 110 M-1 with (R,R)-IV and (S,S)-IV 
respectively]. 
Davis and co-workers synthesized a hindered bicyclic chiral guanidine V and 
performed 1H-NMR experiments with both Naproxen enantiomers.26 Nevertheless, no 
discrimination was reported toward this target. 
In 2001, Kilburn and co-workers published an acyclic thiourea receptor VI 
showing moderate enantioselectivity for a range of amino acid derivatives.27 Binding 
constants measured by 1H-NMR titrations in CDCl3 show only modest differentiation 
for Naproxen enantiomers [Ka = 1570 M-1 and 1870 M-1 for (R) and (S) form 
respectively]. 
                                                 
25 Hamann, B. C.; Branda, N. R.; Rebek, J., Jr. Tetrahedron Lett. 1993, 34, 6837-6840. 
26 a) Davis, A. P.; Dempsey, K. J. Tetrahedron: Asymmetry 1995, 6, 2829-2840. b) Boyle, P. 
H.; Davis, A. P.; Dempsey, K. J.; Hosken, G. D. J. Chem. Soc., Chem. Commun. 1994, 1875-
1876. 
27 Kyne, G. M.; Light, M. E.; Hursthouse, M. B.; de Mendoza, J.; Kilburn, J. D. J. Chem. Soc., 
Perkin Trans. 1 2001, 1258-1263. 
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Fig 5. Receptors by Rebek (IV), Davis (V) and Kilburn (VI). 
 
In 2001, a steroidal guanidine VII was synthesized as an enantioselective 
receptor for N-acyl α-amino acids.28 Modest but significant selectivity was found with 
Naproxen in extraction experiments (1.5:1). 
Recently, Morán and co-workers have synthesized a racemic macrocyclic 
receptor VIII based on bischromenylurea that provides a C2 chiral cavity and 
hydrogen bond donor groups (Fig 6).29 Competitive experiments between racemic 
VIII and a (S)-Naproxen salt gives the highest enantiomeric ratio published so far 
(7.2:1). Molecular mechanics calculations give an energy difference range from 0.5 
kcal/mol to 3 kcal/mol using two different forcefields (MM2 and MMFF). The rigid 
and hindered cavity where host-guest association occurs gives rise to this high 
selectivity (steric repulsion is believed to be decisive for enantiodiscrimination). 
                                                 
28 Lawless, L. J.; Blackburn, A. G.; Ayling, A. J.; Perez-Payan, M. N.; Davis, A. P. J. Chem. 
Soc., Perkin Trans. 1 2001, 1329-1341. 
29 González, S.; Peláez, R.; Sanz, F.; Jiménez, M. B.; Morán, R. J.; Caballero, M.C. Org. Lett. 
2006, 8, 4679-4682. 
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Fig 6. Receptors by Davis (VII) and Morán (VIII). 
 
So far, no receptors capable of selectively extracting (S)-Naproxen from its 
racemic mixture in aqueous media have been reported. 
In this chapter, we aimed at designing and synthesizing a receptor for Naproxen 
which could be employed in a liquid-liquid separation technique such as a U-tube set 
up, membranes or extraction systems. As pointed out in the introduction, we will 
employ the bicyclic guanidinium scaffold allowing extraction of carboxylate anions 
through hydrogen bonds and ion-pair interactions. Thus, we propose two different 
approaches to reach this goal: first, a rational, de novo design and second, a 
combinatorial chemistry approach. 
 
 
3.2 Rational Design Approach 
 
In the preceding Chapter, we have described guanidine receptors bearing urea 
functions in order to improve the binding pocket for oxoanions with four additional 
hydrogen bonds (Fig 7a). ITC titrations of the simpler amide derivatives (two 
additional hydrogen bonds) with acetate salts revealed a 1:2 complex binding mode.30 
The host indeed affords four hydrogen bonds but its conformational freedom allows a 
rearrangement of each arm allowing it to bind two guest molecules. On the contrary, 
symmetric receptors using urea groups as additional hydrogen bond donors present a 
                                                 
30 Blondeau, P. DEA, Universidad Autónoma de Madrid, 2005. 
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1:1 complex binding mode with acetate (affording up to six strong hydrogen bonds to 
the guest) (Fig 7b). Although association constants are similar to a simpler 
guanidinium receptor lacking the additional donors at the side arms (Ka ≈ 105 M-1), the 
enthalpic contribution enhancement constitutes an improvement of the binding pocket 
for oxoanions. As it was previously reported by Schmidtchen and co-workers, it then 
provides a strong argument to take enthalpy instead of the almost exclusively used 
free energy as a design criterion.31 On the other hand, the increased receptor rigidity 
(aromatic ring) and the two additional hydrogen bonds present a considerable benefit 
in order to bring closer the chiral guest center to the host scaffold. In this chapter, we 
will develop guanidinium-urea receptors as multiple hydrogen bond donor hosts 
introducing various groups as bulk, aromatic surfaces and additional chiral barriers (R 
groups). 
N
N
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N
H SS
PF6-
HNNH
OHNO NH
RR
N
N
H
N
H SS
PF6-
OHNO NH
R R
 
     a)      b) 
Fig 7. Symmetric guanidinium receptors with different additional hydrogen 
bond donors: a) amide and b) urea. 
 
3.2.1 Additional Steric Hindrance 
 
A first approach suggested by molecular modeling is the incorporation of bulky 
groups directly connected to the second urea NH (Fig 8). By introduction of such 
groups, the configuration of the guanidinium scaffold (R,R) would lead the 
enantioselection of the guest. Even though the host chiral centers are located far away 
from the guest’s one, the large array of hydrogen bonds should maintain the guest 
close to the host backbone. 
                                                 
31 Haj-Zaroubi, M.; Mitzel, N. W.; Schmidtchen, F. P. Angew. Chem. Int. Ed. 2002, 41, 104-
107. 
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Fig 8. Host-guest interactions between a bulky chiral guanidinium receptor and 
a chiral α-methyl carboxylate anion. 
 
Molecular modeling was performed for receptors 1-4 with both enantiomers of 
Naproxen using the two different forcefields MMFFs and OPLS-AA (Table 2).32 Free 
energy difference goes from 0.1 up to 2.0 kcal mol-1 and enthalpy difference from 0.2 
up to 1.8 kcal mol-1. Both forcefields are in good agreement and according to these 
calculations, receptors 2-4 should afford considerable enantioselectivity. 
Figure 9 shows host-guest interactions between receptor 2 and each enantiomer. 
Both cases reported the well formation of the binding pocket (six H-bonds). The 
environment provided by the bulk 2-tert-butyl-6-methylphenyl groups gives a 
significant stability difference between both complexes. (R)-Naproxen appears to have 
the most stable complex with the (R,R) configuration of the chiral bicyclic 
guanidinium scaffold. 
 
 
 
                                                 
32 Modeling studies were performed by Joe Hayes at Anterio Consult & Research Gmbh, 
Mannheim, Germany. 
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-1.5 (-1.6)-2.0 (-1.6)4: R =
-1.1 (-1.5)-1.5 (-1.5)3: R =
-1.6 (-1.8)-1.1 (-1.3)2: R =
-0.1 (-0.2)-0.4 (-0.9)1: R =
OPLS-AA Forcefield
∆∆GR-S (∆∆HR-S)
MMFFs Forcefield
∆∆GR-S (∆∆HR-S)
Receptor
N
N
H
N
H SS
HNNH
OHNO NH
RR
O
O
 
 
Table 2. Molecular modeling using two different forcefields (MMFFs and 
OPLS-AA) in a continuum solvent GB/SA (CHCl3), ∆ ∆GR-S and ∆ ∆HR-S represent the 
∆G and ∆H difference between the enantiomers of Naproxen respectively (kcal mol-1). 
 
 
   a)     b) 
Fig 9. Optimized models of 2 with a) (S)-Naproxenate and b) (R)-Naproxenate 
(hydrogen atoms are omitted and Naproxen is colored in red). 
 
Receptors 1 and 2 were therefore synthesized as well as an adamantyl analogue 
6 (Scheme 4). Addition of the corresponding isocyanate to the guanidinium diamine 
salt gave the expected product in good yield (73-86%). 
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Reagents and conditions: a) Isocyanate, dry CH2Cl2, sealed tube, 24 h (73-86%). 
Scheme 4. Synthesis of compounds 1, 2 and 6. 
 
Liquid-liquid extraction between an organic solution of receptor (PF6-) dissolved 
in CH2Cl2 (1 mg/mL) and a sodium Naproxenate aqueous solution (0.08 M) was then 
performed. The organic phase was then isolated and the solvent removed. The resulted 
solid was dissolved in MeOH and analyzed by HPLC using a chiral column [(S,S) 
WHELK-01]. Each enantiomer extracted was then quantified but no discrimination 
was observed for any of these three hosts. 
Computer modeling predicted a substantial stability difference according to 
calculations made for each enantiomer separately. Competitive experiments revealed 
no differences between both complexes and pointed again to slight differences in 
energy upon opposite orientations of the α-methyl group of the guest. Restricting 
complex conformational freedom is therefore essential for chiral selection of 
Naproxen. Introducing other kind of interactions as well as rigidifying the receptor 
scaffold should also contribute to this goal. 
 
3.2.2 Pincer-like Receptor 
 
A key feature in the design of a Naproxen host is to bring closer the chiral center 
of the guest to the host’s backbone to allow discrimination between the methyl group 
and the α proton of the carboxylate. As Naproxen possesses an electronically enriched 
ring (methoxynaphthyl), π stacking interactions with a receptor bearing withdrawing 
groups in their aromatic rings would represent an important step for further 
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stabilization of the complex (in green in Fig 10). Moreover, introduction of a new 
chiral center (by a R substituent) near the guest’s one could afford the desired 
selectivity. 
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Fig 10. General design of guanidinium receptors with π-π interactions (green) with 
(S)-Naproxen and additional chiral centers. 
 
 In the following sections, both (R,R) and (R,S) guanidinium scaffolds will be 
used to improve the host-guest interactions by the orientation of the arms. We decided 
to study step by step the design of the receptor so that each variation of the scaffold 
could be evaluated. By both 1H-NMR an ITC techniques, we will first measure the 
importance of the spacer between the aromatic surface and the urea function, then 
introduce a withdrawing group into it and eventually add a chiral center. 
 
3.2.2.1 Spacer Influence 
 
a) (R,R) Guanidinium Scaffold 
 
As π interactions are necessary in order to design pincer-like receptors, we first 
suggested studying the binding pocket formation according to the rigidity and nature 
of the spacer between the urea moiety and the aromatic surface. Therefore, several 
symmetric receptors with six hydrogen bond donors and bearing butyl or phenyl as 
well as benzyl or phenethyl group have been synthesized (Scheme 5). 1H-NMR and 
isothermal calorimetry were used to measure the association between hosts (7-10) and 
guests [TBA AcO and TEA (S)-Nap]. 1H-NMR titration is used as a qualitative tool 
for controlling which proton is affected by host-guest interactions and ITC as a 
 95 
Naproxen Enantiorecognition 
_____________________________________________________________________ 
quantitative tool for accurate determination of binding constants and thermodynamic 
parameters. 
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Reagents and conditions: a) Isocyanate, dry CH2Cl2, sealed tube, 24 h (75-90%). 
Scheme 5. Synthesis of receptors 7, 8, 9 and 10. 
 
1H-NMR titrations between receptors 7-10 and both TBA AcO and TEA (S)-
Nap show a strong downfield shift of guanidinium and urea NHs. The formation of a 
good pre-organized pocket in which the carboxylate part of the guest is forming six 
strong H-bonds with the host is therefore confirmed. Interestingly, 8 has a different 
behavior: protons a, b, c and d suffer indeed a moderate to strong upfield shift as the 
amount of guest is increased [with TEA (S)-Nap, ∆δ from 0.15 up to 0.7 ppm, Fig 11]. 
In receptor 9 the protons are much less affected [with TEA (S)-Nap, ∆δ ≈ 0.1 ppm], as 
well as 10 which has a similar behavior as 7 (operating as a control experiment). As 
the rigidity of the link between the urea and the aromatic surface increases, the 
scaffold needs to rearrange itself in order to permit formation of the binding pocket. In 
addition to highlighting host-guest interactions, NMR strongly evidences the influence 
of the spacer used between the urea and aromatic surface. 
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Fig 11. 1H-NMR titration between (R,R)-8 and TEA (S)-Nap in CD3CN at 298K [from 
bottom to top: 0 to 1.1 equivalents TEA (S)-Nap]. 
 
Ka’s between 8 and both carboxylate salts are one order of magnitude lower than 
for 7, 9 and 10 (Ka from 104 up to 105 M-1, Table 3). For TBA AcO and TEA (S)-Nap, 
the more pronounced negative entropic contribution is the important difference 
between these four hosts. The association for 8 is indeed entropically disfavored and 
contributes to a lower free energy ∆G. Receptors 7, 9 and 10 display a similar binding 
behavior mainly enthalpically driven (Ka from 3.06 x 105 up to 5.41 x 105 M-1). This 
significant enthalpic factor is due to electrostatic interactions whereas the entropic one 
comes from the release of solvent molecules. 8 suffers from an unfavorable spatial 
arrangement to complete complex formation. 
Therefore, both 1H-NMR and ITC techniques are in good agreement to evaluate 
the spacer influence on binding. 8 is thus too rigid to achieve optimal association but 
as the host scaffold is recovering flexibility (by addition of CH2 groups to the linker); 
the stability of the complex is again higher. 
 
 
ab ca c
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 (R,R)-7 (R,R)-8 (R,R)-9 (R,R)-10 
TBA AcO     
 
Ka  
 
3.06 x 105
 
2.57 x 104
 
1.02 x 105
 
5.41 x 105
∆H -6.97 -8.55 -7.32 -8.05 
∆S   2.06 -8.05   2.14 -0.33 
∆G -7.60 -6.11 -7.97 -7.50 
TEA (S)-Nap         
 
Ka  
 
3.98 x 105
 
2.65 x 104
 
1.76 x 105
 
2.59 x 105
∆H -7.78 -7.36 -7.74 -7.98 
∆S   0.01 -4.07 -1.57 -1.57 
∆G -7.78 -6.13 -7.27 -7.27 
 
Table 3. Thermodynamic parameters from ITC titrations in acetonitrile at 303K 
between receptors (R,R)-7-10 and TBA AcO and TEA (S)-Nap (Ka in M-1, ∆H and ∆G 
in kcal mol-1, ∆S in cal mol-1 K-1). 
 
b) (R,S) Guanidinium Scaffold 
 
Synthesis of (R,S) 7-10 was performed like those described in scheme 5 (starting 
from (R,S)-5). (R,S)-9 precipitates in situ and was then filtered off whereas column 
chromatography was the common purification process for all other compounds. 
1H-NMR titrations proved again the formation of a nicely pre-organized pocket 
but no upfield shifts were detected for (R,S)-8 as in the case of (R,R)-8 reported 
previously. The absence of chirality in the bicyclic guanidinium scaffold strongly 
influences the arms’ orientation and therefore the system conformation. 
Addition of a chiral carboxylate salt [TEA (S)-Nap] leads to the splitting of all 
receptor’s proton signals due to the loss of the symmetry axis (Fig 12). NOESY were 
performed for each complex formed but no contacts were detected between the 
aromatic ring of the host and the naphthyl ring of the guest. 
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Fig 12. 1H-NMR spectrum of (R,R)-9 (PF6-), (R,S)-9 [(S)-Nap-], and (R,R)-9 [(S)-
Nap-] in CD3CN at 298K (from bottom to top). 
 
 ITC gives a similar enthalpically driven association for both (R,S) and (R,R)-7 
(Table 4). As revealed by 1H-NMR experiments, (R,S)-8 is not as much affected as 
(R,R)-8 and its behavior is comparable to (R,S)-7 and 10. Moreover, receptor 9 
presents the best binding so far reported with both carboxylate salts [Ka = 2.07 x 107 
M-1 with TBA AcO and Ka = 1.23 x 106 M-1 with TEA (S)-Nap]. Indeed, a favorable 
positive entropic contribution enhances host-guest interactions. The overall binding is 
therefore both enthalpically and entropically driven for this receptor. It is in fact 
important to highlight the role played by entropy in the association behavior. Entropy 
is somewhat more difficult to control than enthalpy in designing receptors, but 
receptor 9 proves that a considerable association increase can be achieved by a proper 
balance between both thermodynamic parameters. 
 
In conclusion, first comparison between (R,R) and (R,S) guanidinium scaffold 
shows the better scaffold organization for (R,S) receptors in order to form the binding 
pocket for carboxylate guests. 
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 (R,S)-7 (R,S)-8 (R,S)-9 (R,S)-10 
TBA AcO     
 
Ka  
 
5.63 x 105
 
2.05 x 105
 
2.07 x 107
 
9.73 x 105
∆H -6.88 -7.01 -6.29 -7.31 
∆S   3.58   1.20   12.7   3.27 
∆G -7.97 -7.37 -10.13 -8.30 
TEA (S)-Nap         
 
Ka  
 
3.39 x 105
 
1.54 x 105
 
1.23 x 106
 
6.56 x 105
∆H -8.00 -7.54 -7.23 -7.63 
∆S -1.14 -1.14   3.99   1.43 
∆G -7.66 -7.19 -8.43 -8.06 
 
Table 4. Thermodynamic parameters from ITC titrations in CH3CN at 303K between 
receptors (R,S)-7-10 and TBA AcO and TEA (S)-Nap (Ka in M-1, ∆H and ∆G in kcal 
mol-1, ∆S in cal mol-1 K-1). 
 
3.2.2.2 π Interactions Evaluation  
 
In order to study π-stacking interaction between Naproxen and an aromatic 
moiety, different (R,R) and (R,S) receptors were synthesized (Scheme 6). A major 
factor in aromatic interactions is the nature of the substituents of the aromatic ring. π-
clouds with partial charges of opposite sign will stack stronger than the ones of the 
same sign. As Naproxen possesses an electronically enriched ring (methoxynaphthyl), 
we decided to use a p-nitroaryl derivative as withdrawing group.33 Receptor 12 was 
obtained by previous activation of p-nitrobenzylamine by CDI in order to get 
imidazolide 13. Yields by either direct addition of isocyanate or imidazolide are 
similar (70%). 
                                                 
33 Cockroft, S. L.; Hunter, C. A.; Lawson, K. R.; Perkins, J.; Urch, C. J. J. Am. Chem. Soc. 
2005, 127, 8594-8595. 
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Reagents and conditions: a) p-nitrophenyl isocyanate, dry CH2Cl2, sealed tube, reflux 24 h 
(70%). b) 13, dry MeOH, sealed tube, reflux, 24 h (70%). c) p-nitrobenzylamine, CDI, THF, 
30 min (70%). 
Scheme 6. Synthesis of receptors 11 and 12. 
 
1H-NMR titrations were performed between both (R,R) and (R,S)-11 and 12 and 
TBA AcO and TEA (S)-Nap in CD3CN. A special attention was given to the CH2 
between the urea group and the phenyl ring upon addition of the (S)-Nap salt (a, Fig 
13). Protons a are only shifted slightly upfield (∆δ = 0.1 ppm). Comparing these data 
with those from (R,R) and (R,S)-9 (which do not have any withdrawing group) 
confirm the absence of relevant new interactions. The upfield shift is rather small and 
cannot be explained as a rigidification of the system due to π-stacking interactions. 
Moreover, NOESY were performed and confirm the absence of contacts between the 
aromatic ring of the host and naphthyl ring of the guest. On the other hand, protons a 
appear as a doublet with AcO- as counterion (due to coupling with the urea NH) 
whereas the CH2 is converted into a doublet of doublets with PF6- or (S)-Nap- (due to 
different environment for each proton). 
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Fig 13. 1H-NMR titrations between (R,R)-12 (right) (R,S)-12 (left) and TEA (S)-Nap in 
CD3CN at 298K [from bottom to top: 0 to 1.1 equivalents TEA (S)-Nap]. 
 
ITC titrations were also performed for those receptors (Table 5). Ka are affected 
moderately (from 6.75 x 104 up to 4.25 x 105 for (R,R)-12 and (R,S)-12 respectively). 
Introducing a nitro group in para position of the phenyl results in an enhancement of 
the binding only for (R,R)-11 due to a less negative entropic factor [for (R,S)-11, Ka 
stays unaffected]. The electronically poor aromatic ring in each leg has such an 
influence on the organization of the host conformation that it allows a better 
carboxylate complexation (stacking between each arm as well as repulsion could take 
place).34 However, incorporation of the nitro group in the benzyl ring decreases the 
association constant, considerably for (R,S)-12 [two orders of magnitude with TBA 
AcO and one with TEA (S)-Nap] and moderately for (R,R)-12 (the entropic 
contribution is decreasing). More than affecting enthalpy, introduction of a 
withdrawing group translates into entropy alteration. Thermodynamic parameters 
measured by ITC are in good agreement with 1H-NMR results and confirm the 
absence of π-stacking interactions between Naproxen and aromatic surfaces of the 
host. 
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 (R,R)-11 (R,R)-12 (R,S)-11 (R,S)-12 
TBA AcO     
 
Ka  
 
1.65 x 105
 
6.75 x 104
 
1.02 x 105
 
4.25 x 105
∆H -7.66 -7.32 -4.07 -6.82 
∆S -1.17 -2.07   9.46   3.22 
∆G -7.25 -6.69 -6.94 -7.80 
TEA (S)-Nap         
 
Ka  
 
1.24 x 105
 
6.92 x 104
 
9.53 x 104
 
3.90 x 105
∆H -8.35 -7.74 -5.82 -7.40 
∆S -4.25 -3.41   3.57   1.15 
∆G -7.06 -6.71 -6.90 -7.75 
 
Table 5. Thermodynamic parameters from ITC titrations in acetonitrile at 303K 
between receptors (R,R) and (R,S)-11 & 12 and TBA AcO and TEA (S)-Nap (Ka in M-1, 
∆H and ∆G in kcal mol-1, ∆S in cal mol-1 K-1). 
 
3.2.2.3 Additional Chirality 
 
Despite the absence of π-stacking interactions between receptors 8-12 and 
Naproxen, we decided to synthesize receptors (R,R) and (R,S) 14-17 containing both 
an aromatic surface and a stereogenic center in α position of the urea NH (Scheme 7). 
N
N
H
N
H SS
PF6-
HNNH
N
N
H
N
H SS
PF6-
H2NNH2
OHNO NH
RR
15: R = 16: R = 17: R =
5
a
14: R =
 
Reagents and conditions: a) Isocyanate, dry CH2Cl2, sealed tube, reflux 24 h (85-90%). 
Scheme 7. Synthesis of compound 14-17. 
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Single liquid-liquid extractions between 14-17 (dissolved in CH2Cl2, 1 mg/mL) 
and aqueous sodium Naproxenate solution (0.08 M) were performed. No 
discrimination was observed for (R,R) and (R,S)-14-17. As it was previously 
demonstrated, those receptors do not work as pincer-like receptors and therefore only 
interact through hydrogen bonds with the carboxylate part of the guest. Naproxen 
chiral center is therefore free to rotate and discrimination between the enantiomers 
cannot be achieved. The aromatic surface is not electronically poor enough and the 
chiral barrier too small to reach the goal. 
 
3.2.3 Pre-Organized Receptors 
 
3.2.3.1 Introduction 
 
As it was stated previously, the too high flexibility of the receptors synthesized 
so far did not lead to selection. To face this problem, we decided to use guanidinium 
based macrocycles endowed with a more rigid scaffold and convergent binding 
groups. 
As a preliminary experiment, we decided to study the binding of Naproxen by 
receptor 18, previously synthesized for nitrate binding. 1H-NMR titrations with TEA 
(S)-Nap confirm the formation of six H-bonds (Fig 14). No rearrangement of the 
scaffold was detected (as pointed out in figure 11 for (R,R)-8 with protons a, b, c and 
d). 
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Fig 14. 1H-NMR titrations between 18 and TEA (S)-Nap in CD3CN at 298K 
[from bottom to top: 0 to 1.1 TEA (S)-Nap equivalents]. 
 
Whereas association with AcO is both enthalpically and entropically driven, 
with both Naproxen enantiomers the binding is mainly entropically driven (due to a 
higher solvent release for the bigger guest). The large desolvation of host and guest 
gives rise to a Ka one order of magnitude higher (from 1.47 x 105 to 2.16 x 106 M-1, 
Table 6). No discrimination was observed by this macrocycle, probably because the 
stereogenic centers of the chiral bicyclic guanidinium are too far away from the guest 
chiral center. Moreover, a single liquid-liquid extraction confirmed this result. 
Even if this host-guest complex only shows a subtle entropy gap (T∆∆S = 1.57 
kJ mol-1) which is annihilated by the enthalpy-entropy compensation,35 it points out 
the previous remark by Schmidtchen about the association entropy as an indicator of 
enantiorecognition.36 Observing an entropy gap considerably higher (T∆∆S = 7.6 kJ 
mol-1) with tartrate enantiomers, Schmidtchen reports that the complex of better 
geometrical fit (lower entropy) displays weaker affinity than the disordered 
counterpart. By extension, he claims that maximizing host-guest affinity is not the 
suitable way to reach enantiorecognition. Similar behavior was previously mentioned 
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35 a) Dunitz, J. D. Chem. Biol. 1995, 2, 709-712. b) Exner, O. Chem. Commun. 2000, 1655-
1656. 
36 Jadhav, V. D.; Schmidtchen, F. P. Org. Lett. 2006, 8, 2329-2332. 
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by Kilburn and co-workers with a thiourea based receptor for the enantiorecognition 
of glutamate and aspartate.19d 
 
 TBA AcO TEA (R)-Nap TEA (S)-Nap 
Ka  1.47 x 105 1.98 x 106 2.16 x 106
∆H -4.89 -3.77 -2.25 
∆S 7.49 16.3 21.5 
∆G -7.16 -8.71 -8.76 
 
Table 6. Thermodynamic parameters from ITC titrations in acetonitrile at 303K 
between receptors 18 and TBA AcO and TEA (R) & (S)-Nap (Ka in M-1, ∆H and ∆G in 
kcal mol-1, ∆S in cal mol-1 K-1). 
 
 
3.2.3.2 Lysine Derivative Macrocycle 
 
Introducing new stereogenic centers was considered essential to reach 
enantioselection. An approach is to induce the chirality in between the two urea 
moieties. This requires some important characteristics, such as a readily available 
chiral molecule (diamine or diisocyanate) capable of affording new interaction(s) with 
the guest. However, few compounds fulfill these requirements. Amino acid derivatives 
present the right features but only lysine provides a diamine function. Lysine, with its 
five carbon atom spacer, is indeed a suitable spacer for the formation of the 
macrocycle. L-lysine p-nitroanilide dihydrobromide possesses an electronically poor 
ring (with a nitro group in para position) for π-interactions, a new stereogenic center 
as well as an additional H-bond donor (amide NH). Macrocycle 19 represents 
therefore a possible chiral receptor for Naproxen (Fig 15). 
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Fig 15. Lysine derivative macrocycle 19. 
 
 Molecular modeling was performed and showed different interactions for each 
enantiomer (Fig 16).37 There is π stacking between the nitrophenyl group of the 
receptor and the methoxynaphthyl of (R)-Naproxenate (Figure 16, (a)). Moreover, the 
side chain is stabilized by a hydrogen bond between the amide NH and one of the 
urea's oxygen atoms. For the (S)-enantiomer, the global minimum is completely 
different with carboxylate binding to the center of the ring by 5 hydrogen bonds 
including the one from the side chain (amide NH) (Figure 16, (b)). Molecular 
modeling showed indeed an important distinction concerning the guanidinium-
carboxylate binding: 
- (R)-Naproxenate: linear hydrogen bonds 
- (S)-Naproxenate: non linear hydrogen bonds. 
 The enthalpy difference between the two complexes is however rather small, 
only ∆∆HR-S = 1.2 kcal mol-1, which does not fully account for the quite different 
geometries predicted for both complexes. The receptor was nevertheless synthesized 
for binding assays with the target. 
                                                 
37 Model studies were performed by Martin Smiesko at Anterio Consult & research GmbH, 
Mannheim (Germany). 
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  a)      b) 
Fig 16. Molecular modeling of 19 with a) (R)-Naproxenate and  
b) (S)-Naproxenate (hydrogen atoms are omitted and Naproxen is colored in red). 
 
 Bisimidazolide intermediate 20 was synthesized from L-lysine p-nitroanilide 
dihydrobromide in good yield (Scheme 8). The formation of receptor 19 was achieved 
but purification process did not afford the pure compound. The desired product was 
indeed detected by LCMS after a first purification by column chromatography. A 
method in semi-preparative HPLC was therefore developed for purification (Column: 
SunFire C18 5 µm, 4.6 x 100 mm, FM: CH3CN (0.1% TFA) / H2O (0.1% TFA), 
Gradient: 10-100% CH3CN (0.1% TFA) in 30 min, Flow: 1 mL/min, ambient Tº). The 
crude obtained from the column chromatography was thus purified by HPLC and 
afford the pure product in a modest 8% yield (Fig 17). 
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Reagents and conditions: a) 20, dry MeOH, sealed tube, reflux 48 h (8%). b) L-lysine p-
nitroanilide, CDI, THF (95%). 
Scheme 8. Synthesis of macrocycle 19. 
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Fig 17. HPLC spectrum of compound 19 before (bottom) and after (top) 
purification by semi-preparative HPLC. 
 
A liquid-liquid extraction between 19 and rac Nap- Na+ was then performed but 
no discrimination was observed. This negative result agrees with the theoretical 
prediction that the energy difference between both complexes is not too high. 
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3.2.3.3 NOBIN Macrocycles 
 
Attempts of designing an enantioselective receptor for (S)-Naproxen were 
unsuccessful so far. Differentiating the orientation of the methyl group is indeed too 
demanding for receptors with too high conformational freedom. One step forward is 
the use of conformationally constrained macrocycles with convergent binding groups 
(Fig 18). Receptor 19 presents these characteristics but the too flexible chiral barrier 
did not translate into selectivity. A CPK model revealed indeed that introducing a rigid 
chiral barrier between the two urea functions would not afford the expected 
interactions without an efficient control of entropy. However, introduction of such a 
chiral barrier between the bicyclic guanidinium scaffold and the urea groups might 
lead to the desired interactions. 
 
+
N
N
N
N N
N NO O
 
OO
R
∗
H H
H
H H
H
 
Fig 18. Host-guest interactions between a guanidinium-based macrocycle 
and an α-methyl carboxylate. 
 
One option is the incorporation of an easily available chiral scaffold. Binaphthol 
and derivatives have been widely used in asymmetric catalysis. Cram also reported its 
use for chiral recognition of α-phenylethylamine.38 However, synthesis of a binaphthol 
derivative with both accessible thiol SH and amine NH2 functions remains difficult to 
achieve.39 An alternative is use of NOBIN,40 a ligand bearing an alcohol function 
                                                 
38 Kyba, E. B,; Koga, K.; Sousa, L. R.; Siegel, M. G.; Cram, D. J. J. Am. Chem. Soc. 1973, 95, 
2692-2693. 
39 Smrčina, M.; Vyskočil, S.; Polívková, J.; Poláková, J.; Sejbal, J.; Hanuš, V.; Polášek, M.; 
Verrier, H.; Kočovskỳ, P. Tetrahedron: Asymmetry 1997, 8, 537-546. 
40 a) Smrčina, M.; Lorenc, M.; Hanuš, V.; Sedmera, P.; Kočovskỳ, P. J. Org. Chem. 1992, 57, 
1917-1920. b) Belokon, Y. N.; Bespalova, N. B.; Churkina, T. D.; Císařová, I.; Ezernitskaya, 
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instead of a thiol that would likely introduce little changes into the binding pocket. On 
the other hand, the suitable five atoms spacer would be maintained between the NHguan 
and the first NHurea (the binaphthyl acts as a simple benzene ring in term of distance). 
Therefore the second H-bond donor located seven atoms away from a guanidinium 
NH would provide a perfect complement for the otherwise unexploited carboxylate 
anti lone pair. 
In an attempt of reducing receptor conformational degree, a short (butyl) or rigid 
aromatic (xylylene) spacer present the desired characteristics for target selection (Fig 
19). In addition, 22 may provide further stabilization by CH-π interactions with the 
xylylene aromatic ring. Assuming formation of the six H-bonds, CPK models gave 
some evidence of a difference in stability between the complexes with each 
enantiomer of Naproxen. 
 
N
N
N
H H
+
O O
NH HN
O ONH HN
PF6
-
21 R = C4H8
22 R =
R  
 
Fig 19. Guanidinium-based macrocycles 21 and 22. 
 
First, deprotection of both silyl groups (OTBDPS and OTBDMS) of 
guanidinium salt 23 was achieved with HCl in 97% yield (Scheme 9). Then, the 
guanidinium dichloride product 25 was obtained by reaction with thionyl chloride 
(95%). As the amine function of (S)-NOBIN is more nucleophilic than the alcohol 
one, a previous BOC protection was performed to afford 28 in a 94% yield.41b The 
guanidinium dichloride salt 25 was then transformed into the diprotected amine 26 
with K2CO3 in a 65% overall yield. Deprotection by 4N HCl in 1,4-dioxane gives 27 
                                                                                                                                 
M.G.; Harutyunyan, S. R.; Hrdina, R.; Kagan, H. B.; Kočovskỳ, P.; Kochetkov, A.; Larionov, 
O. V.; Lyssenko, K. A.; North, M.; Polášek, M.; Peregudov, A. S.; prisyazhnyuk, V. V.; 
Vyskočil, S. J. Am. Chem. Soc. 2003, 125, 12860-12871.
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(PF6-) in a 98% yield. Reaction with the appropriate diisocyanate in a sealed tube 
afforded the final products 21 and 22 in 57 and 55% yield, respectively. 
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Reagents and conditions: a) 3N HCl/CH3CN (1:2) (97%). b) SOCl2, reflux (95%). c) 28, 
K2CO3, acetone (50%). d) 4N HCl, 1,4-dioxane, 0,1N NH4PF6 (98%). e) 21: 1,4-
diisocyanatobutane, dry CH2Cl2, sealed tube, 24 h (57%); 22: m-xylylene diisocyanate, dry 
CH2Cl2, sealed tube, 24 h (55%). f) (S)-NOBIN, (BOC)2O, toluene (94%). 
Scheme 9. Synthesis of macrocycles 21 and 22. 
 
 21 (Cl-) was able to be recrystallized in CH3CN and a solid state X-ray structure 
was resolved (Fig 20), revealing an unpredicted structure for the complex. The host-
guest ion pair is indeed not formed with the guanidinium salt as widely described so 
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far in our group and in the literature. One oxygen atom from a urea function is thus 
hydrogen bonded to the guanidinium (N···O 2.863 and 2.789 Å, respectively) whereas 
the chloride counter-ion is only bound by the two NHs from the second urea (N···Cl 
3.088 and 3.247 Å). The orientation of the (S)-NOBIN induced each arm to fold apart 
in order to give the NHurea pointing away from the cavity instead of wrapping around 
the spherical guest. In addition, each urea function is stabilized by additional 
intermolecular hydrogen bonds with an urea from another receptor molecule: the 
NHurea from the function complexed by the guanidinium as well as the oxygen atom 
from the one bound to the chloride (N···O 2.785 and 2.755 Å). All attempts to obtain a 
single crystal of a complex with a carboxylate guest for X-ray analysis failed. 
 
 
 
Fig 20. X-ray solid state structure of guanidinium-based macrocycles 21(Cl-). 
 
At NMR concentration in CH3CN, 21 crystallized with Cl- as counter-ion 
whereas it precipitates in situ with AcO-. Increasing the temperature to 375K, 21 
dissolved again with both counter-ions. With Cl-, NHgua and NHurea suffered a 
downfield shift (0.45 up to 0.65 ppm) whereas with AcO- the NH signals were not 
detected because of fast equilibrium. 1H-NMR could not afford any additional data on 
the binding mode of 21 with regard to the counter-ion employed. 
Thus, single liquid-liquid extractions were run with receptors 21, 22 and 26. The 
NHBoc groups of 26 are probably also involved in the binding pocket so 26 should 
therefore be considered also as a potential receptor for enantiorecognition (by 1H-
NMR downfield shift of 0.7 ppm from PF6- to AcO- for NHBoc, 1 ppm for NHgua). 
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The e.e. determined by chiral HPLC was however modest: 10 % for 26, 20% for 21 
and 22% for 22 (Table 7). The (R/S) ratio is enhanced from 26 to 21-22 proving again 
the advantage of a conformationally restrained macrocyclic structure over a more 
flexible open one. Nevertheless, from this experiment, the discrimination is quite weak 
considering the very low selectivity measured (1.5:1). 
 
 26 21 22 
Naproxen 10 % (55/45) 20 % (60/40) 22 % (61/39) 
 
Table 7. Enantiomeric excess determined by HPLC from liquid-liquid extraction 
between receptor 26, 21 and 22 and Naproxenate sodium salt. 
(R/S ratio is indicated in parenthesis)
 
3.3 Combinatorial Approach 
 
3.3.1 Introduction 
 
3.3.1.1 General principles 
 
Designing a host for a concrete guest is one of the current challenging goals of 
supramolecular chemistry. To do so, two different approaches have so far been 
developed: the rational design and the “irrational design”41. Designing receptors with 
predictable association and selectivity towards small to medium-sized molecules has 
reached a good degree of success.42 Nevertheless, the main drawback of this approach 
is that the goodness of the design is only validated at the end of the study, after 
receptor synthesis and binding properties evaluation. The precedent chapter provides a 
number of typical examples. Besides, as the target is becoming trickier to be 
selectively recognized, in particular for enantiomers, the host design turns out to be a 
less certain method. Alternatively, efforts have been employed to use a more 
“biomimetic approach”. Combinatorial chemistry proposes indeed to generate a large 
                                                 
41 Brenner, S.; Lerner, R. A. Proc. Nati. Acad. Sci. 1992, 89, 5381-5383. 
42 Lavigne, J. J.; Anslyn, E.V. Angew. Chem. Int. Ed. 2001, 40, 3118-3130. 
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number of compounds capable of binding a target. Selection of the most suitable one 
for its desired property is though achieved by rapid screening of the library. Synthetic 
expenditure is reduced while the possibilities of generating an effective receptor are 
enhanced highlighting this approach as very attracting. 
The combinatorial chemistry concept was first reported in 198843 and published 
in 1991.44 Since then, this approach has been widely employed and successfully 
reported. One reason of this fast growth is the rapid generation of compounds and 
screening of biological activity.45 Combinatorial chemistry first played a significant 
role in chemical biology and currently extends to almost all fields of chemistry such as 
host-guest chemistry.46 The combinatorial approach to the identification of selective 
peptide receptors was pioneered by Still in the 1990’s.47 Afterwards, another approach 
for receptor discovery appears by the use of dynamic combinatorial libraries (DCL) 
pioneered by the research group of Sanders and Lehn.48
Considering the field of supramolecular chemistry, combinatorial receptor 
design is the first step toward the generation of a library. “Tweezers” or “two-armed” 
receptors have been then widely developed.49 Such receptors possess a scaffold or 
“head group” which pre-organizes the substrate binding arms as well as containing the 
binding functionality. Attachment of this scaffold to a solid support is necessary for 
solid phase synthesis of the library. Parallel synthesis of the arms by means of Split 
 
43 Furka, A.; Sebestyen, F.; Asgedom, M.; Dibo, G. Abstr. 14th Int. Congre. Biochem., Prague, 
Czechoslovakia, 1988, Budapest, Hungary, 288. 
44 a) Furka, A.; Sebestyen, F.; Asgedom, M.; Dibo, G. Int. J. Pept. Protein Res. 1991, 37, 487-
493. b) Houghten, R. A.; Pinilla, C.; Blondelle, S. E.; Appel, J. R.; Dooley, C. T.; Cuervo, J. H. 
Nature 1991, 354, 84-86. c) Lam, K.; Salmon, S.; Herch, E.; Hruby, V.; Kazmierski, W.; 
Knapp, R. Nature, 1991, 354, 82-84. 
45 Lowe, G. Chem. Soc. Rev. 1995, 309-317. 
46 Linton, B.; Hamilton, A. D. Curr. Opin. Chem. Biol. 1999, 3, 307-312. 
47 Still, W. C. Acc. Chem. Res. 1996, 29, 155-163. 
48 a) Huc, I.; Lehn, J. M. Proc. Natl. Acad. Sci. U.S.A. 1997, 94, 2106-2110. b) Otto, S.; 
Burlan, R. L. E.; Sanders, J. K. M. Curr. Opin. Chem. Biol. 2002, 6, 321-327. c) Rowan, S. J.; 
Cantrill, S. J.; Cousins, G. R. L.; Sanders, J. K. M.; Stoddart, J. F. Angew. Chem. Int. Ed. 2002, 
41, 898-952. 
49 Srinivasan, N.; Kilburn, J. D. Curr. Opin. Chem. Biol. 2004, 8, 305-310. 
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and Mix method is then achieved using different monomer units (Fig 22). Higher 
order or multi-armed receptors have also been reported. 
X
Scaffold 
or 
“Head 
group”
X
X
Scaffold 
or 
“Head 
group”
“Side-arms”
 
 
Fig 22.Combinatorial approach to tweezers receptors proceeds. 
 
Combinatorial chemistry generates large libraries and detection method of the 
effective compound is therefore the major feature of this approach. A common 
strategy has been to attach fluorescent or color dyes to the receptor (or to the guest) in 
order to accelerate the detection process. Beads that show the greatest fluorescence or 
color are selected and decoded to identify the compound structure. This methodology 
has been successfully employed over the years for different kind of host-guest systems 
(an example is shown in Fig 23 with sulfonamide tweezers)50. High-throughput 
detection is indeed based on visual examination and is part of the rapid expansion of 
combinatorial approach for receptor chemistry. 
 
 
 
Fig 23. Photographs of a screening assay of tweezers receptors for binding to a bead-
supported tripeptide library. 
                                                 
50 Löwik, D. W. P M.; Weingarten, M. D.; Broekema, M.; Brouwer, A. J.; Still, W. C. 
Liskamp, R. M. J. Angew. Chem. Int. Ed. 1998, 37, 1846-1850. 
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 Still and co-workers have successfully applied the chemosensor process to the 
sequence-selective peptide detection.51 The peptide-binding receptors contain both a 
fluorophore (F) and a quencher (Q) (Fig 24). In the absence of binding, F is quenched 
intramolecularly by the second fluorophore Q. When peptide analyte is bound in 
chloroform, the separation between F and Q increases causing the enhancement of 
fluorescence emission and can be visually detected. Besides, the fluorescence 
amplification was used to measure the binding constants between the selected 
receptors and tripeptides (by fluorescence-monitored titrations). 
 
F
Q
F
Q
Synthetic receptor
Peptide
analyte
  
   a)             b) 
Fig 24. a) Analyte binding to the synthetic receptor increases the average separation 
between F and Q, resulting in enhanced fluorescence and b) fluorescence of the 
receptor with (bottom) or without (top) their peptide. 
 
3.3.1.2 Combinatorial Approach based on Guanidinium Receptors 
 
In the process of designing combinatorial receptor, various functionalities have 
been incorporated in its scaffold depending on the target desired. A few research 
groups synthesized combinatorial libraries based on guanidinium receptors because of 
forming a good complement with a carboxylate terminus of peptides. 
Kilburn and co-workers synthesized a library of symmetrical tweezers 
constituted by 2197 members incorporating a guanidinium scaffold and two tripeptide 
arms.52 Screening of the library with the dye-labeled tripeptide Glu(OtBu)-Ser(OtBu)-
                                                 
51 Chen, C. T.; Wagner, H.; Still, W. C. Science 1998, 279, 851-853. 
52 Jensen, K. B.; Braxmeier, T. M.; Demarcus, M.; Frey, J. G.; Kilburn, J. D. Chem. Eur. J. 
2002, 8, 1300-1309. 
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Val allows identification of a selective receptor in aqueous solvent (Fig 25a). The 
receptor was then synthesized by an independent way and binding constants, measured 
by UV titrations, confirmed its selectivity over the tripeptide enantiomer and the side 
chain deprotected tripeptide. 
Kilburn has also recently reported the synthesis of an unsymmetrical 15625-
membered library (Fig 25b).53 Screening of the library with the bacteria wall cell 
precursor tripeptide N-Ac-Lys-D-Ala-D-Ala was achieved in order to identify a 
selective receptor. Binding study on solid state demonstrates its selectivity over the 
diastereoisomeric peptide N-Ac-Lys-L-Ala-L-Ala. 
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Fig 25. Two receptor libraries derived from a guanidinium scaffold:  
a) symmetrical and b) unsymmetrical tweezers. 
                                                 
53 Sheperd, J.; Gale, T.; Jensen, K. B.; Kilburn, J. D. Chem. Eur. J. 2006, 12, 713-720. 
 118
3.3 Combinatorial Approach  
_____________________________________________________________________ 
Schmuck employs combinatorial receptor library in order to extend his 
guanidiniocarbonyl pyrrole scaffold (good complement for dipeptides) to larger 
substrates as tetrapeptides.54 Particularly interesting is the introduction of a statistical 
method QSAR analysis (quantity structure-analysis relationship) in order to show that 
a nonhydrophobic tetrapetpide could be bound by a one-armed receptor in water 
without additional hydrophobic interaction or metal-ligand interactions.55 Ion-pair 
formation in combination with hydrogen bonds is indeed the main driving force of the 
complex formation. 
Recently, Schmuck and co-workers reported a remarkable stereoselectivity 
between D and L-Ala in a combinatorial library of 320 substrates (Fig 26). The 
stereoselectivity is only observed when the position of D/L-Ala exchange takes place 
is fixed at both sides by strong electrostatic interactions between the receptor and the 
substrate.56
 
 
Fig 26. Stereoselectivity of receptor (top) depends on the sequence of the bound 
substrate (bottom). 
 
 As an alternative to produce a highly selective receptor, Anslyn introduced the 
concept of “differential” receptors, i.e. receptors that have different binding 
                                                 
54 Schmuck, C. Coord. Chem. Rev. 2006, 250, 3053-3067 and references herein. 
55 Schmuck, C.; Heil, M.; Scheiber, J.; Baumann, K. Angew. Chem. Int. Ed. 2005, 44, 7208-
7212. 
56 Schmuck, C.; Vich, P. Angew. Chem.Int. Ed. 2006, 45, 4277-4281. 
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characteristics but none of which is necessarily very specific or selective.57 An array 
of sensors are generated and the composite signal evaluated by pattern-recognition 
protocols. Using this model, Anslyn and co-workers reported a sensing method 
utilizing a combinatorial library of receptors that can differentiate between structurally 
similar analytes, such as nucleotide phosphates (ATP, GTP and AMP) in water. The 
receptors possess guanidinium groups (known for their good affinity with nucleotide 
triphosphates) and two tripeptide arms for differential binding (Fig 27). A 4913-
membered library was then generated and thirty beads were then selected and 
fluorescein was though introduced and bound to the receptor. On binding the analyte, 
the fluorescein is displaced and the beads lose the staining from the dye (the light 
emission was recorded and analyzed). This study demonstrates that each receptor 
responded differently to the three nucleotide phosphates.58
 
AA1-AA2-AA3
AA1-AA2-AA3
AA1-AA2-AA3
AA1-AA2-AA3
Analyte
Cationic
receptor
Resin Tripeptide arm
Fluorescein
 
 
Fig 27. Signal transduction scheme used to detect nucleotide phosphates within the 
resin bound sensor. 
 
3.3.1.3 Combinatorial Approach for Enantioselective Substrate 
 
Combinatorial approach appears as an excellent alternative for the very 
demanding selective recognition of a single enantiomer. 
                                                 
57 Lavigne, J. J.; Anslyn, E. V. Angew. Chem. Int. Ed. 2001, 40, 3118-3130. 
58 a) Schneider, S. E.; O’Neil, S. N.; Anslyn, E. V. J. Am. Chem. Soc. 2000, 122, 542-543. b) 
McCleskey, S. C.; Griffin, M. J.; Schneider, S. E.; McDevitt, J. T.; Anslyn, E. V. J. Am. Chem. 
Soc. 2003, 125, 1114-1115. 
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Still’s research group reported a 60-membered library of receptors for 
enantiorecognition of proline derivatives.59 Module A (15 D- and L-amino acids) 
carries the nucleophilic/basic amine, module B (RR or SS stereoisomers) links module 
A and C toward one another and Module C (RRRR or SSSS) provides the large 
functionalized surface (Fig 28). Screening with dye-labeled amino acid derivatives 
shows beads that turn blue (binding of the L configuration) or red (for the D-
enantiomer). No enantiorecognition was concluded when brown color was obtained. 
Enantioselectivity excesses range from 39 to 81%. 
 
CH2NH2 CO(CH2)2CON
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NH2
Polystryrene
support
Module B
Module A
Module C
COX
R
HN COX
R
HNBlue-Linker
 
Red-Linker
L-1 D-1
60-membered library screened with
equimolar mixture of dye-labeled
amino acid derivative in CHCl3
                                                
 
Fig 28. 60-membered library for enantiorecognition of proline derivatives. 
 
 
59 Weingarten, M. D.; Sekanina, K.; Still, W. C. J. Am. Chem. Soc. 1998, 120, 9112-9113. 
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Fréchet and co-workers used combinatorial chemistry for developing highly 
selective chiral stationary phases (CSP) for HPLC. A first approach uses the principle 
of reciprocal association.60 A single enantiomer of the target racemate is immobilized 
on a solid support and tested for separation of a 140-membered library of substituted 
dihydropyrimidines. The compound with the highest separation is synthesized and one 
enantiomer is attached to a solid support, thus the new CSP affords an effective 
medium for separation of the target. A second approach employs libraries of mixed 
chiral selectors immobilized on polymer beads.61 The chiral phases are tested in the 
separation of racemic targets followed by deconvolution in order to obtain an 
optimized separation medium (Fig 29). In this context, only 11 different columns are 
necessary instead of 36 for a classical approach. 
 
 
 
Fig 29. The mixed selector column approach by Fréchet et al.
 
 Gagné et al. have recently reported the first use of a racemic dynamic 
combinatorial library (DCL) for enantiomeric recognition of (-)-adenosine.62 
Templating the racemic DCL with the enantiopure (-)-adenosine indeed amplifies the 
                                                 
60 Lewandowski, K.; Murer, P.; Svec, F.; Fréchet, J. M. J. Chem. Commun. 1998, 2237-2238. 
61 Murer, P.; Lewandowski, K.; Svec, F.; Fréchet, J. M. J. Chem. Commun. 1998, 2559-2560. 
62 Voshell, S. M.; Lee, S. J.; Gagné, M. R. J. Am. Chem. Soc. 2006, 128, 12422-12423. 
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most suitable host (Fig 30). Rac-IX is composed of a racemic proline and an achiral 
peptide. The addition of TFA deprotects the acetal and initiates reversible hydrazone 
exchange to form cyclic oligomers. Templating the racemic DCL amplified the dimer 
over higher order oligomers. Examining then the template effect of (-)-adenosine with 
(S)-IX and (R)-IX DCL showed the increased formation of dimer with (S)-DCL. Laser 
polarimetry allows indeed detection of the enantioselective peptide-like receptor (S,S)-
X. 
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Fig 30. a) Racemic DCL for (-)-adenosine;b) enantioselective receptor (S,S)-X. 
 
3.3.2 Combinatorial Approach to (S)-Naproxen Enantiorecognition 
 
3.3.2.1 Previous Work 
 
A receptor for enantiorecognition of (S)-Naproxen was previously synthesized 
in our group according to a strategy balanced between rational design and 
combinatorial approach.63 One arm was designed to fix the complex by means of one 
additional hydrogen bond (amide NH) and π-interactions; the second arm was 
synthesized from the screening of a dipeptide library (Scheme 10a). 13 different 
amino acids were used for the dipeptide library creating 169 members. On the other 
hand, a red dye was attached to each enantiomer of Naproxen for the screening of the 
potential receptor. Some of these beads that colored on adding red-dyed (S)-Naproxen 
 
63 Pérez-Velasco, Alejandro 2002, DEA Universidad Autónoma de Madrid. 
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but not with (R)-Naproxen were identified. The sequence Trp-Ser appeared three times 
and therefore a receptor containing this dipeptide was synthesized (Scheme 10b). 
Extraction was performed between racemic Naproxenate and the final receptor. 
However, 1H-NMR as well as chiral HPLC pointed out the lack of selectivity of this 
receptor. Besides, two equivalents of guest were extracted whereas guanidinium 
receptors form only 1:1 complexes with the guest. Likely, a too low number of dyed 
beds were selected for screening, so the found consensus was simply an artifact. This 
was due to the deconvolution method employed, based on quite expensive Edman 
degradation sequences, that prevented a larger number of beads to be screened. 
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   a)     b) 
Scheme 10. a) Previous combinatorial approach to enantiorecognition of 
(S)-Naproxen and b) receptor synthesized. 
 
3.3.2.2 New Approach 
 
It appears essential to generate a peptide library because of the presence of the 
amino acid chiral center as well as the additional peptidic hydrogen bonds. Here, we 
aim at employing a larger peptide library using 8 different amino acids with 4 
coupling steps: a library of 4096 members is therefore available. 
In addition to the creation of a larger library, the combinatorial receptor was 
redesigned in order to get closer the peptide to the chiral center of the guest. Attaching 
the tetrapeptide directly to the receptor scaffold through an amine function located 
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three atoms away from the guanidinium moiety should better orient the discrimination 
of one enantiomer (Scheme 11a). A second proposal is based on an asymmetric 
receptor incorporating a urea function in one arm and the peptide library in the other 
(scheme 11b). The carboxylate part of the guest would bind to both guanidinium and 
urea NH getting a different orientation towards the peptide library. It was particularly 
attractive to compare screening results from these two receptors in order to look for 
the more effective one. 
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   a)    b) 
Scheme 11. New tetrapeptidic guanidinium receptors. 
 
Dye-labeled substrates are often giving misleading results due to false visual 
interpretations of the colored beads. A fluorescent probe appears to be a more reliable 
tool for screening. Moreover, its use has been successfully reported so far.54 To do so 
the good chromophore Dansyl was attached to each enantiomer of the Naproxen 
through its methoxy group in order to not influence the chiral recognition process 
(scheme 12). 
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Scheme 12. Fluorescent Naproxen. 
 
3.3.2.3 Synthesis of Guanidinium Receptors Libraries 
 
Among the principal methods used in combinatorial chemistry, the Split and 
Mix one was employed for the synthesis of the tetrapeptide library.64 At the end of the 
synthesis, one bead contains one single compound. An exemple of a Split and Mix 
method for three different amino acids with three coupling steps is shown in scheme 
13. First, the resin is partionated in three different batches with the same amount of 
resin. After the amino acid coupling, a capping agent is added in a 15% yield in the 
resin periphery for tagging purposes. This agent will allow amino acid sequence 
identification by mass specrrometry, a more convenient and economic way than 
Edman degradation65 sequencing. Batches are then mixed together followed by a 
deprotection step. Three different batches are then partionated again with the same 
amount of resine. The same procedure as previously described is performed: amino 
acid coupling, capping agent reaction, mixing, deprotection and division in three 
batches. This procedure is then repeated once again. For this example, with three 
different amino acids added each step, and three coupling steps, 33 = 27 different beads 
are obtained corresponding to each single compound. 
                                                 
64 The tetrapeptide library synthesis and the screening experiments were performed by Dr. 
Sandrine Peroche in collaboration with Jon Shepherd at Prof. Jeremy Kilburn’s laboratory in 
Southampton, U.K.. 
65 Edman, P.; Begg, G. Eur. J. Biochem. 1967, 1, 80-91. 
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The exact loading of the resin was determined by colorimetry with UV 
spectroscopy. The degree of substitution was established to be 0.215 mmol/g, in good 
agreement with theoretical value (0.21 mmol/g). 
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Recombine
Recombine
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Scheme 13. Split and Mix method for three amino acids with three synthetic cycles. 
 
 The synthesis of our first combinatorial receptor 31 is described in scheme 14. 
Selective deprotection of the TBDMS group was followed by the activation as a 
methanosulfonate derivative 30 in a 98% yield. Incorporation of the tetrapeptide 
library was achieved with DIPEA in DMF on solid phase in order to afford receptor 
31.64 
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Reagents and conditions: a) H2O-HOAc-THF (1:3:1), 24 H (98%). b) Ms2O, NMM, THF 
(95%). c) DIPEA, DMF. 
Scheme 14. Synthesis of guanidinium receptor 31. 
 
Scheme 15 describes the synthesis of the second combinatorial receptor 36. 
Introduction of the 2-aminothiophenol group was achieved with Cs2CO3 in 70% yield 
followed by urea formation upon addition of butylisocyanate in dry CH2Cl2 in a sealed 
vessel in 75% yield. Deprotection of the second protecting group TBDPS by TBAF 
was again followed by activation as methansulfonate derivative 35 in 90% yield. 
Coupling with the tetrapeptide library was done with DIPEA in DMF in order to 
afford final receptor 36. 
 128
3.3 Combinatorial Approach  
_____________________________________________________________________ 
a b
30
c
N
N
N
H H
+
OMs OTBDPS
PF6-
N
N
N
H H
+
S OTBDPS
PF6-
NH2
N
N
N
H H
+
S OTBDPS
PF6-
NH
NHO
N
N
N
H H
+
S OH
PF6-
NH
NHO
N
N
N
H H
+
S OMs
PF6-
NH
NHO
N
N
N
S NHHH
NH
AA2
AA1
O NH
AA4
AA3
PF6
-
de
32 33
3435
36
 
Reagents and conditions: a) 2-aminothiophenol, Cs2CO3, CH2Cl2 (70%). b) butylisocyanate, 
dry CH2Cl2 (75%). c) TBAF, dry THF (86%). d) Ms2O, NMM, THF (90%). e) DIPEA, DMF. 
Scheme 15. Synthesis of guanidinium receptor 36. 
 
3.3.2.4 Synthesis of a Fluorescent Naproxen 
 
At first, fluorescein was chosen as the chromophore to be attached to the 
Naproxen. Fluorescein was previously employed by our research group and attached 
to a tetraguanidinium receptor.66 The fluorescent (R) and (S)-Naproxen 37 was 
therefore synthesized (Scheme 16).67
Afterwards, screening experiments were performed on adding the fluorescent 
(R) or (S)-Naproxen 37 to the receptor library 31. However, all beads turned out to be 
fluorescent and no selectivity was therefore noticed. The fluorescein carboxylate 
                                                 
66 Fernández-Carneado, J.; Van Gool, M.; Martos, V.; Castel, S.; Prados, P.; de Mendoza, J.; 
Giralt, E. J. Am. Chem. Soc. 2005, 127, 869-874. 
67 (R) and (S)-37 were synthesized by Dr. Sandrine Peroche, unpublished results. 
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moiety may act as a competitive function to the carboxylate part of the Naproxen and 
be responsible for the overall fluorescence.64 
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Scheme 16. Fluorescent (R) and (S)-Naproxen 37. 
 
 As an alternative to fluorescein, the dansyl group was thus attached to the 
Naproxen. Demethylation of the naphthyl group of the Naproxen followed by the 
protection of the carboxylic acid function was the successful strategy to introduce the 
dansyl group (Scheme 17).68 A chain large enough has to be introduced between the 
fluorophore and the Naproxen to avoid interaction with the host. 
 A Boc was preferred over a benzyl or methyl group as the protective group of 
the carboxylic acid function of the Naproxen during the synthesis. Alkylation of such 
compounds was indeed rather complicated and never afforded the desired product. 
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P: protective group (R ) or (S)-Naproxen
 
Scheme 17. Retrosynthetic pathway to the fluorescent dansyl-Naproxen. 
                                                 
68 A similar strategy was previously used for the introduction of a dye: see ref. 63.  
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 Demethylation of the naphthyl group was first achieved with BBr3 in CH2Cl2 at 
0ºC in quantitative yield. However, characterization of purified 38 by chiral HPLC 
(Whelk-01(S,S)) revealed a partial racemization of the compound. Almost 40% of (R)-
38 was formed starting from (S)-Naproxen. The procedure using BBr3 was then 
replaced by HBr and eventually HCl at reflux giving the desired compound 38 without 
racemization (according to results reported by Dickinson et al.)69. The too harsh 
conditions of BBr3 procedure may induce a proton transfer in α position of the 
carboxylic acid moiety through formation of the corresponding, easily enolizable acyl 
bromide. 
 Protection of the carboxylic acid function was then performed with 
trifluoroacetic anhydride and tert-butanol in dry CH3CN in 87% yield.70
 Starting from dansyl chloride, the derivatives 41 and 42 with respectively two 
different leaving groups MsO and Br were obtained in good yields. However, coupling 
the chromophore derivatives 41 or 42 with the protected Naproxen 39 never produced 
the desired compound. It seems that 41 or 42 degrades during the reaction prior to 
reacting. 39 was indeed recovered unchanged (Scheme 18). 
 
 
 
 
69 Lo, A.; Addison, R. S.; Hooper, W. D.; Dickinson, R. G. Xenobiotica, 2001, 31, 309-319. 
70 Optimization synthesis of 39 was performed by Dr. Sandrine Peroche. 
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Reagents and conditions: a) HCl reflux (88%). b) (CF3CO)2O, tBuOH, dry THF (87%). c) 
Et3N, THF (99%). d) for X = OMs : Ms2O, NMM, THF (88%); for X = Br : CBr4, PH3P, 
CH2Cl2 (70%). e) K2CO3, THF. 
Scheme 18. Synthesis attempt of fluorescent Dansyl-Naproxen. 
 
 A reverse strategy was then employed: alkylation of the naphthyl group 
followed by introduction of the dansyl part (Scheme 19). Alkylation of 39 by 1,3-
dibromopropane was achieved in THF with K2CO3. Yield increased from 50 up to 
75% as the number of 1,3-dibromopropane equivalents is increased from one to five 
(to prevent disubstitution). 
 Besides, dansyl amine 44 was obtained from dansyl chloride in 50 % yield.71 
Reaction between protected Naproxen 43 and dansyl amine 44 gives the desired 
compound 45 in a 90% yield. Deprotection of the Boc group in the presence of 30% 
TFA in dichloromethane and a catalytic amount of triethylsilane gives the final 
compound 46 in 95% yield. 
 
                                                 
71 Jersey, J. A.; Choshen, E.; Jensen, J. N.; Johnson, J. D. Environ. Sci. Technol. 1990, 24, 
1536-1541. 
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Reagents and conditions: a) 1,3-dibromopropane, K2CO3, THF (75%). b) NH3 (30%), (50%). 
c) K2CO3, CH3CN (90%). d) Et3SiH, TFA, CH2Cl2 (95%). 
Scheme 19. Synthesis of fluorescent (R) and (S) Dansyl-Naproxen 46. 
 
 The chromatogram of final products (R) and (S)-46 in chiral HPLC is shown in 
figure 29. A ratio of 90/10 was measured for each enantiomer. Some racemization 
occurs during the final step, however. Recrystallization was attempted in several 
solvents and mixed solvents without success. For this reason, purification at a small 
scale (just a few milligrams to perform the experiments) was achieved by analytical 
chiral HPLC (Fig. 29 bottom). 
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3.3.2.5 Screening Experiments 
 
 Screening experiments were carried out with library 31, 36 as well as the free 
tetrapeptide 48 using the fluorescent guests (S) and (R)-46. Screening experiments 
were carried out in CH3CN. A library sample was equilibrated in CH3CN for one hour 
and the fluorescent guest (S)-46 (as tetrabutylammonium salt) dissolved in CH3CN is 
added. The selectivity in binding the receptor can be judged by observation of 
fluorescent beads, visualized under an optical microscope (Fig 32). 
 Control experiments with dansyl chloride showed that the observed fluorescence 
activity is indeed due to selective complexation by the receptor and not to the 
chromophore. 
 After selecting the most fluorescent beads (about 50 in each of the 3 cases), the 
beads were washed several times to remove the Naproxen derivative (S)-46. The same 
procedure was then carried out with (R)-46, but now the ones that did not form a 
complex with the R enantiomer were isolated. Indeed, the beads that can form a 
complex with the S enantiomer and not with the R one are likely containing the 
enantioselective receptors. Five beads were therefore selected for mass spectrometry 
analysis in each of the three receptor libraries. 
 
 
  a)   b)   c) 
Fig 32. Photographs of screening assay of receptors a) 31, b) 36 and c) the free 
tetrapeptide libraries for binding to (S)-46. 
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 As an alternative to the widely used Edman degradation for determination of the 
sequence of bead-based peptides, a new encoding methodology developed by Kilburn 
et al.72 has been employed. Split and Mix peptide libraries have been indeed encoded 
by capping a cleavable sequence with p-bromobenzoic acid (Fig. 33). The resin 47 
was thus prepared by sequential coupling of methionine, arginine (Pbf) and two 
aminohexanoic acid moieties on to a tentagel resin. Four rounds of Split and Mix 
synthesis using eight amino acids (Asp(OtBu), Gln, Tyr(OtBu), Trp(Boc), Thr(OtBu), 
Val, Gly, Pro) followed each time by incorporation of the capping agent gave the 
encoded library 48. The beads selected were cleaved and then analyzed by mass 
spectrometry (MALDI-TOF MS). The mass analysis of the single bead cleavage 
followed by processing the bromine isotopes gave the peptide sequence by calculating 
the mass difference of the amino acid residues (Fig 34). The complexity of the 
spectrum can be dramatically reduced by just plotting the peaks differing by two mass 
units (those containing bromine). This simplification allows an easy detection of the 
relevant masses. 
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Fig. 33. Split and Mix tetrapeptide library encoded by a capping reaction with p-
bromobenzoic acid (15-20 mol% of resin loading). 
 
                                                 
72 Sheperd, J.; Langley, G. J.; Herniman, J. M.; Kilburn, J. D. Eur. J. Org. Chem. 2007, 1345-
1356. 
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765.5
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m/z  
Fig 34. Mass spectra of sample from a single cleaved bead of 36, top: raw data, 
down: processed to identified Br-isotope patterns.  
 
 Sequencing was unsuccessful for three beads isolated suggesting either 
unsuccessful coupling or a cleavage reaction (Table 8). On the other hand, four 
sequences could not be entirely determined because of the absence of bromine 
isotopes or too weak peaks in mass analysis. Tetrapeptide sequences of libraries 48 
and 31 are probably too small and appear to lack enough consensus to conclude about 
any specific amino acid in each position. However, library 36 gave four entire 
sequences and one with only the first amino acid identified. Thus, Asp is present three 
times in position 4 as well as two times in position 2. Apart the presence of two Val in 
position 1, no other repeats were present in the sequences. Asp appears in four beads 
of 36 suggesting that it is an important amino acid for selectivity of the target. 
 The sequences identified do not show a specific agreement between the beads 
isolated even if the presence of certain amino acid (Asp) is recurrent. It is curious that 
no Trp was detected despite its tendency to form π-stacking interactions with the 
aromatic ring of Naproxen. 
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Bead aa1 aa2 aa3 aa4
48     
1 Gly - - - 
2 Gln - - - 
3 Val Asp Asp Tyr 
4 Val Asp - - 
5 - - - - 
31     
1 Asp Asp - - 
2 Tyr Thr Gly - 
3 Val Gln Gln - 
4 - - - - 
5 - - - - 
36     
1 Val Val Asp Asp 
2 Asp Asp Gln Asp 
3 Pro Asp Tyr Gly 
4 Val Gly Val Asp 
5 Gln - - - 
 
Table 8. Sequencing results for 5 beads identified from screening experiments of 
receptor libraries 48, 31 and 36 with (S)-46 and (R)-46 in CH3CN. 
 
3.4 Conclusions 
 
In this chapter, flexible chiral guanidinium receptors as well as rigid 
macrocycles have been synthesized with none to rather low enantioselectivity towards 
Naproxen. 
NOBIN-based macrocycles present however a modest discrimination (1.5:1). 
An X-ray solid state structure has been resolved for 21 (Cl-) and showed an 
unprecedented intermolecular binding of the macrocycle. 
Further studies with those macrocycles with other targets as for instance 
protected amino acid are currently ongoing. 
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A combinatorial approach was also attempted. A fluorescent (S) and (R)-46 
dansyl-Naproxen was synthesized. Two guanidinium libraries 31 and 36 bearing a 
tetrapeptide arm were synthesized. Screening experiments showed selectivity towards 
the substrate. Identification was then achieved but could not afford a reliable 
consensus of optimal amino acid sequence. 
 
3.5 Experimental Section 
 
3.5.1 General Procedures 
 
Molecular modeling. MMFFs and OPLS-AA force fields were used for 
molecular mechanics in chloroform for all complexes (continuum solvent GB/SA 
(CHCl3). MacroModel (Schrodinger Inc.) were used for conformational search in 
Mixed Mode MCMM (torsional angles)/LMCS (vibrational mode following). 20,000 
MCMM/LMCS steps were run for L/D bound complex. MINTA computation was 
used for of ∆∆GS-R (as an indication of relative ee´s). 
 
3.5.2. Synthesis 
 
 General procedure for the synthesis of compounds 1, 2, 6, 8-11, 14-17. The 
appropriate isocyanate (2 eq) was added, under nitrogen atmosphere, to a solution of 5 
(1 eq) in dry CH2Cl2 (2 mL) in a sealed tube and the mixture was stirred at 45 ºC 
overnight. After evaporation of the solvent, the resulting solid was dissolved in CH2Cl2 
and the organic layer was washed with 0.1M NH4PF6 solution, dried (Na2SO4), filtered 
over cotton and concentrated at reduced pressure. Purification of the crude was achieved 
by column chromatography on silica gel exept for (R,R)-1 and (R,S)-9 which do 
precipitate in situ, and were thus filtered over a Büchner funnel. 
 Compounds 8-11 were synthezised with both (R,R) and (R,S) stereochemistries, 
full characterisation (Mp, 1H-NMR, 13C-NMR and ESI-MS) is provided for only one 
stereochemistry [namely (R,R) one] for those compounds in order to avoid unecesssary 
duplications. Thus, unless otherwise stated, all guanidinium derivatives are of (R,R) 
configuration. 
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(2R,8R)-2,8-Bis-{[2-(3-benzhydrylureido)phenylthio]methyl}-2,3,4,6,7,8-
hexahydro-2H-pyrimido[1,2-a]pyrimidin-9-ium hexafluorophosphate (1). 
Prepared from diphenylmethyl isocyanate (0.04 mL, 0.19 mmol) and 5 (50 mg, 0.09 
mmol). Purification by filtration over a Büchner funnel afforded 1 as a light yellow 
solid (75 mg, 86%). Mp 221-223ºC. [α]D25 -94.46 (c = 1, CH3CN). 1H-NMR (500 
MHz, CD3OD) δ 7.64 (d, J = 8.1 Hz, 2H, CHAr), 7.40 (d, J = 7.4 Hz, 2H, CHAr), 7.20 
(m, 24H, NHguan, CHAr), 6.96 (t, J = 7.8 Hz, 2H, CHAr), 6.88 (s, 2H, NHurea), 6.58 (t, 
2H, NHurea), 5.95 (s, 2H, CH(Ph)2), 3.05 (m, 6H, CH2γ, CHα), 2.90 (dd, J = 6.1, 13.9 
Hz, 2H, CH2S), 2.68 (dd, J = 7.8, 13.5 Hz, 2H, CH2S), 1.85-1.65 (m, 4H, CH2β). 13C-
NMR (CD3OD, 125 MHz) δ 155.6 (Curea), 150.0 (Cguan), 141.3, 139.2, 138.4, 134.2, 
129.5, 128.3, 126.4, 123.4, 122.1, 119.9, (CHAr, CAr), 55.6 (CH(Ph)2), 47.9 (CHα), 
45.4 (CH2S), 39.5 (CH2γ), 25.6 (CH2β). ESI-MS m/z 832.3 (M-PF6-)+. 
 
(2R,8R)-2,8-Bis-{[2-(3-(2-tert-butyl-6-methylphenyl)ureido)phenylthio] methyl}-
2,3,4,6,7,8-hexahydro-2H-pyrimido[1,2-a]pyrimidin-9-ium hexafluorophosphate 
(2). 
 139 
Prepared from 2-tert-butyl-6-methylphenyl isocyanate (35.5 mg, 0.19 mmol) and 5 
(50 mg, 0.09 mmol). Purification by column chromatography on silica gel 
(CH2Cl2/MeOH, 98:2) afforded 2 as a light yellow solid (65 mg, 77%). Mp 210-
212ºC. [α]D25 -105.76 (c = 1, CH3CN). 1H-NMR (500 MHz, CD3CN) δ 7.60 (d, J = 
7.9 Hz, 2H, CHAr), 7.40 (d, J = 7.5 Hz, 2H, CHAr), 7.20 (m, 8H, NHguan, CHAr), 7.01 
(m, 4H, CHAr), 6.94 (s, 2H, NHurea), 6.60 (s, 2H, NHurea), 3.09 (m, 6H, CH2γ, CHα), 
2.90 (dd, J = 6.4, 13.5 Hz, 2H, CH2S), 2.68 (dd, J = 7.5, 13.4 Hz, 2H, CH2S), 2.12 (s, 
6H, CH3), 1.85-1.65 (m, 4H, CH2β), 1.35 (s, 18H, CH3t-Bu). 13C-NMR (CD3CN, 125 
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MHz) δ 155.1 (Curea), 150.1 (Cguan), 141.2, 139.2, 138.4, 134.2, 129.5, 128.3, 126.4, 
124.5, 123.9, 123.4, 120.2, 118.3 (CHAr, CAr), 47.9 (CHα), 45.1 (CH2S), 39.5 (CH2γ), 
31.5 (CH3t-Bu), 25.5 (CH2β), 17.3 (CH3). ESI-MS m/z 792.4 (M-PF6-)+. 
 
(2R,8R)-2,8-Bis-{[2-(3-adamantylureido)phenylthio]methyl}-2,3,4,6,7,8-
hexahydro-2H-pyrimido[1,2-a]pyrimidin-9-ium hexafluorophosphate (6). 
Prepared from 1-adamantyl isocyanate (32 mg, 0.19 mmol) and 5 (50 mg, 0.09 mmol). 
Purification by column chromatography on silica gel (CH2Cl2/MeOH, 98:2) afforded 6 
as a light yellow solid (60 mg, 73%). Mp 232-234ºC. [α]D25 -89.66 (c = 1, CH3CN). 
1H-NMR (500 MHz, CD3CN) δ 7.77 (d, J = 7.2 Hz, 2H, CHAr), 7.46 (d, J = 7.8 Hz, 
2H, CHAr), 7.21 (t, J = 7.5 Hz,  2H, CHAr), 7.16 (s, 2H, NHguan), 7.06 (t, J = 7.4 Hz, 
2H, CHAr), 6.69 (s, 2H, NHurea), 5.54 (s, 2H, NHurea), 3.31 (m, 6H, CH2γ, CHα), 2.99 
(dd, J = 6.2, 13.5 Hz, 2H, CH2S), 2.68 (dd, J = 7.1, 13.8 Hz, 2H, CH2S), 2.06 (m, 12H, 
CH2), 1.89 (m, 6H, CH), 1.84-1.70 (m, 10H, CH2β, CH), 1.65 (m, 12H, CH). 13C-
NMR (CD3CN, 125 MHz) δ 155.6 (Curea), 150.0 (Cguan), 138.4, 134.2 129.5, 122.1, 
119.9, 117.5 (CHAr, CAr), 47.9 (CHα), 45.4 (CH2S), 40.8 (CH2), 39.5 (CH2γ), 38.6 (C), 
36.4 (CH2), 29.2 (CH), 25.6 (CH2β). ESI-MS m/z 768.4 (M-PF6-)+. 
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(2R,8R)-2,8-bis{[2-(3-phenylureido)phenylthio]methyl}-2,3,4,6,7,8-hexahydro-2H-
pyrimido[1,2-a]pyrimidin-9-ium hexafluorophosphate [(R,R)-8]. 
Prepared from phenyl isocyanate (0.03 mL, 0.19 mmol) and 5 (50 mg, 0.09 mmol). 
Purification by column chromatography on silica gel (CH2Cl2/MeOH, 98:2) afforded 8 
as a light yellow solid (60 mg, 84%). Mp 226-228ºC. [α]D25 -106.15 (c = 1, CH3CN). 
 140
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1H-NMR (500MHz, CD3CN) δ 8.10 (s, 2H, NHguan), 7.94 (d, J = 7.2 Hz, 2H, CHAr), 
7.74 (s, 2H, NHurea), 7.52 (d, J = 7.8 Hz, 2H, CHAr), 7.45 (d, J = 7.7 Hz, 4H, CHAr), 
7.29 (m, 6H, CHAr), 7.09 (t, J = 7.4 Hz, 2H, CHAr), 7.04 (t, J = 7.3 Hz, 2H, CHAr), 6.72 
(s, 2H, NHurea), 3.25 (m, 6H, CH2γ, CHα), 3.00 (dd, J = 6.4, 13.8 Hz, 2H, CH2S), 2.71 
(dd, J = 7.0, 13.6 Hz, 2H, CH2S), 1.92-1.78 (m, 4H, CH2β). 13C-NMR (125 MHz, 
CD3CN) δ 153.1 (Curea), 150.1 (Cguan), 139.6, 138.9, 134.0, 128.9, 128.7, 124.1, 122.8, 
119.2 (CHAr, CAr), 47.3 (CHα), 44.4 (CH2S), 38.8 (CH2γ), 24.4 (CH2β). ESI-MS m/z 
652.2 (M-PF6-)+. 
 
(2R,8S)-2,8-bis{[2-(3-phenylureido)phenylthio]methyl}-2,3,4,6,7,8-hexahydro-2H-
pyrimido[1,2-a]pyrimidin-9-ium hexafluorophosphate [(R,S)-8]. 
Prepared from phenyl isocyanate (0.03 mL, 0.19 mmol) and (R,S)-5 (50 mg, 0.09 
mmol). Purification by column chromatography on silica gel (CH2Cl2/MeOH, 98:2) 
afforded (R,S)-8 as a light yellow solid (65 mg, 91%). 
 
(2R,8R)-2,8-bis{[2-(3-benzylureido)phenylthio]methyl}-2,3,4,6,7,8-hexahydro-2H-
pyrimido[1,2-a]pyrimidin-9-ium hexafluorophosphate [(R,R)-9]. 
Prepared from benzyl isocyanate (0.03 mL, 0.19 mmol) and 5 (50 mg, 0.09 mmol). 
Purification by column chromatography on silica gel (CH2Cl2/MeOH, 98:2) afforded 9 
as a light yellow solid (55 mg, 75%). Mp 223-225ºC. [α]D25 -81.35 (c = 1, CH3CN). 
1H-NMR (500MHz, CD3CN) δ 7.68 (d, J = 7.3 Hz, 2H, CHAr), 7.50-7.30 (m, 16H, 
NHguan, CHAr), 7.04 (t, J = 7.41 Hz, 2H, CHAr), 6.72 (s, 2H, NHurea), 6.30 (t, 2H, 
NHurea), 4.34 (m, 4H, CH2), 3.12-3.00 (m, 8H, CHα, CH2γ, CH2S) 2.63 (dd, J = 7.1, 
13.5 Hz, 2H, CH2S), 1.92-1.58 (m, 4H, CH2β). 13C-NMR (125 MHz, CD3CN) δ 156.3 
(Curea), 149.9 (Cguan), 139.5, 138.2, 133.3, 128.5, 128.1, 126.7, 124.7, 124.3, 119.8 
(CHAr, CAr), 46.9 (CH2α), 44.2 (CH2S), 43.0 (CH2), 38.8 (CH2γ), 24.6 (CH2β). ESI-MS 
m/z 680.3 (M-PF6-)+. 
 
(2R,8S)-2,8-bis{[2-(3-benzylureido)phenylthio]methyl}-2,3,4,6,7,8-hexahydro-2H-
pyrimido[1,2-a]pyrimidin-9-ium hexafluorophosphate [(R,S)-9]. 
Prepared from benzyl isocyanate (0.03 mL, 0.19 mmol) and (R,S)-5 (50 mg, 0.09 
mmol). Purification by filtration over a Büchner funnel afforded (R,S)-9 (60 mg, 81 
%) as a pure white solid. 
Naproxen Enantiorecognition 
_____________________________________________________________________ 
 142
(2R,8R)-2,8-bis{[2-(3-phenethylureido)phenylthio]methyl}-2,3,4,6,7,8-hexahydro-
2H-pyrimido[1,2-a]pyrimidin-9-ium hexafluorophosphate [(R,R)-10]. 
Prepared from phenethyl isocyanate (0.03 mL, 0.19 mmol) and 5 (50 mg, 0.09 mmol). 
Purification by column chromatography on silica gel (CH2Cl2/MeOH, 98:2) afforded 
10 as a light yellow solid (58 mg, 76%). Mp 218-220ºC. [α]D25 -85.54 (c = 1, CH3CN). 
1H-NMR (500MHz, CD3CN) δ 7.70 (d, J = 7.3 Hz, 2H, CHAr), 7.47 (d, J = 7.4 Hz, 
2H, CHAr), 7.50-7.30 (m, 12H, NHguan, CHAr), 7.09 (t, J = 7.2 Hz, 2H, CHAr), 6.90 (s, 
2H, NHurea), 5.84 (t, 2H, NHurea), 3.43 (q, J = 7.6 Hz, 4H, CH2), 3.28 (m, 6H, CHα, 
CH2γ), 3.13 (dd, J = 4.4, 14.5 Hz, 2H, CH2S), (t, J = 6.8 Hz, 4H, CH2), 2.71 (dd, J = 
10.1, 12.4 Hz, 2H, CH2S), 2.04-1.72 (m, 4H, CH2β). 13C-NMR (125 MHz, CD3CN) δ 
157.6 (Curea), 150.1 (Cguan), 139.5, 138.2, 134.4, 130.0, 129.6, 128.1, 126.6, 125.8, 
120.5 (CHAr, CAr), 48.4 (CH2α), 45.8 (CH2S), 44.6 (CH2), 40.4 (CH2γ), 26.7 (CH2β). 
ESI-MS m/z 708.3 (M-PF6-)+. 
 
(2R,8S)-2,8-bis{[2-(3-phenethylureido)phenylthio]methyl}-2,3,4,6,7,8-hexahydro-
2H-pyrimido[1,2-a]pyrimidin-9-ium hexafluorophosphate [(R,S)-10]. 
Prepared from phenethyl isocyanate (0.03 mL, 0.19 mmol) and (R,S)-5 (50 mg, 0.09 
mmol). Purification by column chromatography on silica gel (CH2Cl2/MeOH, 98:2) 
afforded (R, S)-10 as a light yellow solid (65 mg, 85%). 
 
(2R,8R)-2,8-Bis{[2-(3-(4-nitrophenyl)ureido)phenylthio]methyl}-2,3,4,6,7,8-
hexahydro-2H-pyrimido[1,2-a]pyrimidin-9-ium hexafluorophosphate [(R,R)-11]. 
Prepared from p-nitrophenyl isocyanate (30 mg, 0.19 mmol) and 5 (50 mg, 0.09 
mmol). Purification by column chromatography on silica gel (CH2Cl2/MeOH, 98:2) 
afforded 6 as a light yellow solid (57 mg, 72%). Mp 215-217ºC. [α]D25 -109.58 (c = 1, 
CH3CN).1H-NMR (500MHz, CD3CN) δ 8.62 (s, 2H, NHguan), 8.12 (d, J = 7.1 Hz, 4H, 
CHAr), 8.00 (d, J = 7.2 Hz, 2H, CHAr), 7.87 (s, 2H, NHurea),7.69 (d, 4H, J = 7.7 Hz, 
CHAr), 7.57 (d, J = 7.3 Hz, 2H, CHAr), 7.31 (t, J = 7.4 Hz, 2H, CHAr), 7.14 (t, J = 7.3 
Hz, 2H, CHAr), 6.25 (s, 2H, NHurea), 3.24-3.18 (m, 6H, CH2γ, CHα), 3.03 (dd, J = 5.7, 
13.8 Hz, 2H, CH2S), 2.72 (dd, J = 9, 14.9 Hz, 2H, CH2S), 1.90-1.70 (m, 4H, CH2β). 
13C-NMR (125 MHz, CD3CN) δ 153.1 (Curea), 150.1 (Cguan), 139.6, 138.9 134.0, 
128.9, 128.7, 124.1, 122.8, 119.2 (CHAr, CAr), 47.3 (CH2α), 44.4 (CH2S), 38.8 (CH2γ), 
24.4 (CH2β). ESI-MS m/z 742.2 (M-PF6-)+. 
 
3.5 Experimental Section  
_____________________________________________________________________ 
(2R,8S)-2,8-Bis{[2-(3-(4-nitrophenyl)ureido)phenylthio]methyl}-2,3,4,6,7,8-
hexahydro-2H-pyrimido[1,2-a]pyrimidin-9-ium hexafluorophosphate ((R, S)-11). 
Prepared from p-nitrophenyl isocyanate (30 mg, 0.19 mmol) and (R, S)-5 (50 mg, 0.09 
mmol). Purification by column chromatography on silica gel (CH2Cl2/MeOH, 98:2) 
afforded (R, S)-11 as a light yellow solid (60 mg, 76%). 
 
(2R,8R)-2,8-bis{[2-(3-(4-nitrobenzyl)ureido)phenylthio]methyl}-2,3,4,6,7,8-
hexahydro-2H-pyrimido[1,2-a]pyrimidin-9-ium hexafluorophosphate [(R,R)-12]. 
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5 12  
Procedure 
A solution of guanidinium salt 5 (50 mg, 0.09 mmol) and 13 (66 mg, 0.27 mmol) in 
dry CH3CN (2 mL) in a sealed tube was stirred overnight at 70ºC under nitrogen 
atmosphere. After removing the solvent, the resulting solid was dissolved in CH2Cl2, 
and the organic layer was washed with a 0.1M NH4PF6 solution, dried (Na2SO4), 
filtered over cotton and concentrated at reduced pressure. The crude was purified by 
column chromatography on silica gel (CH2Cl2/MeOH 98:2) to afford the pure 
compound as a yellow solid (55 mg, 67%). Mp 234-236ºC. [α]D25 -108.63 (c = 1, 
CH3CN). 1H-NMR (500MHz, CD3CN) δ 8.13 (d, J = 7.4 Hz, 4H, CHAr), 7.65 (d, J = 
7.3 Hz, 2H, CHAr), 7.51-7.42 (m, 8H, NHguan, CHAr), 7.26 (t, J = 7.4 Hz, 2H, CHAr), 
7.13 (t, J = 7.5 Hz, 2H, CHAr), 6.81 (s, 2H, NHurea), 6.48 (t, J = 5.8 Hz, 2H, NHurea), 
4.46 (qd, J = 5.9, 16.9 Hz, 4H, CH2), 3.20-3.11 (m, 8H, CHα, CH2γ, CH2S), 2.58 (dd, J 
= 10.3, 13.7 Hz, 2H, CH2S), 1.92-1.58 (m, 4H, CH2β). 13C-NMR (125 MHz, CD3CN) 
δ 156.3.1 (Curea), 149.9 (Cguan), 139.5, 138.2, 133.3, 128.5, 128.1, 126.7, 124.7, 124.3, 
120.3 (CHAr, CAr), 46.9 (CHα), 44.2 (CH2S), 43.0 (CH2), 38.8 (CH2γ), 24.6 (CH2β). 
ESI-MS m/z 770.2 (M-PF6-)+. 
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(2R,8S)-2,8-bis{[2-(3-(4-nitrobenzyl)ureido)phenylthio]methyl}-2,3,4,6,7,8-
hexahydro-2H-pyrimido[1,2-a]pyrimidin-9-ium hexafluorophosphate [(R,S)-12]. 
Prepared from guanidinium salt (R,S)-5 (50 mg, 0.09 mmol) and 13 (66 mg, 0.27). 
Purification by column chromatography on silica gel (CH2Cl2/MeOH, 98:2) afforded 
(R, S)-11 as a light yellow solid (65 mg, 79%). 
 
N-(4-nitrobenzyl)-1H-imidazole-1-carboxamide (13). 
 
NO2NO2
NH2 NH
ON
N
CDI, dry THF
(70%)
13  
Procedure 
A solution of 4-nitrophenylamine (360 mg, 2.359 mmol) and CDI (314 mg, 2.359 
mmol) in dry THF was stirred during 1 hour. The solvent was removed and the crude 
was purified by column chromatography on silica gel (hexane/EtOAc 6:3) to afford 13 
as a pure yellow solid (410 mg, 70%). Mp 158-159ºC. 1H-NMR (500 MHz, CDCl3) δ 
8.23 (d, J = 7.3 Hz, 2H, CHAr), 8.12 (s, 1H, CHAr), 7.63 (d, J = 7.7 Hz, 2H, CHAr), 
7.51 (s, 1H, CHAr), 7.46 (s, 1H, NH), 7.05 (s, 1H, CHAr), 4.65 (d, J = 6.9 Hz, 2H, 
CH2). 13C-NMR (125 MHz, CDCl3) δ 160.0 (CO), 146.1, 136.1, 130.0, 128.3, 123.5, 
117.3, 116.3 (CHAr, CAr), 43.4 (CH2). 
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(2R,8R)-2,8-bis{[2-(3-((S)-1-phenylethyl)ureido)phenylthio]methyl}-2,3,4,6,7,8-
hexahydro-2H-pyrimido[1,2-a]pyrimidin-9-ium hexafluorophosphate [(R,R)-14]. 
Prepared from (R)-(−)-α-methylbenzyl isocyanate (0.03 mL, 0.19 mmol) and 5 (50 
mg, 0.09 mmol). Purification by column chromatography on silica gel 
(CH2Cl2/MeOH, 98:2) afforded 14 as a light yellow solid (65 mg, 85%). Mp 195-
197ºC. [α]D25 -70.84 (c = 1, CH3CN). 1H-NMR (500 MHz, CD3CN) δ 7.79 (d, J = 6.8 
Hz, 2H, CHAr), 7.68 (d, J = 7.6 Hz, 2H, CHAr), 7.40 (s, 2H, NHguan),7.35-7.20 (m, 12H, 
CHAr), 7.10 (t, J = 7.4 Hz, 2H, CHAr), 6.55 (s, 2H, NHurea), 6.26 (s, 2H, NHurea), 4.84 
(m, 2H, CH), 3.18 (m, 6H, CHα, CH2γ), 3.05 (dd, J = 5.1, 13.2 Hz, 2H, CH2S), 2.67 
(dd, J = 9.3, 13.0 Hz, 2H, CH2S), 1.92-1.58 (m, 4H, CH2β), 1.44 (d, J = 7.0 Hz, 6H, 
CH3). 13C-NMR (125 MHz, CD3CN) δ 156.3.1 (Curea), 149.9 (Cguan), 139.5, 138.2, 
133.3, 128.5, 128.1, 126.7, 124.7, 124.3, 119.8 (CHAr, CAr), 50.8 (CH), 46.9 (CHα), 
44.2 (CH2S), 38.8 (CH2γ), 24.6 (CH2β), 21.2 (CH3). ESI-MS m/z 708.3 (M-PF6-)+. 
 
(2R,8S)-2,8-bis{[2-(3-((S)-1-phenylethyl)ureido)phenylthio]methyl}-2,3,4,6,7,8-
hexahydro-2H-pyrimido[1,2-a]pyrimidin-9-ium hexafluorophosphate [(R,S)-14]. 
Prepared from (R)-(−)-α-methylbenzyl isocyanate (0.03 mL, 0.19 mmol) and (R, S)-5 
(50 mg, 0.09 mmol). Purification by column chromatography on silica gel 
(CH2Cl2/MeOH, 98:2) afforded (R, S)-14 as a light yellow solid (68 mg, 89%). Mp 
195-197ºC. [α]D25 -18.31 (c = 1, CH3CN). 1H-NMR (500 MHz, CD3CN) δ 7.89 (d, J = 
9.1 Hz, 1H, CHAr), 7.63 (d, J = 8.1 Hz, 1H, CHAr), 7.52 (d, J = 7.6 Hz, 1H, CHAr), 7.48 
(d, J = 7.6 Hz, 1H, CHAr), 7.32-7.19 (m, 14H, CHAr, NHguan), 7.16 (t, J = 7.3 Hz, 1H, 
CHAr), 7.10 (t, J = 7.3 Hz, 1H, CHAr), 6.73 (s, 1H, NHurea), 6.64 (s, 1H, NHurea), 6.28 
(m, 2H, NHurea), 4.89 (m, 1H, CH), 4.81 (m, 1H, CH), 3.16 (m, 6H, CHα, CH2γ), 3.01-
2.85 (m, 4H, CH2S), 2.01-1.57 (m, 4H, CH2β), 1.46 (d, J = 7.0 Hz, 3H, CH3), 1.41 (d, J 
= 7.0 Hz, 3H, CH3). 13C-NMR (125 MHz, CD3CN) δ 155.2, 154.9 (Curea), 150.3 
(Cguan), 139.3, 138.2, 133.9, 133.6, 129.1, 128.7, 128.5, 128.3, 126.9, 126.8, 125.8, 
125.6, 125.5, 125.0. 124.0, 122.9 (CHAr, CAr), 50.1, 49.8 (CH), 47.9, 47.4 (CHα), 45.2, 
44.9 (CH2S), 39.7, 38.6 (CH2γ), 25.1, 24.8 (CH2β), 22.4, 22.3 (CH3). ESI-MS m/z 
708.3 (M-PF6-)+. 
 
(2R,8R)-2,8-bis{[2-(3-((R)-1-phenylethyl)ureido)phenylthio]methyl}-2,3,4,6,7,8-
hexahydro-2H-pyrimido[1,2-a]pyrimidin-9-ium hexafluorophosphate [(R,R)-15]. 
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Prepared from (S)-(+)-α-methylbenzyl isocyanate (0.03 mL, 0.19 mmol) and 5 (50 mg, 
0.09 mmol). Purification by column chromatography on silica gel (CH2Cl2/MeOH, 
98:2) afforded 15 as a light yellow solid (65 mg, 85%). [α]D25 -96.30 (c = 1, CH3CN). 
 
(2R,8S)-2,8-bis{[2-(3-((R)-1-phenylethyl)ureido)phenylthio]methyl}-2,3,4,6,7,8-
hexahydro-2H-pyrimido[1,2-a]pyrimidin-9-ium hexafluorophosphate [(R,S)-15]. 
Prepared from (S)-(+)-α-methylbenzyl isocyanate (0.03 mL, 0.19 mmol) and (R, S)-5 
(50 mg, 0.09 mmol). Purification by column chromatography on silica gel 
(CH2Cl2/MeOH, 98:2) afforded (R, S)-15 as a light yellow solid (68 mg, 89%). [α]D25 
41.52 (c = 1, CH3CN). 
 
(2R,8R)-2,8-bis{[2-(3-((S)-1-(naphthalen-1-yl)ethyl)ureido)phenylthio]methyl}-
2,3,4,6,7,8-hexahydro-2H-pyrimido[1,2-a]pyrimidin-9-ium hexafluorophosphate 
[(R,R)-16]. 
Prepared from (R)-(−)-α-methylnaphthyl isocyanate (0.03 mL, 0.19 mmol) and 5 (50 
mg, 0.09 mmol). Purification by column chromatography on silica gel 
(CH2Cl2/MeOH, 98:2) afforded 16 as a light yellow solid (75 mg, 88%). Mp 209-
211ºC. [α]D25 -61.04 (c = 1, CH3CN). 1H-NMR (500 MHz, CD3CN) δ 8.15 (d, J = 7.8 
Hz, 2H, CHAr), 7.94 (d, J = 7.9 Hz, 2H, CHAr), 7.83 (d, J = 7.8 Hz, 2H, CHAr), 7.74 (d, 
J = 7.6 Hz, 2H, CHAr), 7.66 (d, J = 8.0 Hz, 2H, CHAr), 7.53 (m, 6H, CHAr), 7.42 (d, J = 
7.8 Hz, 2H, CHAr), 7.36 (s, 2H, NHguan), 7.24 (t, J = 7.5 Hz, 2H, CHAr), 7.08 (t, J = 7.4 
Hz, 2H, CHAr), 6.44 (s, 2H, NHurea), 6.36 (s, 2H, NHurea), 5.64 (m, 2H, CH), 2.97 (m, 
8H, CHα, CH2γ, CH2S), 2.46 (m, 2H, CH2S), 1.74 (m, 2H, CH2β), 1.59 (d, J = 6.1 Hz, 
6H, CH3), 1.30 (m, 2H, CH2β). 13C-NMR (CD3CN, 125 MHz) δ 156.1 (Curea), 150.2 
(Cguan), 139.3, 138.9, 133.9, 129.1, 128.7, 128.5, 127.2, 126.8, 125.6, 124.0, 122.8 
(CHAr, CAr), 47.7 (CHα), 45.1 (CH2S), 38.9 (CH2γ), 25.6 (CH2β), 21.8 (CH3). ESI-MS 
m/z 808.3 (M-PF6-)+. 
 
(2R,8S)-2,8-bis{[2-(3-((S)-1-(naphthalen-1-yl)ethyl)ureido)phenylthio]methyl}-
2,3,4,6,7,8-hexahydro-2H-pyrimido[1,2-a]pyrimidin-9-ium hexafluorophosphate 
[(R,S)-16]. 
Prepared from (R)-(−)-α-methylnaphthyl isocyanate (0.03 mL, 0.19 mmol) and (R,S)-5 
(50 mg, 0.09 mmol). Purification by column chromatography on silica gel 
(CH2Cl2/MeOH, 98:2) afforded (R,S)-16 as a light yellow solid (75 mg, 88%). Mp 
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209-211ºC. [α]D25 -20.32 (c = 1, CH3CN). 1H-NMR (500 MHz, CD3CN) δ 8.15 (d, J = 
7.0 Hz, 1H, CHAr), 7.93 (m, 4H, CHAr), 7.83 (d, J = 7.5 Hz, 1H, CHAr), 7.80 (d, J = 7.3 
Hz, 1H, CHAr), 7.69 (d, J = 6.9 Hz, 1H, CHAr), 7.66 (d, J = 7.0 Hz, 1H, CHAr), 7.46 
(m, 9H, NHguan, CHAr), 7.34 (s, 1H, NHguan), 7.29 (t, J = 7.0 Hz, 1H, CHAr), 7.22 (t, J = 
7.4 Hz, 1H, CHAr), 7.09 (m, 3H, CHAr), 6.68 (s, 1H, NHurea), 6.44 (m, 2H, NHurea), 6.29 
(s, 1H, NHurea), 5.68 (m, 1H, CH), 5.61 (m, 1H, CH), 3.13 (m, 1H, CH2S), 2.89 (m, 
6H, CHα, CH2γ, CH2S), 2.66 (m, 1H, CHα), 2.45 (m, 2H, CHα, CH2S), 1.79 (m, 1H, 
CH2β), 1.64 (m, 1H, CH2β), 1.58 (d, J = 6.0 Hz, 3H, CH3), 1.55 (d, J = 6.0 Hz, 3H, 
CH3), 1.43 (m, 1H, CH2β). 13C-NMR (CD3CN, 125 MHz) δ 156.1 (Curea), 150.2 
(Cguan), 139.3, 138.9, 133.9, 133.6, 129.1, 128.9, 128.7, 128.5, 128.3, 127.2, 127.0, 
126.8, 125.8, 125.6, 125.5, 125.0, 124.3, 124.0, 122.9, 122.8 (CHAr, CAr), 48.1, 48.0 
(CHα), 45.3, 45.1 (CH2S), 38.9, 38.6 (CH2γ), 25.7, 25.6 (CH2β), 21.8, 21.5 (CH3).ESI-
MS m/z 808.3 (M-PF6-)+. 
 
(2R,8R)-2,8-bis{[2-(3-((R)-1-(naphthalen-1-yl)ethyl)ureido)phenylthio]methyl}-
2,3,4,6,7,8-hexahydro-2H-pyrimido[1,2-a]pyrimidin-9-ium hexafluorophosphate 
[(R,R)-17]. 
Prepared from (S)-(+)-α-methylnaphthyl isocyanate (0.03 mL, 0.19 mmol) and 5 (50 
mg, 0.09 mmol). Purification by column chromatography on silica gel 
(CH2Cl2/MeOH, 98:2) afforded 17 as a light yellow solid (75 mg, 88%). [α]D25 -134.06 
(c = 1, CH3CN). 
 
(2R,8S)-2,8-bis{[2-(3-((R)-1-(naphthalen-1-yl)ethyl)ureido)phenylthio]methyl}-
2,3,4,6,7,8-hexahydro-2H-pyrimido[1,2-a]pyrimidin-9-ium hexafluorophosphate 
[(R,S)-17]. 
Prepared from (S)-(+)-α-methylnaphthyl isocyanate (0.03 mL, 0.19 mmol) and (R,S)-5 
(50 mg, 0.09 mmol). Purification by column chromatography on silica gel 
(CH2Cl2/MeOH, 98:2) afforded (R,S)-17 as a light yellow solid (75 mg, 88%). [α]D25 
10.05 (c = 1, CH3CN). 
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Macrocycle 19. 
 
N
N
H
N
H SS
PF6-
HNNH
OHNO NH
O
HN
NO2
N
N
H
N
H SS
Cl-
H2NNH2
5 19
20, dry MeOH
(8%)
 
 
Procedure 
A solution of guanidinium salt 5 (Cl-) (90 mg, 0.20 mmol) and 20 (91 mg, 0.20 mmol) 
in dry MeOH (10 mL) in a sealed tube was stirred during two days at 80ºC under 
argon atmosphere. The solvent was removed and the residue purified by column 
chromatography on silica gel (CH2Cl2/ MeOH from 100:0 to 98:2). The residue was 
then purified by semi-preparative HPLC (Column: SunFire C18 5 µm, 4.6 x 100 mm, 
FM: ACN (0.1% TFA) / H2O (0.1% TFA), Gradient: 10-100% ACN (0.1% TFA) in 
30 min, Flow: 1 mL/min, ambient temperature) to afford 19 as pure white product. A 
solution of 19 in MeOH was then eluted through a Dowex resin (PF6-) column to 
homogenize the counterion as PF6- (13 mg, 8 %). Mp 231-233ºC. [α]D25 -105.76 (c = 
1, CH3CN). 1H-NMR (500MHz, CD3CN) δ 9.21 (s, 2H, NHguan), 7.35 (dd, J = 1.5, 7.6 
Hz, 2H, CHAr), 7.18 (m, 6H, NHurea, CHAr), 7.09 (td, J = 1.3, 7.5 Hz, 2H, CHAr), 6.67 
(dd, J = 1.2, 7.9 Hz, 2H, CHAr), 6.61 (td, J = 1.1, 7.3 Hz, 2H, CHAr), 3.40 (m, 2H, 
CHα), 4.24 (m, 1H, CHN), 3.50-3.35 (m, 10H, CH2, CH2γ), 3.05-2.95 (m, 2H, CH2S), 
2.16-1.85 (m, 4H, CH2β), 1.51 (m, 4H, CH2). ESI-MS m/z 731.9 (M-PF6-)+. 
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(S)-N,N'-[6-(4-nitrophenylamino)-6-oxohexane-1,5-diyl]bis(1H-imidazole-1-
carboxamide) (20). 
NN
OHNO NH
O
HN
NO2
N N
NH2NH2
O
HN
NO2
CDI, THF
(95%)
20  
Procedure 
To a solution of carbonyldiimidazol (476 mg, 2.98 mmol) in THF, L-lysine p-
nitroanilide dihydrobromide (0.114 mL, 0.978 mmol) was added and the mixture 
stirred for 24 hours. The solvent was removed and the pure compound precipitates in 
ethyl acetate as a white solid (280 mg, 95%). Mp 154-157ºC. [α]D25 -31.40 (c = 1, 
MeOH). 1H-NMR (500 MHz, CD3OD) δ 8.37 (d, J = 9.6 Hz, 2H, CHAr), 8.27 (s, 1H, 
NH), 8.20 (s, 2H, CHAr), 7.77 (d, J = 9.2 Hz, 2H, CHAr), 7.63 (s, 1H, NH), 7.29 (s, 4H, 
CHAr), 7.07 (s, 1H, NH), 4.32 (dd, J = 4.1, 6.5 Hz, 1H, CH), 3.43 (t, J = 7.1 Hz, 2H, 
CH2), 2.00 (m, 2H, CH2), 1.73 (m, 2H, CH2), 1.64 (m, 2H, CH2). 13C NMR (125 MHz, 
CD3OD) δ 168.5, 150.8 (CO), 137.8, 136.0, 128.6, 126.3, 123.6, 120.3, 116.4 (CHAr, 
CAr), 56.7 (CH), 47.0 (CH2), 40.0 (CH2), 28.5 (CH2), 21.6 (CH2). 
 
(2R,8R)-2,8-Bis-[(S)-2'-tert-butylcarbamate-1,1'-binaphthyl-2-oxymethyl]-
3,4,6,7,8,9-hexahydro-2H-pyrimido[1,2-a]pyrimidin-1-ium chloride (26). 
 
N
N
N
H H
+
Cl Cl
Cl-
N
N
N
H H
+
O O
NHBoc
Cl-
BocHN
25 26
28 , K2CO3, Acetone
(50%)
 
Procedure 
To a solution of 25 (50 mg, 0.18 mmol) in acetone was added 28 (149 mg, 0.39 mmol) 
and K2CO3 (55 mg, 0.40 mmol) and the mixture was stirred for 24 hours. The mixture 
was concentrated in vacuo, the residue was dissolved in CH2Cl2 and washed with 
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water. The organic layer was dried (Na2SO4), filtered over cotton and concentrated at 
reduced pressure. Purification by column chromatography on silica gel 
(CH2Cl2/MeOH from 100:0 to 96:4) affords 26 (86 mg, 50%) as a pure brown solid. 
Mp 258-260ºC. [α]D25 -125.69 (c = 1, MeOH). 1H-NMR (500 MHz, CDCl3) δ 8.14 (d, 
J = 7.8 Hz, 2H, CHAr), 8.07 (d, J = 7.7 Hz, 2H, CHAr), 8.00 (d, J = 7.4 Hz, 2H, CHAr), 
7.87 (d, J = 7.7 Hz, 2H, CHAr), 7.82 (d, J = 7.6 Hz, 2H, CHAr), 7.62 (s, 2H, NHguan), 
7.56 (d, J = 7.5 Hz, 2H, CHAr), 7.41 (td, J = 6.1, 7.8 Hz, 2H, CHAr), 7.29 (td, J = 5.4, 
7.3 Hz, 2H, CHAr), 7.20 (td, J = 5.8, 7.9 Hz, 2H, CHAr), 6.99 (td, J = 5.8, 7.8 Hz, 2H, 
CHAr), 6.96 (d, J = 7.5 Hz, 2H, CHAr), 6.89 (d, J = 7.4 Hz, 2H, CHAr), 6.68 (s, 2H, 
NHBoc), 3.99 (m, 4H, CH2O), 3.19 (m, 2H, CHα), 2.40-2.26 (m, 4H, CH2γ), 1.36-1.20 
(m, 4H, CH2β), 1.18 (s, 18H, CH3). 13C-NMR (125 MHz, CDCl3) δ 154.2 (CBoc), 150.1 
(Cguan), 133.4, 130.7, 129.7, 128.3, 127.8, 127.1, 126.5, 125.1, 124.8, 124.3, 117.3, 
115.0 (CHAr, CAr), 70.9 (CH2O), 47.1 (CHα), 43.9 (CH2γ), 27.4 (CH3), 21.7 (CH2β). 
ESI-MS m/z 934.4 (M-PF6-)+. 
 
(2R,8R)-2,8-Bis-[(S)-2'-amino-1,1'-binaphthyl-2-oxymethyl]-3,4,6,7,8,9-
hexahydro-2H-pyrimido[1,2-a]pyrimidin-1-ium hexafluorophosphate (28). 
 
26 28
N
N
N
H H
+
O O
NHBoc
Cl-
BocHN
N
N
N
H H
+
O O
NH2
PF6
-
H2N
4M HCl
(98%)
 
 
Procedure 
A solution of 26 (120 mg, 0.12 mmol) in HCl (1 mL, 4M) in 1,4-dioxane was stirred 
overnight. The solvent was removed and the crude was dissolved in CH2Cl2, washed 
with water, then with a 0.1M NH4PF6 solution. The organic layer was dried (Na2SO4), 
filtered over cotton and concentrated at reduced pressure in order to give a pure 
maroon solid (106 mg, 98 %). Mp 253-255ºC. [α]D25 -102.9 (c = 1, CH3CN). 1H-NMR 
(500 MHz, CDCl3) δ 8.14 (d, J = 7.8 Hz, 2H, CHAr), 8.17 (d, J = 7.7 Hz, 2H, CHAr), 
8.03 (d, J = 7.6 Hz, 2H, CHAr), 7.64 (d, J = 7.5 Hz, 2H, CHAr), 7.58 (d, J = 7.3 Hz, 4H, 
CHAr), 7.45 (td, J = 6.5, 7.5 Hz, 2H, CHAr), 7.32 (td, J = 6.3, 7.2 Hz, 2H, CHAr), 7.04 
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(m, 6H, CHAr), 6.90 (td, J = 6.2, 7.8 Hz, 2H, CHAr), 6.72 (d, J = 7.5 Hz, 2H, CHAr), 
6.05 (s, 2H, NHguan), 4.26 (dd, J = 6.5, 7.9 Hz, 2H, CH2O), 4.01 (s, 4H, NH2), 3.93 
(dd, J = 6.1, 7.8 Hz, 2H, CH2O), 3.22 (m, 2H, CHα), 2.81-2.69 (m, 4H, CH2γ), 1.70-
1.47 (m, 4H, CH2β). 13C-NMR (125 MHz, CDCl3) δ 150.2 (Cguan), 133.4, 130.7, 129.7, 
128.3, 127.8, 127.1, 126.5, 125.1, 124.8, 124.3, 117.3, 115.0 (CHAr, CAr), 70.9 
(CH2O), 47.1 (CHα), 43.9 (CH2γ), 21.7 (CH2β). ESI-MS m/z 734.3 (M-PF6-)+. 
 
Macrocycle 21. 
 
N
N
N
H H
+
O O
NH2
PF6
-
H2N
N
N
N
H H
+
O O
NH
PF6
-
HN
O NH OHN
28 21
1,4-diisocyanato-
butane, dry CH2Cl2
(57%)
 
 
Procedure 
To a solution of 28 (0.03 g, 0.04 mmol) in dry CH2Cl2 (5 mL) in a sealed tube was 
added under nitrogen atmosphere 1,4-diisocyanatobutane (0.004 mL, 0.04 mmol) and 
the mixture was stirred at 45ºC during 48 hours. After evaporation of the solvent, the 
resulting solid was dissolved in CH2Cl2 and the organic layer was washed with a 0.1M 
NH4PF6 solution, dried (Na2SO4), filtered over cotton and concentrated at reduced 
pressure. Purification of the crude by column chromatography on silica gel 
(CH2Cl2/MeOH 98:2) afforded 21 as a pure white solid (20 mg, 57 %). Mp 270-
272ºC. [α]D25 -177.45 (c = 1, CH3CN). 1H-NMR (500 MHz, CD3CN) δ 8.29 (d, J = 
8.1 Hz, 2H, CHAr), 8.13 (m, 4H, CHAr), 8.05 (d, J = 7.6 Hz, 4H, CHAr), 7.71 (d, J = 7.5 
Hz, 2H, CHAr), 7.48 (m, 4H, CHAr), 7.35 (m, 4H, CHAr, NHguan), 7.28 (t, J = 7.5 Hz, 
2H, CHAr), 7.04 (d, J = 7.6 Hz, 2H, CHAr), 7.00 (d, J = 7.8 Hz, 2H, CHAr), 6.52 (s, 2H, 
NHurea), 5.37 (t, 2H, NHurea), 3.90 (dd, J = 6.3, 7.9 Hz, 2H, CH2O), 3.69 (m, 2H, 
CH2O), 3.31 (m, 2H, CHα), 3.09 (m, 6H, CH2γ, CH2), 2.89 (m, 2H, CH2), 1.68-1.44 
(m, 4H, CH2β), 1.30 (m, 4H, CH2). 13C-NMR (125 MHz, CD3CN) δ 155.1 (CO), 150.2 
(Cguan), 133.4, 130.7, 129.7, 128.3, 127.8, 127.1, 126.5, 125.1, 124.8, 124.3, 117.3, 
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115.0 (CHAr, CAr), 70.9 (CH2O), 47.1 (CHα), 43.9 (CH2γ), 39.9 (CH2), 26.2 (CH2), 21.7 
(CH2β). ESI-MS m/z 874.4 (M-PF6-)+. 
Crystal data for 21 (Cl-) at 100 K: C55H52ClN7O4, 909.38 gmol-1, monoclinic, P21, a = 
15.9831(14) Å, b = 15.2438(14) Å, c = 23.763(2) Å, α = 90°, β = 100.466(2)°, γ =90º, 
V = 5693.4(9) Å3, Z = 2, ρcalcd = 1.253 Mg/m3, R1 = 0.1007, wR2 = 0.2510 for 87423 
reflections with I>2σ(I) (for 41035 reflections [Rint: 0.0908] with a total measured of 
30934 reflections), goodness-of-fit on F2 = 1.022, Flack: 0.01(2), largest diff. peak 
(hole) = 1.379 and -0.658 e.Å
-3. 
 
Macrocycle 22. 
 
28 22
m-xylylene diiso-
cyanate, dry CH2Cl2
(57%)
N
N
N
H H
+
O O
NH2
PF6
-
H2N
N
N
N
H H
+
O O
NH
PF6
-
HN
O NH OHN
 
Procedure 
To a solution of 28 (0.03 g, 0.04 mmol) in dry CH2Cl2 (5 mL) in a sealed tube was 
added under nitrogen atmosphere m-xylylene diisocyanate (0.004 mL, 0.04 mmol) and 
the mixture was stirred at 45ºC during 48 hours. After evaporation of the solvent, the 
resulting solid was dissolved in CH2Cl2 and the organic layer was washed with a 0.1M 
NH4PF6 solution, dried (Na2SO4), filtered over cotton and concentrated at reduced 
pressure. Purification of the crude by column chromatography on silica gel 
(CH2Cl2/MeOH 98:2) afforded 21 as a pure white solid (20 mg, 57 %). Mp 280-
282ºC. [α]D25 -309.84 (c = 1, CH3CN). 1H-NMR (500 MHz, CD3CN) δ 8.17 (d, J = 
8.0 Hz, 2H, CHAr), 8.05 (d, J = 8.1 Hz, 2H, CHAr), 7.98 (m, 4H, CHAr), 7.65 (d, J = 7.6 
Hz, 2H, CHAr), 7.48 (m, 10H, CHAr), 7.01 (m, 8H, CHAr,), 6.84 (s, 2H, NHguan), 6.25 
(s, 2H, NHurea), 5.95 (t, 2H, NHurea), 4.61 (dd, J = 6.5, 8.7 Hz, 2H, CH2N), 3.95 (m, 
6H, CH2O, CH2N), 3.05 (m, 6H, CHα, CH2γ), 1.70-1.40 (m, 4H, CH2β).13C-NMR (125 
MHz, CD3CN) δ 154.9 (CO), 150.2 (Cguan), 136.8, 133.4, 130.7, 129.7, 128.3, 127.8, 
127.1, 126.5, 126.3, 125.1, 124.8, 124.3, 123.5, 123.2, 117.3(CHAr, CAr), 70.9 (CH2O), 
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47.1 (CHα),45.0 (CH2N), 43.9 (CH2γ), 39.9 (CH2), 26.2 (CH2), 21.7 (CH2β). ESI-MS 
m/z 922.4 (M-PF6-)+. 
 
(S)-tert-butyl 2'-hydroxy-1,1'-binaphthyl-2-ylcarbamate (S)-(-)-(28). 
 
OH
NHBoc
OH
NH2
28
(BOC)2O, toluene
(94%)
 
Procedure 
(BOC)2O (220 mg, 0.94 mmol) was added to a stirred solution of (S)-NOBIN (300 
mg, 1.05 mmol) in toluene (3 mL) and the stirring was continued for another 12 h at 
80 ºC. The mixture was concentrated in vacuo and the residue was purified by flash-
chromatography on silica gel (hexane/EtOAc 6:1) to afford 28 (380 mg, 94%). Mp 
170-172ºC. [α]25D = -68.51 (c = 1.0, CHCl3). 1H-NMR (500 MHz, CDCl3) δ 8.52 (d, J 
= 7.6 Hz, 1H, CHAr), 8.04 (d, J = 7.4 Hz, 1H, CHAr), 7.99 (d, J = 7.7 Hz, 1H, CHAr),  
7.91 (m, 2H, CHAr), 7.40 (m, 3H, CHAr), 7.30 (m, 2H, CHAr), 7.08 (d, J = 7.3 Hz, 1H, 
CHAr), 7.06 (d, J = 7.7 Hz, 1H, CHAr), 6.27 (s, 1H, NHBoc), 5.03 (s, 1H, OH), 1.41 (s, 
9H, CH3). 13C-NMR (125 MHz, CDCl3): δ 152.0 (CO), 136.6, 131.2, 130.8, 130.3, 
129.7, 129.3, 128.3, 128.2, 127.3, 124.9, 124.4, 120.0, 118.0 (CHAr, CAr), 28.3 (CH3). 
 
(2R,8R)-2-(tert-butyldiphenylsilanyloxymethyl)-8-hydroxymethyl-3,4,6,7,8,9-
hexahydro -2H-pyrimido[1,2-a]pyrimidin-1-ium methansulfonate (29). 
 
N
N
N
H H
+
OH OTBDPS
PF6-
N
N
N
H H
+
Cl-
OTBDPSTBDMSO
23 29
H2O-HOAc-THF (1:3:1)
(98%)
 
Procedure 
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A solution of 23 (6 g, 10.20 mmol) in a mixture of H2O-HOAc-THF (1:3:1) was 
stirred at room temperature for 20 h. After removing the solvent, the crude product 
was dissolved in dichloromethane (150 mL) and washed subsequently with a sat 
solution of Na2CO3 (100 mL) and 2% (v/v) methanesulfonic acid (100 mL). The 
organic phase was dried over cotton and after evaporating the solvent, the remaining 
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oil was triturated with toluene/diethyl ether, yielding 29 (5.33 g, 98%) as a white solid. 
M.p. 130-132ºC. [α]25D -42.01 (c = 0.85, CHCl3). 1H-NMR (500 MHz, CDCl3) δ 9.23 
(s, 1H, NHguan), 7.78 (s, 1H, NHguan), 7.67-7.63 (m, 4H, CHAr), 7.46-7.40 (m, 6H, 
CHAr), 3.83 (dd, J = 3.5, 14.5 Hz, 1H, CH2OSi), 3.73 (dd, J = 12.5, 5.2 Hz, 1H, 
CH2OSi), 3.63-3.47 (m, 4H, CH2O, CHα), 3.36-3.21 (m, 4H, CH2γ), 2.13-1.86 (m, 5H, 
OH, CH2β), 1.07 (s, 9H, C(CH3)3). 13C-NMR (125 MHz, CDCl3) δ 151.2 (Cguan), 
135.5, 135.4, 132.6, 129.8, 128.9, 127.8 (CHAr, CAr), 65.3, 63.7 (CH2O), 50.6, 49.3 
(CHα), 45.6, 44.6 (CH2γ), 26.7 (C(CH3)3), 22.7 (CH2β), 19.1 (C(CH3)3). ESI-MS m/z 
474.5 [(M-PF6-)+. 
 
(2R,8R)-2-(tert-butyldiphenylsilanyloxymethyl)-8-methansulfonyloxymethyl-
3,4,6,7,8,9-hexahydro-2H-pyrimido[1,2-a]pyrimidin-1-ium hexafluorophosphate 
(30). 
 
29 30
N
N
N
H H
+
OH OTBDPS
PF6-
N
N
N
H H
+
OMs OTBDPS
PF6-
Ms2O, NMM, THF
(96%)
 
 
Procedure 
To a solution of 29 (1.54 g, 2.89 mmol) in THF (50 mL) was added N-
methylmorpholine (1.15 mL, 11.56 mmol) and methanesulfonic anhydride (1.14 g, 
7.23 mmol) and the mixture was stirred at room temperature for 40 min. The solvent 
was removed at reduced pressure and the crude product dissolved in CH2Cl2. The 
organic phase was washed with a 0.1M NH4PF6 solution. The solvent was removed 
and the crude product was purified by column chromatography on silica gel 
(CH2Cl2/MeOH, 98:2), to afford 30 (1.82 g, 96%) as a white solid. M.p. 60-62ºC. 
[α]25D -43.51 (c = 0.5, MeOH). 1H-NMR (500 MHz, CDCl3) δ 7.67-7.63 (m, 4H, 
CHAr), 7.46-7.40 (m, 6H, CHAr), 6.24 (s, 1H, NHguan), 6.08 (s, 1H, NHguan), 4.30 (m, 
1H, CH2OMs), 4.17 (m, 1H, CH2OMs), 3.80 (m, 1H, CHα), 3.66-3.63 (m, 2H, 
CH2OSi), 3.57 (m, 1H, CHα), 3.33 (m, 4H, CH2γ), 3.08 (s, 3H, CH3SO3), 2.05-1.89 (m, 
4H, CH2β), 1.06 (s, 9H, C(CH3)3). 13C-NMR (125 MHz, CDCl3) δ 150.6 (Cguan), 135.5, 
132.5, 130.0, 128.9 (CHAr, CAr), 69.5 (CH2OMs), 66.2 (CH2OSi), 50.1, 47.7 (CHα), 
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45.3, 44.9 (CH2γ), 37.1 (CH3SO3), 26.7 (C(CH3)3), 22.4, 21.9 (CH2β), 19.1 (C(CH3)3). 
ESI-MS m/z 516.2 [(M-PF6-)+. 
Compound 31. 
 
3130
N
N
N
H H
+
OMs OTBDPS
PF6-
N
N
N
OTBDPSHH
PF6-
HN
AA2
AA1
AA4
AA3
DIPEA, DMF
 
Procedure 
To a suspension of resin (150 mg) in DMF, was added a solution of 30 (23 mg, 0.03 
mmol) and DIPEA (3 drops) and the suspension was shaken during 2 days. Solvent 
was removed and the resin was subsquently washed with DMF and CH2Cl2. The 
ninhydrin test was negative (no free amine function NH2 left). 
 
(2R,8R)-2-(tert-butyldiphenylsilanyloxymethyl)-8-(2-aminobenzenethiolmethyl)-
3,4,6,7,8,9-hexahydro-2H-pyrimido[1,2-a]pyrimidin-1-ium hexafluorophosphate 
(32). 
30 32
N
N
N
H H
+
OMs OTBDPS
PF6-
N
N
N
H H
+
S OTBDPS
PF6-
NH2
2-aminothiophenol,
0.25M NaOMe
(70%)
 
Procedure 
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A solution of 30 (200 mg, 0.30 mmol) and 2-aminothiophenol (0.096 mL, 0.91 mmol) 
in NaOMe (3.60 mL, 0.25M) was stirred overnight under argon atmosphere. The 
solvent was removed and the crude dissolved in CH2Cl2, washed with a 0.1M NH4PF6 
solution, dried over Na2SO4 and concentrated in vacuo. The residue was purified by 
column chromatography on silica gel (CH2Cl2/ MeOH 96:4) to afford 32 as a pure 
maroon solid (145 mg, 70%). M.p. 165-167ºC. [α]25D -47.50 (c = 0.5, MeOH). 1H-
NMR (500 MHz, CDCl3) δ 7.65-7.60 (m, 4H, CHAr), 7.50-7.41 (m, 7H, CHAr), 7.13 (t, 
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J = 6.4 Hz, 1H, CHAr), 6.72 (m, 2H, CHAr), 6.67 (s, 1H, NHguan), 6.07 (s, 1H, NHguan), 
4.43 (s, 2H, NH2), 3.72 (m, 2H, CH2S), 3.57 (m, 1H, CHα), 3.35-3.26 (m, 5H, CH2γ, 
CHα), 2.95-2.79 (m, 2H, CH2O), 2.12-1.85 (m, 4H, CH2β), 1.00 (s, 9H, C(CH3)3). 13C-
NMR (125 MHz, CDCl3) δ 150.4 (Cguan), 148.5, 136.3, 135.6, 132.1, 130.6, 130.0, 
127.9, 119.5, 116.2, 115.9 (CHAr, CAr), 65.2 (CH2O), 49.9, 48.3 (CHα), 45.6, 45.0 
(CH2γ), 40.0 (CH2S), 26.8 (CH3), 25.4, 22.4 (CH2β), 19.4 (C(CH3)3). ESI-MS m/z 
545.3 [(M-PF6-)+. 
 
(2R,8R)-2-(tert-butyldiphenylsilanyloxymethyl)-8-[1-butyl-3-(2-
mercaptophenyl)ureamethyl]-3,4,6,7,8,9-hexahydro-2H-pyrimido[1,2-
a]pyrimidin-1-ium hexafluorophosphate (33). 
 
32 33
N
N
N
H H
+
S OTBDPS
PF6-
NH2
N
N
N
H H
+
S OTBDPS
PF6-
NH
NHO
butylisocyanate,
dry CH2Cl2
(75%)
 
Procedure 
To a solution of 32 (100 mg, 0.14 mmol) in dry CH2Cl2 (5 mL), butyl isocyanate (0.05 mL, 0.43 mmol) 
was added under argon atmosphere and the mixture was stirred overnight. The solvent was removed; the 
crude was then dissolved in CH2Cl2, washed with a 0.1 M NH4PF6 solution, dried (Na2SO4) and 
concentrated in vacuo. The residue was purified by column chromatography on silica gel (CH2Cl2/ MeOH 
98:2) to afford 33 as a pure white solid (86 mg, 75 %). M.p. 116-118ºC. [α]25D -60.12 (c = 1, CH3CN). 
1H-NMR (500 MHz, CD3CN) δ 7.65 (m, 4H, CHAr), 7.50 (m, 8H, CHAr), 7.24 (m, 4H, NHguan, CHAr), 
6.61 (s, 2H, NHurea), 5.85 (s, 2H, NHurea), 3.64 (m, 1H, CH2), 3.24-2.84 (m, 12H, CHα, CH2γ, CH2S, 
CH2O), 1.92-1.78 (m, 4H, CH2β), 1.58 (m, 4H, CH2), 1.39 (m, 4H, CH2), 1.06 (s, 9H, CH3), 0.89 (t, 3H, 
CH3). 13C-NMR (CD3CN, 125 MHz) δ 155.6 (Curea), 150.0 (Cguan), 135.6, 135.5, 129.9, 128.8, 127.9, 
122.1, 120.4 (CHAr, CAr), 65.9 (CH2O), 49.9, 47.9 (CHα), 45.4 (CH2S), 39.1 (CH2γ), 32.1 (CH2), 26.1 
(CH2β), 22.5 (CH2), 19.9 (CH3), 14.6 (CH3). ESI-MS m/z 545.3 [(M-PF6-)+. 
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(2R,8R)-2-hydroxymethyl-8-[1-butyl-3-(2-mercaptophenyl)ureamethyl]-
3,4,6,7,8,9-hexahydro-2H-pyrimido[1,2-a]pyrimidin-1-ium hexafluorophosphate 
(34). 
33 34
N
N
N
H H
+
S OTBDPS
PF6-
NH
NHO
N
N
N
H H
+
S OH
PF6-
NH
NHO
TBAF, dry THF
(86%)
 
 
Procedure 
A solution of 33 (250 mg, 0.32 mmol) and tetrabutylammonium fluoride (0.32 mL, 
1M in THF) was stirring in dry THF overnight under argon atmosphere. The solvent 
was removed; the crude was then dissolved in CH2Cl2, washed with a 0.1 M NH4PF6 
solution, dried (Na2SO4) and concentrated in vacuo. The residue was purified by 
column chromatography on silica gel (CH2Cl2/ MeOH 100 to 96:4) to afford 34 as a 
pure white solid (150 mg, 86%). M.p. 90-92ºC. [α]25D -50.21 (c = 1, CH3CN). 1H-
NMR (500 MHz, CD3CN) δ 7.63 (d, J = 7.5 Hz, 1H, CHAr), 7.43 (d, J = 7.3 Hz, 1H, 
CHAr), 7.32 (t, J = 7.5 Hz, 1H, CHAr), 7.28 (s, 1H, NHguan), 7.21 (m, 2H, NHguan, 
CHAr), 6.55 (s, 1H, NHurea), 3.44-3.15 (m, 11H, CH2, CHα, CH2γ, CH2S, CH2O), 2.81 
(dd, J = 6.9, 13.5 Hz, 1H, CH2O), 1.92-1.84 (m, 4H, CH2β), 1.56 (m, 4H, CH2), 1.41 
(m, 4H, CH2), 0.91 (t, J = 7.8 Hz, 3H, CH3). 13C-NMR (CD3CN, 125 MHz) δ 155.6 
(Curea), 150.0 (Cguan), 135.6, 135.5, 129.9, 128.8, 127.9, 122.1, 120.4 (CHAr, CAr), 65.9 
(CH2O), 49.9, 47.9 (CHα), 45.4 (CH2S), 41.0 (CH2) 39.1 (CH2γ), 32.1 (CH2), 26.1 
(CH2β), 22.5 (CH2), 14.5 (CH3). ESI-MS m/z 406.2 [(M-PF6-)+. 
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(2R,8R)-2-methanesulfonyloxymethyl-8-[1-butyl-3-(2-
mercaptophenyl)ureamethyl]-3,4,6,7,8,9-hexahydro-2H-pyrimido[1,2-
a]pyrimidin-1-ium hexafluorophosphate (35). 
 
34 35
N
N
N
H H
+
S OH
PF6-
NH
NHO
N
N
N
H H
+
S OMs
PF6-
NH
NHO
Ms2O, NMM , dry CH2Cl2
(90%)
 
 
Procedure 
To a solution of 34 (72 mg, 2.89 mmol) in dry CH2Cl2 (10 mL) was added N-
methylmorpholine (0.06 mL, 0.52 mmol) and methanesulfonic anhydride (51 mg, 0.37 
mmol) and the mixture was stirred at room temperature for 2 hours. The solvent was 
removed; the crude was then dissolved in CH2Cl2, washed with a 0.1 M NH4PF6 
solution, dried (Na2SO4) and concentrated in vacuo. The residue was purified by 
column chromatography on silica gel (CH2Cl2/ MeOH 100 to 98:2) to afford 35 as a 
pure white solid (74 mg, 90%). M.p. 87-89ºC. [α]25D -47.25 (c = 1, CH3CN). 1H-NMR 
(500 MHz, CD3CN) δ 7.63 (d, J = 7.5 Hz, 1H, CHAr), 7.43 (d, J = 7.3 Hz, 1H, CHAr), 
7.32 (t, J = 7.5 Hz, 1H, CHAr), 7.28 (s, 1H, NHguan), 7.21 (m, 2H, NHguan, CHAr), 6.55 
(s, 1H, NHurea), 5.57 (s, 1H, NHurea), 3.44-3.15 (m, 14H, CH2, CHα, CH2γ, CH2S, 
CH2O, CH3), 2.81 (dd, J = 6.8, 13.7 Hz, 1H, CH2O), 1.92-1.84 (m, 4H, CH2β), 1.56 
(m, 4H, CH2), 1.41 (m, 4H, CH2), (t, J = 7.8 Hz, 3H, CH3). 13C-NMR (CD3CN, 125 
MHz) δ 155.6 (Curea), 150.0 (Cguan), 135.6, 135.5, 129.9, 128.8, 127.9, 122.1, 120.4 
(CHarom, CAr), 65.9 (CH2O), 49.9, 47.9 (CHα), 45.4 (CH2S), 39.9, 39.1 (CH2γ), 37.1 
(CH3SO3), 32.1 (CH2), 26.1 (CH2β), 22.5 (CH2), 14.5 (CH3). ESI-MS m/z 484.2 [(M-
PF6-)+. 
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Compound 36. 
 
35 36
N
N
N
H H
+
S OMs
PF6-
NH
NHO
N
N
N
S NHHH
NH
AA2
AA1
O NH
AA4
AA3
PF6-
DIPEA, DMF
 
Procedure 
To a suspension of resin (150 mg) in DMF, was added a solution of 35 (20 mg, 0.03 
mmol) and DIPEA (3 drops) and the suspension was shaken during two days. Solvent 
was removed and the resin was subsquently washed with DMF and CH2Cl2. The 
ninhydrin test was negative (no free amine function NH2 left). 
 
(R)-2-(6-hydroxy-naphthalen-2-yl)-propionic acid (R)-38. 
 
OH
O
OMe
OH
O
OH 38
4M HCl
(85%)
 
Procedure 
A solution of (R)-Naproxen (1.0 g, 4.34 mmol) in a 4M HCl solution (5 ml) was 
stirred for 48 hours at reflux. The mixture was allowed to cool down to room 
temperature, filtered and the resulted solid was washed with very cold water to afford 
(R)-38 as a pure white solid (0.80 g, 85 %). M.p. 144-146ºC. [α]25D -53.2 (c = 1.5, 
acetone). 1H-NMR (500 MHz, [D6]-DMSO) δ 9.65 (s, 1H, OH), 7.73 (d, J = 8.7 Hz, 
1H, CHAr), 7.62 (m, 2H, CHAr), 7.32 (m, 1H, CHAr), 7.05 (m, 2H, CHAr), 3.75 (q, J = 
7.1 Hz, 1H, CH), 1.42 (d, J = 7.1Hz, 3H, CH3,). 13C-NMR (125 MHz, [D6]-DMSO) δ 
175.5 (CO), 155.1, 135.4, 133.5, 127.6, 126.2, 126.1, 125.5, 126.1, 118.8, 106.8 
(CHAr, CAr), 44.6 (CH), 18.4 (CH3). 
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(S)-2-(6-hydroxy-naphthalen-2-yl)-propionic acid (S)-38. 
Prepared from (S)-Naproxen (3.0 g, 13.03 mmol) in a 4M HCl solution (15 ml) in 
order to afford (S)-38 as a pure white solid (2.56 g, 91 %). [α]25D +54.7 (c = 1.5, 
acetone). 
 
(R)-2-(6-Hydroxy-naphthalen-2-yl)-propionic acid tert-butyl ester (R)-39. 
 
38
OH
O
OH
O
O
OH
39
(87%)
ter t-butanol, dry THF
 
Procedure 
The Naproxen derivative (R)-38 (0.78 g, 3.39 mmol) was dissolved in dry THF (35 
ml) under nitrogen atmosphere. The solution was cooled to 0 °C before trifluoroacetic 
anhydride (2.8 mL, 20.30 mmol) was added dropwise. The mixture was further stirred 
for 4 hours maintaining the temperature below 5 °C. tert-Butanol (8 ml) was added 
dropwise and the resulting mixture was then allowed to rise to room temperature and 
was vigorously stirred overnight. The reaction was cooled again to ice-bath 
temperature and NH4OH (35 % in water, 3 mL) was added dropwise. After completing 
addition, the mixture was allowed to warm up to room temperature again and was 
eventually stirred for further 30 minutes before the volatiles were evaporated under 
vacuum. The residue was triturated with boiling CH2Cl2 and the crystalline solid 
formed was removed by filtration. The filtrate was washed with an aqueous NaHCO3 
saturated solution, dried (MgSO4) and concentrated in vacuo. Purification by column 
chromatography on silica gel (Hexane / AcOEt 75:25) affords (R)-39 as a white solid 
(775 mg, 87%). M.p. 160-162ºC. [α]25D -25.8 (c = 1.0, CHCl3). 1H-NMR (500 MHz, 
CDCl3) δ 7.69 (d, J = 8.7 Hz, 1H, CHAr), 7.63 (m, 2H, CHAr), 7.39 (dd, J = 1.8, 8.5 
Hz, 1H, CHAr), 7.11-7.06 (m, 2 H, CHAr), 3.75 (q, J = 7.1 Hz, 3H, CH3), 1.53 (d, J = 
7.2 Hz, 1H, CH), 1.41 (s, 9H, CH3t-Bu). 13C-NMR (125 MHz, CDCl3) δ 175.2 (CO), 
155.6, 136.0, 133.5, 129.8, 126.7, 126.6, 126.0, 125.3, 118.0, 109.4 (CHAr, CAr), 46.6 
(CH), 28.1 (Ct-Bu), 18.4 (CH3). 
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(S)-2-(6-Hydroxy-naphthalen-2-yl)-propionic acid tert-butyl ester (S)-39. 
Prepared form (S)-38 (2.5 g, 10.85 mmol) in dry THF (110 mL), trifluoroacetic 
anhydride (9.1 mL, 65.14 mmol), tert-butanol (26 mL), NH4OH (35 % in water, 7.5 
mL) in order to afford (S)-39 as a white solid (2.46 g, 83%). [α]25D +27.2 (c = 1.0, 
CHCl3). 
 
(R)-2-(6-(3-bromopropoxy)naphthalen-2-yl)propionic acid tert-butyl ester (R)-43. 
 
O
O
OH
O
O
O
Br
1,3-dibrompropane,
K2CO3, dry CH3CN
(70%)
39 43
 
 
Procedure 
To a solution of (R)-39 (400 mg, 1.47 mmol) and K2CO3 (168 mg, 1.21 mmol) in dry 
CH3CN (10 ml) under nitrogen atmosphere was added 1,3-dibromopropane (0.66 mL, 
5.88 mmol) and the reaction mixture was stirred at 60ºC for 48 hours. After removing 
the solvent, the residue was dissolved in CH2Cl2, washed with water, dried (MgSO4) 
and concentrated in vacuo. Purification by column chromatography on silica gel 
(hexane/AcOEt 9:1) afforded (R)-43 as a pure colorless oil (400 mg, 70%). M.p. 158-
160ºC. [α]25D -31.5 (c = 1, CHCl3). 1H-NMR (500 MHz, CDCl3) δ 7.72 (m, 3H, 
CHAr), 7.44 (dd, J = 1.6, 8.4 Hz, 1H, CHAr), 7.17 (m, 2 H, CHAr), 4. 24 (t, J = 5.8 Hz, 
2H, CH2O), 3.76 (q, J = 7.2 Hz, 1H, CH), 3.66 (t, J = 6.4 Hz, 2H, CH2Br), 2.40 (q, J = 
6.1 Hz, 2H, CH2), 1.55 (d, J = 7.1 Hz, 3H, CH3), 1.41 (s, 9H, CH3t-Bu). 13C-NMR (125 
MHz, CDCl3) δ 174.0 (CO), 156.6 (CO), 136.7, 133.7, 129.5, 129.2, 127.2, 127.1, 
126.6, 125.9, 119.0, 106.8 (CHAr, CAr), 80.6 (C(CH3t-Bu)), 65.5 (CH2O), 46.6 (CH), 
32.5 (CH2Br), 30.1 (CH2), 28.1 (CH3t-Bu), 18.5 (CH3). 
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(S)-2-[6-(3-bromopropoxy)naphthalen-2-yl]propionic acid tert-butyl ester (S)-43. 
Prepared from (S)-39 (400 mg, 1.47 mmol), K2CO3 (168 mg, 1.21 mmol), dry CH3CN 
(10 ml), 1,3-dibromopropane (0.66 mL, 5.88 mmol) in order to afford (S)-43 as a pure 
colorless oil (400 mg, 70%). [α]25D +30.3 (c = 1, CHCl3). 
 
(R)-tert-Butyl-2-{6-[3-(5-(dimethylamino)naphthalene-1-sulfonamido)propoxy] 
naphthalen-2-yl}propanoate [(R)-45]. 
 
43 45
O
O
O
O
O
O
HN
S
O
O
N
Br
44, K2CO3,
dry CH3CN
(80%)
 
 
Procedure 
A solution of (R)-43 (35 mg, 0.09 mmol), 44 (33 mg, 0.14 mmol) and K2CO3 (18 mg, 
0.14 mmol) in dry CH3CN was stirred under nitrogen at 80ºC during 24 hours. After 
removing the solvent, the residue was dissolved in CH2Cl2, washed with water, dried 
(MgSO4) and concentrated in vacuo. Purification by column chromatography on silica 
gel (from hexane/AcOEt 95:5 to CH2Cl2 95:5) afforded (R)-45 as a pure yellow solid 
(40 mg, 80%). M.p. 192-194ºC. [α]25D -48.5 (c = 1, CHCl3). 1H-NMR (500 MHz, 
CDCl3) δ 8.50 (d, J = 8.5 Hz, 1H, CHAr), 8.29 (d, J = 8.6 Hz, 2H, CHAr), 7.66 (m, 3H, 
CHAr), 7.51 (m, 1H, CHAr), 7.43 (m, 2H, CHAr), 7.11 (d, J = 7.2 Hz, 1H, CHAr), 7.03 
(d, J = 7.2 Hz, 1H, CHAr), 6.93 (m, 1H, CHAr), 5.09 (t, J = 5.8Hz, 1H, NH), 4.15 (q, J 
= 6.1 Hz, 2H, CH2N), 3.98 (t, J = 5.8 Hz, 2H, CH2O), 3.75 (q, J = 7.2 Hz, 1H, CH), 
3.17 (q, J = 6.6 Hz, 2H, CH2), 2.85 (s, 6H, CH3), 1.55 (d, J = 7.1 Hz, 3H, CH3), 1.42 
(s, 9H, CH3t-Bu). 13C-NMR (125 MHz, CDCl3) δ 174.0 (CO), 156.6 (CO), 151.9, 
136.8, 130.5, 129.8, 129.3, 128.4, 127.0, 126.4, 125.7, 123.2, 118.7, 118.5, 115.2, 
106.5 (CHAr, CAr), 65.7 (CH2O), 46.6 (CH), 45.4 (Ct-Bu), 41.2 (CH2N), 28.9 (CH2), 
28.0 (CH3t-Bu), 18.6 (CH3). 
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(S)-tert-Butyl-2-{6-[3-(5-(dimethylamino)naphthalene-1-sulfonamido)propoxy] 
naphthalen-2-yl}propanoate [(S)-45]. 
Prepared from (S)-43 (110 mg, 0.28 mmol), 44 (105 mg, 0.42 mmol) and K2CO3 (58 
mg, 0.42 mmol) in order to afford (S)-45 as a pure yellow solid (140 mg, 89%). [α]25D 
+50.0 (c = 1, CHCl3). 
 
(R)-2-{6-[3-(5-(dimethylamino)naphthalene-1-sulfonamido)propoxy]naphthalen-
2-yl}propanoic acid [(R)-46]. 
 
O
O
O
HN
S
O
O
N
OH
O
O
HN
S
O
O
N
45 46
TFA, Et3SiH
(90%)
 
 
Procedure 
A solution of (R)-45 (32 mg, 0.06 mmol), TFA (0.5 mL) and Et3SiH (0.2 mL) in 
CH2Cl2 was stirred during 24 hours. After removing the solvent, the residue was 
dissolved in CH2Cl2, washed with water, dried (MgSO4) and concentrated in vacuo. 
Purification by column chromatography on silica gel (hexane/AcOEt 1:9) afforded 
(R)-46 as a pure yellow solid (26 mg, 90%). M.p. 187-189ºC. [α]25D -41.3 (c = 1, 
CHCl3). 1H-NMR (500 MHz, CDCl3) δ 8.48 (d, J = 8.5 Hz, 1H, CHAr), 8.29 (m, 2H, 
CHAr), 7.68 (m, 3H, CHAr), 7.43 (m, 3H, CHAr), 7.07 (d, J = 7.2 Hz, 1H, CHAr), 7.01 
(d, J = 7.1 Hz, 1H, CHAr), 6.89 (m, 1H, CHAr), 5.26 (s, 1H, NH), 3.98 (t, J = 5.8 Hz, 
2H, CH2O), 3.94 (m, 3H, CH, CH2O), 3.18 (q, J = 6.1 Hz, 2H, CH2), 2.82 (s, 6H, 
CH3), 1.94 (m, 2H, CH2), 1.62 (d, J = 7.1 Hz, 3H, CH3). 13C-NMR (125 MHz, CDCl3) 
δ 180.0 (CO), 156.5 (CO), 152.0, 135.1, 133.8, 130.5, 129.8, 129.7, 129.3, 128.9, 
128.4, 127.4, 126.2, 126.1, 123.2, 118.9, 118.5, 115.2, 106.5 (CHAr, CAr), 65.5 
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(CH2O), 45.5 (CH), 45.4 (Ct-Bu), 41.0 (CH2N), 28.9 (CH2), 18.2 (CH3). ESI-MS m/z 
506.1 (M-PF6-)+. 
 
(S)-2-{6-[3-(5-(dimethylamino)naphthalene-1-sulfonamido)propoxy]naphthalen-
2-yl}propanoic acid [(S)-46]. 
Prepared from (S)-45 (180 mg, 0.32 mmol), TFA (3.0 mL) and Et3SiH (1.2 mL) in 
CH2Cl2 (10 mL) to afford (S)-46 as a pure yellow solid (150 mg, 92%). [α]25D +43.4 (c 
= 1, CHCl3). 
 
5-dimethylamino-N-(5-hydroxypentyl)naphthalene-1-sulfonamide (40). 
 
N
S OO
Cl
N
S OO
HN OH5-aminopentanol,
NEt3, dry THF
(100%)
40  
Procedure 
A mixture of dansyl chloride (520 mg, 1.89 mmol), triethylamine (790 µl, 5.66 mmol) 
and 5-aminopentanol (195 mg, 2.00 mmol) was stirred in dry THF (40 ml) at room 
temperature during two days. The solvent was removed and the crude dissolved in 
CH2Cl2, washed twice with water and once with brine, dried on MgSO4 and 
concentrated in vacuo. The residue was purified by column chromatography on silica 
gel (AcOEt / Hexane 8:2) to afford 40 as a pure yellow solid (530 mg, 100%). M.p. 
75-77ºC. 1H-NMR (500 MHz, CDCl3) δ 8.52 (d, J = 8.5 Hz, 1H, CHAr), 8.33 (d, J = 
8.6 Hz, 1H, CHAr), 8.22 (d, J = 7.3 Hz, 1H, CHAr), 7.53 (m, 2H, CHAr), 7.16 (d, J = 7.2 
Hz, 1H, CHAr), 5.44 (t, J = 6.1 Hz, 1H, NH), 3.46 (t, J = 6.4 Hz, 2H, CH2O), 2.89 (m, 
8H, CH2N, CH3), 1.37 (m, 4H, CH2), 1.26 (m, 2H, CH2). 13C-NMR (125 MHz, 
CDCl3) δ 151.9, 134.9, 130.3, 129.9, 129.6, 129.5, 128.3, 123.3, 118.9, 115.2 (CHAr, 
CAr), 62.4 (CH2O), 45.4 (CH3), 43.0 (CH2), 31.8 (CH2), 29.1 (CH2), 22.6 (CH2). 
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5-[5-(dimethylamino)naphthalene-1-sulfonamido]pentyl methanesulfonate (41). 
 
40
N
S OO
HN OH
N
S OO
HN OMs
Ms2O, NMM, THF
(88%)
41  
Procedure 
To a solution of 40 (1.08 g, 3.35 mmol) and NMM (1.5 ml, 13.4 mmol) in dry THF 
(15 ml) was added a solution of Ms2O (1.20 g, 6.70 mmol) in dry THF (5 ml) under 
nitrogen atmosphere at room temperature. The mixture was stirred overnight and the 
solvent was removed. The crude was dissolved in CH2Cl2 and washed twice with 
water and brine, dried over MgSO4 and then concentrated in vacuo. The crude product 
was then purified by column chromatography on silica gel (AcOEt / Hexane 7:3) to 
afford 41 as a pure yellow solid (611 mg, 88%). M.p. 72-74ºC. 1H-NMR (500 MHz, 
CDCl3) δ 8.56 (d, J = 8.5 Hz, 1H, CHAr), 8.33 (d, J = 8.6 Hz, 1H, CHAr), 8.22 (d, J = 
7.3 Hz, 1H, CHAr), 7.53 (m, 2H, CHAr), 7.16 (d, J = 7.2 Hz, 1H, CHAr), 5.44 (t, J = 6.1 
Hz, 1H, NH), 4.05 (t, J = 6.4 Hz, 2H, CH2O), 2.98 (s, 3H, CH3), 2.89 (m, 8H, CH2N, 
CH3), 1.55 (m, 2H, CH2), 1.43 (m, 2H, CH2), 1.31 (m, 2H, CH2). 13C-NMR (125 
MHz, CDCl3) δ 152.4 (CN), 134.9, 130.5, 129.9, 129.8, 129.6, 128.4, 123.2, 118.7, 
115.3 (CHAr, CAr), 69.7 (CH2N), 45.5 (CH3N), 42.9 (CH2O), 37.3 (CH3S), 28.9 (CH2), 
28.4 (CH2), 22.3 (CH2). 
 
N-5-bromopentyl-5-(dimethylamino)naphthalene-1-sulfonamide (42). 
 
40 42
N
S OO
HN OH
N
S OO
HN Br
Ph3P, CBr4, dry CH2Cl2
(70%)
 
Procedure 
A solution of 40 (50 mg, 0.15 mmol), Ph3P (117 mg, 0.44 mmol) and CBr4 (146 mg, 
0.45 mmol) in dry CH2Cl2 (5 ml) was stirred overnight under nitrogen atmosphere at 
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room temperature. The solvent was removed and the residue was dissolved in CH2Cl2 
and washed with brine, dried (Na2SO4) and then concentrated in vacuo. Purification by 
column chromatography on silica gel (AcOEt / Hexane 7:3) affords 42 as a pure 
yellow solid (40 mg, 70%). M.p. 80-82ºC. 1H-NMR (500 MHz, CDCl3) δ 8.60 (d, J = 
8.4 Hz, 1H, CHAr), 8.32 (d, J = 8.4 Hz, 1H, CHAr), 8.28 (d, J = 8.3 Hz, 1H, CHAr), 7.58 
(m, 2H, CHAr), 7.16 (d, J = 7.2 Hz, 1H, CHAr), 4.82 (t, J = 5.9 Hz, 1H, NH), 3.35 (t, J 
= 6.4 Hz, 1H, CH2Br), 3.25 (t, J = 6.3 Hz, 1H, CH2Br), 2.89 (m, 8H, CH2N, CH3), 
1.85-1.50 (m, 6H, CH2). 13C-NMR (125 MHz, CDCl3) δ 152.1 (CN), 134.8, 130.5, 
129.9, 129.8, 129.6, 128.5, 123.2, 118.7, 115.2 (CHAr, CAr), 45.5 (CH3N), 43.0 (CH2) 
31.8 (CH2), 28.8 (CH2), 24.9 (CH2), 23.7 (CH2). 
 
5-(dimethylamino)naphthalene-1-sulfonamide (44). 
 
N
S OO
Cl
N
S OO
NH2
NH3 (30%), MeOH
(50%)
44  
 
Procedure 
Dansyl chloride was stirred in NH3 (30%, 30 mL)/MeOH (10 mL) during 8 hours. The 
solvent was removed and the residue was purified by column chromatography on 
silica gel (Hexane/ AcOEt 1:1) to afford 44 as a pure white solid (230 mg, 50%). M.p. 
60-62ºC. 1H-NMR (500 MHz, CD3CN) δ 8.57 (d, J = 8.7 Hz, 1H, CHAr), 8.31 (d, J = 
8.5 Hz, 1H, CHAr), 8.22 (d, J = 8.7 Hz, 1H, CHAr), 7.62 (q, J = 8.1 Hz, 2H, CHAr), 7.31 
(d, J = 8.2 Hz, 1H, CHAr), 5.83 (s, 2H, NH2), 2.91 (s, 6H, CH3). 13C-NMR (125 MHz, 
CD3CN) δ 152.1, 134.8, 130.5, 129.9, 129.8, 129.6, 128.5, 123.2, 118.7, 115.2 (CHAr, 
CAr), 45.5 (CH3). 
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3.5.3 Library synthesis and Screening Experiments 
 
Chloranil Test.73
 
 To a small sample were added two drops of 2% acetaldehyde/DMF and two 
drops of 2% p-chloranil/DMF. The sample was allowed to stand for 5 minutes. Blue 
stained beads indicate the presence of secondary amines on the resin (“positive” 
result). 
 
Resin Synthesis  
 
The Tentagel NH2 resin (1.0902, loading 0.51 mmol) was swelled in CH2Cl2. It 
was then washed several times with DMF. Met(Fmoc)OH (0.381 mg, 1.02 mmol), 
DIC (240 µL, 1.53 mmol) and HOBT (208 mg, 1.53 mmol) were dissolved in DMF 
(2ml) and added to the resin. A solution of DIPEA (262 µL, 1.53 mmol) in DMF was 
added. The funnel was degazed and DMF was added about for ¾ of the tube. The 
solution was stirred during two hours. The solvent was removed by filtration. DMF 
was added and filtered. The resin was washed with CH2Cl2 (three times), DMF (once). 
A qualitative ninhydrin test was negative. The Fmoc group was removed using 
treatment by 20% piperidine in DMF during 20 min and the resin washed with DMF 
and CH2Cl2. A qualitative ninhydrin test was positive. 
 
A solution of FmocArg(Pbf)OH (0.663 mg, 1.02 mmol), DIC (240 µL, 1.53 
mmol) and HOBT (208 mg, 1.53 mmol) in DMF (2 mL) was added to the resin, 
followed by DIPEA (262 µL, 1.53 mmol) and the suspension was shaken overnight. 
Solvent was removed and the resin was subsquently washed with DMF, CH2Cl2, DMF 
and CH2Cl2. The ninhydrin test was negative. Fmoc deprotection was achieved by 
20% piperidine-DMF solution. A qualitative ninhydrin test was positive. 
 
 
 
 
 
73 Vojkovsky, T. Pept. Res., 1995, 8, 236-237. 
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Synthesis of FmocAhx.74
 
OH
O
FmocHNOH
O
H2N
 
 
 
Ahx (1.167 g, 8.9 mmol) was dissolved in a H2O/dioxane mixture (16:14 mL) and 
Na2CO3 (1.890 g, 17.8 mmol) was added. The mixture was cooled to 0°C. A solution 
of FmocCl (2.300 g, 8.9 mmol) in dioxane (14 mL) was added dropwise. The mixture 
was stirred for one hour at 0°C and then at room temperature for 16 hours. The 
reaction mixture was diluted with water (about 100 mL) and washed with Et2O. The 
aqueous phase was acidified with concentrated HCl and extracted with AcOEt. The 
organic phase was then dried (MgSO4) and evaporated to give the expected product as 
a white solid (2.95 g, 94%). 
 
The resin was first washed with a 1:1 DIPEA-DMF solution three times. A 
solution of FmocAhx (0.360 mg, 1.02 mmol), DIC (240 µL, 1.53 mmol) and HOBT 
(208 mg, 1.53 mmol) in DMF (2 mL) was added to the resin, followed by DIPEA (262 
µL, 1.53 mmol) and the suspension was shaken all night. Solvent was removed and 
the resin was subsquently washed with DMF, CH2Cl2, DMF and CH2Cl2. The 
ninhydrin test was negative Fmoc deprotection was achieved by 20% piperidine-DMF 
solution. A qualitative ninhydrin test was positive. This coupling was realized twice. 
 
Determination of the exact loading of the resin. 
 
To a known quantity (3-5 mg) of  resin was added ninhydrin A solution (3 
drops) and ninhydrin B solution (1 drop). A control was also prepared simply using 
the stains without the resin present. The three tests tubes (resin in double) were then 
heated in the hot block at 100°C for 5 minutes. Approx 2 ml of 60% EtOH aqueous 
solution was added to each test glass and then the solution was transferred to a 25 mL 
volumetric flask by pipetting through a glass wool plug-in pipette. The volume was 
then made up to 25 mL with 60% EtOH aqueous solution. 
                                                 
74 Narasimhan, C.; Lai, C.-S.; Joseph, J. Bioorg. Chem. 1996, 24, 50-58. 
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UV absorbance is measured at 570 nm. Use the control as a blank, i.e. the 
background with it, then measure the absorbance of the resin sample. 
Substitution (mmol/g) = (A570. V.103) / E.m 
Where m: mass (mg) 
           V: volume (mL) 
           E = 1.5.104 (M/cm) 
 
Done four times: Substitution: 0.215 mmol/g: theoretical: 0.210 mmol/g  
 
“Split and Mix” synthesis. 
 
The peptide library was then prepared, using four cycles of “split and mix 
method”. The resulting resin was divided in eight equal portions. To each resin portion 
one of the following Fmoc amino acids was added: L-Asp (OtBu), L-Gln, L-Tyr(tBu), 
L-Trp(BOC), L-Thr(tBu), L-Val, L-Gly, L-Pro (0.72 mmol amino acid per resin 
portion), along with HOBt (16 mg, 1.1 mmol), EDCI (18 µL, 1.1 mmol), followed by 
DIPEA addition (2 drops) in DMF. The reaction mixture was shaken for 2 hours. 
Qualitative ninhydrin test was carried out to check that all the couplings were 
complete. The terminal Fmoc-groups were removed with 20% piperidine in DMF 
during 20 minutes. 
Ninhydrin test was different for Pro (secondary amine): to a sample of resin 
were added 2 drops of 2% acetaldehyde in DMF and 2 drops of 2% p-chloranil/DMF. 
The sample was allowed to stand for 5 mn. Blue stained beads indicate the presence of 
the secondary amines of the resin (positive deprotection). 
 
Capping agent coupling. 
 
In order to know the amino acid sequence of a selected bead, a capping agent is 
coupled in 15% on the resin periphery. It is introduced by a classical coupling 
reaction. As the loading is proportional to the amount of resin (about 0.170 g of resin 
and 0.215 mmol/g), a stock solution of bomophenylacetic acid is prepared and added 
to the resin.  
To be sure that the distribution will be in all the beads, the solution was stirred 
during 1 hour with the capping agent and then coupling reagents (HOBT, EDCI and 
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DIPEA) were added. The reagents were not weighted: they were added with a spatula 
and a pipette. 
Stock solution : 0.05 mol/L of bromophenylacetic acid in DMF 
 
For example:  
Tube 1. 168.0 mg resin: 36.1 x 10-2 mmol: 15%: 5.42 x 10-3 mmol : 0.108 mL  
Tube 2. 164.5 mg resin: 35.4 x 10-2 mmol: 15%: 5.30 x 10-3 mmol : 0.106 mL 
Tube 3. 174.5 mg resin: 37.5 x 10-2 mmol: 15%: 5.63 x 10-3 mmol : 0.113 mL  
Tube 4. 166.3 mg resin: 35.7 x 10-2 mmol: 15%: 5.36 x 10-3 mmol : 0.107 mL 
Tube 5. 175.4 mg resin: 37.7 x 10-2 mmol: 15%: 5.66 x 10-3 mmol : 0.113 mL 
Tube 6. 167.0 mg resin: 35.9 x 10-2 mmol: 15%: 5.40 x 10-3 mmol : 0.108 mL 
Tube 7. 166.2 mg resin: 35.7 x 10-2 mmol: 15%: 5.35 x 10-3 mmol : 0.107 mL 
Tube 8. 167.0 mg resin: 35.9 x 10-2 mmol: 15%: 5.38 x 10-3 mmol : 0.108 mL  
 
Reactions were shaken for two days. The solvent was removed. The mixtures 
were individually washed with DMF- CH2Cl2 sequences washes. The different resins 
were mixed together and dried during one hour under vacuum. Resins were split again 
into eight equal portions and the procedure repeated three times to build up the 
receptor library. 
 
 
                   Second sequence                     Third sequence                  Fourth sequence 
               AA (mg)   CA (µl)          AA (mg)     CA (µl)       AA (mg)    CA(µl) 
 
Tube 1. Asp:         42             119                   38               108             42              104 
Tube 2. Gln:          34            117                    41               106             46              104 
Tube 3. Tyr:          44            119                    35               106             50              101 
Tube 4. Trp:          58            119                    39               105             39              104 
Tube 5. Thr:          42            119                    33               106             40              104 
Tube 6. Val:          36            115                    31               105             41              104 
Tube 7. Gly:          34            119                    43               110             57              106 
Tube 8. Pro:          34            119                     37              108             46              105 
CA: capping agent 
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Screening Experiments 
 
 A sample of library 31 (25.0 mg) was equilibrated in CH3CN (300 µL) for 24 h. 
A solution of guest (S)-46 (20 µM, 500 µL) in CH3CN was added to the library sample 
to give a 12.5 µM concentration in guest. Equilibration was continued for 24 h. Beads 
were analyzed in flat-bottomed glass pots under a Leica inverted DML microscope 
and fifty highly fluorescent beads were selected with tweezers and washed several 
times to remove the Naproxen derivative (S)-46. The same procedure was then carried 
out with (R)-46, but now the ones that did not form a complex with the R enantiomer 
were isolated. 
 In addition, screening experiments were achieved for library 36 as well as for 
the free tetrapeptide library 48 with both (R)-46 and (S)-46. 
 As control experiments, a sample of the library 31 was equilibrated in CH3CN 
for 24 h and a solution of Dansyl chloride was added to the equilibrated solution. The 
concentrations and conditions were the same as described above for the screening 
experiments. After 48 h (to allow for equilibration time) no selective staining was 
observed. 
 
Deprotection and cleavage of material from the single resin beads 
 
 A single resin bead to be analyzed was placed in a glass insert using tweezers. 
For Pbf deprotection: the bead was treated with 50 µL of 50% TFA/CH2Cl2 for 1 hour. 
The solvent was then removed under vacuum. 
Cleavage was performed by treatment of the bead with 20 µL of a solution of CNBr in 
1:1 TFA/H2O (concentration 50-80mg/mL) and incubation in the dark for 18 hours, 
sealed. The cleavage solution was evaporated from the sample tubes in vacuo. 20 µL 
of CH3CN was then added to the tube. The samples were sonicated for 5 minutes. 1 
µL of each sample was spotted onto MALDI-platen. 1 µL of a solution of matrix was 
then applied on top and the sample mixed on the platen surface. The spot was allowed 
to dry under a stream of air before analysis.  
The α-cyanahydroxycinnamic acid matrix was prepared as a saturated solution in 
acetone for application as above. 
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Summary 
 
This thesis reports the synthesis and design of guanidinium-based receptors as 
multiple hydrogen bond hosts for molecular recognition of anions with a special 
emphasis on small anions such as nitrate and the anti-inflammatory drug Naproxen. 
 
The first chapter reviews the guanidinium-based artificial receptors for 
molecular recognition of oxoanions such as carboxylates as well as biologically 
relevant phosphates and sulfates in order to introduce the objectives of this work. 
Chiral recognition is also reported as catching a large interest in supramolecular 
chemistry focusing on the enantiorecognition of amino acids. 
 
Despite its significant involvement in environmental pollution, little attention 
has been given to nitrate by supramolecular chemists. Chapter two reports the design 
of several macrocycles combining a guanidinium and two urea moieties for an optimal 
complement of size, charge and binding sites to nitrate. Synthesis of hosts of different 
sizes, rigidity and stereochemistry as well as quantification of their binding affinity 
towards small anions is reported. Although association constants evaluated for nitrate 
with one of the receptors described herein is one the highests reported so far for this 
anion, spherical chloride is the most suitable guest for stabilization of the complex. 
Both results in solution and in solid state are in good agreement to show encapsulation 
of nitrate, chloride and acetate guest inside the host cavities. 
 
Chapter tree presents two different approaches for Naproxen enantiorecognition, 
such as a rational design and a combinatorial chemistry approach. Naproxen is the 
only Non-Steroidal Anti-Inflammatory drug (NSAID) marketed as a pure enantiomer. 
The industrial preparation of the drug involves the synthesis of the racemic acid 
followed by a resolution process to afford the desired compound (resolution accounts 
for two thirds of the production costs). Here, we propose as an alternative the use of a 
physical separation method (liquid-liquid extraction) employing a chiral receptor. 
Various guanidinium receptors have been synthesized based on concepts of 
steric hindrance, tweezers and pre-organization. None to small enantioselectivity was 
observed by this approach. 
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A tetrapeptide library was synthesized by solid phase synthesis and attached to 
two guanidinium receptors. On the other hand, a fluorescent derivative of Naproxen 
was prepared for the screening of the libraries highlighting the selectivity of the 
receptors by enhancement of fluorescence of several beads. Identification of receptors 
was then achieved by mass spectrometry analysis but could not afford a reliable 
consensus of optimal amino acid sequence. 
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Introducción general y resultados 
 
Más allá de la química de los enlaces covalentes, que unen los átomos para 
formar moléculas, la química supramolecular1 es la química de las interacciones 
débiles: una disciplina que agrupa el concepto de reconocimiento de las moléculas 
entre sí mismas hacia una mayor estabilidad. En esta memoria se trata una parte 
específica de dicho campo: el reconocimiento de aniones cuyo desarrollo, en 
comparación al de los cationes, está mucho menos avanzado. Los receptores descritos 
en este trabajo llevan una unidad de guanidinio como esqueleto principal. De hecho, la 
naturaleza utiliza frecuentemente grupos guanidinio, como por ejemplo en la cadena 
lateral del aminoácido arginina, que permite establecer pares iónicos fuertes con 
grupos carboxilatos o fosfatos de sistemas biológicos. 
 
En el primer Capítulo se revisa la importancia de la interacción guanidinio-
oxoaniones a través de la bibliografía, con ejemplos característicos de reconocimiento 
de carboxilatos así como de fosfatos y sulfatos.2 Se pone especial énfasis en el 
reconocimiento quiral de moléculas de relevancia biológica, como los aminoácidos. 
Tras la introducción, los objetivos de la tesis se presentan de forma resumida: el 
reconocimiento del anión nitrato y el reconocimiento quiral del fármaco Naproxeno. 
 
Uno de los problemas más importantes del nitrato es su presencia en el agua 
procedente de la filtración de pesticidas utilizados por los agricultores. Una vez 
ingerido, el nitrato es reducido por el organismo a nitrito, y éste es responsable de 
diversas enfermedades infantiles. Las técnicas utilizadas para eliminar los nitratos del 
agua son esencialmente el intercambio de aniones, la osmosis inversa y la 
electrodiálisis. Una alternativa sería el uso de un receptor capaz de extraer el anión de 
una fase acuosa a otra mediante extracciones en paralelo o transporte a través de 
membranas liquidas. Este concepto ha sido ya descrito por nuestro grupo de 
investigación en relación con los aminoácidos.3
1 Lehn, J.-M. Science 1985, 227, 849-851. 
2 Blondeau, P.; Segura, M.; Pérez-Fernández, R.; de Mendoza, J. Chem. Soc. Rev. 2007, 36, 
198-210. 
3 Breccia, P.; Van Gool, M.; Pérez-Fernández, R.; Martin-Santamaria, S.; Gago, F.; Prados, P.; 
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A continuación, en el Capítulo 2, se describe el diseño de macrociclos con una 
subunidad de guanidinio y dos de urea para complementar el nitrato de forma ideal en 
cuanto a tamaño, carga y centros de unión. Se describe la síntesis de macrociclos de 
diferente tamaño, rigidez y estereoquímica para alcanzar la mejor estabilización del 
complejo con el anión. Por calorimetría isotérmica, las constantes de asociación han 
sido medidas, extrayéndose conclusiones sobre la selectividad de cada compuesto. Se 
ha conseguido así una de las asociaciones con el nitrato más altas descritas hasta 
ahora.4 Sin embargo, los compuestos presentan mejores constantes de complejación 
con el esférico anión cloruro. Estructuras resueltas por difracción de rayos X muestran 
el tipo de interacciones presentes entre el receptor y el anión. Tanto los resultados en 
disolución como los obtenidos en estado sólido ponen en evidencia la inclusión de 
nitrato, acetato y cloruro en el interior de la cavidad del macrociclo. 
 
Cada año, el porcentaje de fármacos enantioméricamente puros que salen al 
mercado aumenta, hasta superar un 30% en el año 2000. El Naproxeno es el único 
fármaco anti-inflamatorio no esteroídico vendido como un único enantiómero. La 
forma (S) es de hecho 28 veces más efectiva que la (R). Tras la síntesis de la mezcla 
racémica se lleva a cabo la resolución del acido para obtener el enantiómero deseado 
(más de 66% de los costes de la producción provienen de esta última etapa de 
resolución). Así pues, nos proponemos emplear métodos de separación física (como 
extracción líquido-líquido) mediante un receptor quiral para reconocer un enantiómero 
del Naproxeno. Ninguna molécula ha sido descrita con la capacidad de extraer 
enantioselectivamente este fármaco hasta ahora. El Capítulo 3 muestra dos estrategias 
complementarias utilizadas para alcanzar dicho objetivo: el diseño de novo y la 
química combinatoria. 
Además de incorporar una unidad de guanidinio y dos de urea, los receptores 
requieren de otras interacciones, además de centros de quiralidad adicionales, para 
alcanzar la selectividad entre ambos enantiómeros. Unos grupos voluminosos o 
superficies aromáticas se incorporan en primer lugar sobre receptores abiertos, sin que 
se produzca ninguna discriminación. Receptores con más pre-organizados han sido 
 
de Mendoza, J. J. Am. Chem. Soc. 2003, 125, 8270-8284. 
4 Blondeau, P.; Benet-Buchholz, J.; de Mendoza, J. New J. Chem. 2007, in press, DOI: 
10.1039/b616409a. 
 177
sintetizados a continuación, mediante la introducción de un derivado del aminoácido 
lisina o del ligando de catálisis NOBIN, con poca selectividad en este último caso. 
El secundo método implica el uso de química combinatoria como medio para 
sintetizar un gran conjunto de receptores para luego identificar el más selectivo. Una 
librería de tetrapéptidos ha sido sintetizada en fase sólida y luego incorporada a la 
unidad de guanidinio. Al Naproxeno se le ha incorporado un grupo fluorescente para 
realizar los experimentos de selectividad. Las partículas poliméricas se tornan 
fluorescentes cuando la interacción con el Naproxeno es fuerte y se pueden identificar 
por espectrometría de masas. Las secuencias identificadas no presentan suficiente 
consenso como para llevar a una conclusión definida respeto a una secuencia optima 
de aminoácidos. 
